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ABSTRACT 	 A	Severe	Combined	Immunodeficient	(SCID)	Yorkshire	pig	line	has	been	identified	at	Iowa	State	University.	Since	SCID	animals	lack	an	adaptive	immune	system	they	are	instrumental	models	for	biomedical	and	immunological	research.	An	important	goal	for	this	thesis	and	for	development	of	the	ISU	SCID	pig	is	to	characterize	its	natural	immune	parameters,	and	use	the	SCID	pig	as	a	biomedical	model	for	exploring	research	questions.		To	establish	a	SCID	colony	that	can	reliably	and	efficiently	produce	SCID	animals,	bone	marrow	transplantations	were	performed	to	create	immune-competent,	genetically	SCID,	breeding	animals.	Interestingly,	three	of	these	BMT	pigs	were	diagnosed	with	cancer;	two	with	lymphoma,	one	with	additional	leukemia,	and	a	nephroblastoma.	This	suggests	the	SCID	pig	may	be	interesting	as	a	cancer	model.	Another	major	component	in	developing	the	SCID	colony	was	the	creation	of	the	“bubble”	facilities	and	associated	protocols.	Two	bubbles	were	designed	to	limit	the	exposure	of	SCID	piglets	to	opportunistic	pathogens.	This	facilitates	the	production	of	specific	pathogen	free	(SPF)	SCID	piglets	and	non-SCID	littermates	for	further	characterization	and	model	development	for	use	in	immunological	and	biomedical	research.		The	SCID	pig	lacks	T	and	B	lymphocytes	but	has	Natural	Killer	(NK)	cells	present.	The	functionality	of	NK	cells	has	important	implications	for	engraftment	success	for	SCID	patients	and	the	extent	of	immunity	present	in	the	animal.	It	was	important	to	determine	the	functionality	of	the	SCID	porcine	NK	cell.	We	found	SCID	NK	cells	could	be	activated	to	lyse	tumor	target	cells	(cytotoxicity)	in	vitro	when	activated	with	stimulating	cytokines,	and	are	capable	of	producing	IFN-g	and	intracellular	perforin.	We	concluded	that	intrinsically,	SCID	NK	cells	are	functional	in	vitro.	
 xii 
 
Research	has	established	murine	NK	cells	can	exhibit	memory-like	behavior.	Methods	illustrating	specific,	long-lived	memory	responses	include	hapten-induced	contact	hypersensitivity	(CHS).	To	establish	CHS	responses	exist	in	swine,	commercial	pigs	were	sensitized	on	the	back	and	re-challenged	by	ear	injection	with	hapten	and	control	combinations.	CHS	responses,	measured	as	hapten	specific	ear	swelling,	showed	hapten	specific	memory	exists	in	the	swine	model,	and	consistent	with	the	mouse	literature,	was	associated	with	increased	activation	of	hepatic	NK	cells.
  
1 
CHAPTER 1. GENERAL INTRODUCTION 
Introduction	
SCID	is	primarily	defined	by	lymphopenia	(absence	of	T	cells	and	depending	on	the	defect,	B	cells	and/or	NK	cells)(Cossu	2010).	Although	naturally	occurring	in	humans,	mice,	horses,	dogs,	and	pigs	(Cossu	2010;	Perryman	et	al.	2014;	Cino	Ozuna	et	al.	2012).	The	porcine	SCID	phenotype	was	initially	identified	in	Iowa	State	University’s	residual	feed	intake	inbred	lines	of	Yorkshire	pigs	after	an	unexpected	reaction	to	a	Porcine	Reproduction	and	Respiratory	Syndrome	Virus	(PRRSV)	challenge	study	in	collaboration	with	Kansas	State	University	(KSU)	(Cino	Ozuna	et	al.	2012).	A	Genome-Wide	Association	Analysis	identified	a	5.6	Mb	region	on	sus	scrofa	chromosome	10	that	contained	the	Artemis	(DCLRE1C)	gene.	Further	genetic	analyses	of	this	region	revealed	two	independent	mutations	that	cause	the	SCID	phenotype	in	homozygous	or	compound	heterozygous	states	(Waide	et	al.	2015).			To	utilize	the	ISU	SCID	pig	as	a	large	animal	biomedical	model	it	is	important	to	both	develop	a	breeding	colony	of	animals	and	a	facility	adequate	to	produce	and	maintain	the	health	of	this	immune-compromised	large	animal	model.	The	SCID	mutation	is	inherited	in	a	Mendelian	recessive	manner,	as	matings	between	normal	phenotype	carriers	produce	litters	of	25%	SCID	piglets	(Waide	et	al.	2015).	To	first	create	breeding	animals,	nine	SCID	animals	received	opposite	sex,	full	MHC	matched,	bone	marrow	transplants.	Successful	engraftment	would	generate	genetically	SCID,	phenotypically	normal	pigs,	who	would	be	bred	to	carriers	to	produce	litters	composed	of	50%	SCID	piglets.	Although	four	animals	successfully	engrafted,	three	had	to	be	euthanized	due	to	failing	health	at	approximately	one	year	of	age.	Interestingly,	all	three	were	diagnosed	with	cancer;	two	T	cell	lymphomas,	
  
2 
one	with	an	additional	leukemia,	and	the	third	with	a	nephroblastoma.	The	T	cell	lymphomas	were	of	particular	interest	as	the	literature	describes	hypomorphic	human	Artemis	SCID	patients	(‘leaky’	phenotypes)	that	are	also	associated	with	T	cell	lymphoma	(Moshous	et	al.	2003).	Although	the	SCID	pig	has	not	yet	been	investigated	for	leaky	syndrome,	the	T	cell	lymphomas	were	identified	to	be	host	based,	leaving	the	leaky	phenotype	as	a	possible	explanation	(Powell	et	al.	submitted	(1),	Chapter	3).	The	fourth	male	lived	four	years	and	was	a	successful	breeding	boar	until	he	succumbed	to	heart	failure.		To	achieve	the	second	goal	of	adequate	SCID	pig	facilities,	a	state-of-the-art	‘bubble’	was	constructed	within	the	Iowa	State	University	School	of	Veterinary	Medicine	Laboratory	Animal	Research	wing.	In	accompaniment,	protocols	were	developed	for	snatch	farrowing	SCID	containing	litters	aseptically	into	a	short	term	positive	pressure	bubble,	as	well	as	raising	piglets	using	unique	pasteurized	pig	colostrum	and	irradiated	milk	replacer.	After	female	piglets	are	tested	for	specific	pathogen	free	(SPF)	status	they	are	cleared	to	be	transferred	to	the	long	term	bubble	where	they	can	be	raised	to	sexual	maturity,	artificially	inseminated,	and	naturally	farrow	SPF	SCID	and	non-SCID	piglets	to	be	used	for	meaningful	research	(Powell	et	al.	Submitted	(2),	Chapter	4).		As	seen	in	other	SCID	species	with	a	defect	in	Artemis,	at	a	young	age	our	pigs	lack	the	characteristic	adaptive	cells	(B	cells	and	T	cells)	(Cossu	2010;	Ewen	et	al.	2014).	They	do	however	possess	natural	killer	(NK)	cells.	NK	cells	are	innate	lymphocyte	with	immune	defense	responsibilities	against	cells	not	presenting	classical	‘self’	Major	Histocompatibility	Complex	1	(MHC	class	1),	primarily	tumor	and	virally	infected	cells	(Vivier	et	al.	2011).	They	can	kill	target	cells	by	granule	exocytosis	(release	of	perforin	and	granzyme	B	
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proteins)	(Maher	et	al.	2002),	as	well	as	produce	immune	signal	cytokines	such	as	IFN-γ	(Duluc	et	al.	2009).	A	key	component	of	developing	the	naturally	occurring	SCID	pig	model	is	to	understand	the	extent	of	innate	immunity	present,	including	major	effector	cell	populations	such	as	NK	cells.	Early	after	the	initial	characterization	of	the	SCID	pigs,	a	group	at	Kansas	State	University	(KSU)	found	that	the	SCID	pigs	did	not	reject	xenografts	from	two	different	kinds	of	human	cancer	injected	in	the	ears	(Basel	et	al.	2012).	This	raised	questions	about	the	functionality	of	the	SCID	pig’s	resistant	NK	cells	which	should	have	anti-tumor	activity.	To	test	this,	we	examined	the	NK	cell’s	cytotoxicity	against	K562	cancer	target	cells,	and	their	production	of	activating	proteins	and	cytokines	such	as	perforin	and	IFN-g.	We	found	that	in	vitro,	SCID	NK	cells	respond	to	IL-2	or	IL-12	and	IL-18	activation	to	produce	perforin	and	IFN-g,	and	kill	tumor	targets	comparable	to	normal	NK	cells	(Powell	et	al.	2016).	Although	this	does	not	fully	encompass	in	vivo	activation	questions	about	the	SCID	environment,	intrinsically	the	SCID	NK	cells	appear	to	be	functional	in	vitro.		The	physiological	similarity	of	the	human	to	the	pig	is	increasing	the	interest	in	developing	the	porcine	immunology	model,	and	the	parameters	of	the	SCID	pig	offers	a	distinctive	opportunity	to	investigate	the	relationship	between	the	innate	and	adaptive	immune	system.	Interestingly,	work	in	mouse	models	has	found	that	NK	cells	can	exhibit	memory	like	behavior	in	response	to	hapten	contact	hypersensitivity	(CHS),	which	is	a	characteristic	previous	only	associated	with	adaptive	cells	(Majewska-Szczepanik	et	al.	2013;	O’Leary	et	al.	2006;	Paust	et	al.	2010;	Paust	et	al.	2011).	Evidence	from	adoptive	transfer	studies	in	mice	suggests	these	educated	NK	cells	are	found	in	the	liver,	and	have	been	found	to	migrate	to	areas	of	re-challenge	(Majewska-Szczepanik	et	al.	2013;	O’Leary	
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et	al.	2006).	As	a	first	step	in	developing	the	pig	model	for	this	type	of	research,	we	chose	to	establish	that	CHS	memory	also	exists	in	a	porcine,	non-rodent	model.	We	sensitized	pigs	with	2,4-dinitrofluorobenzene	(DNFB),	oxazolone	(OXA),	or	acetone	and	olive	oil	vehicle	on	the	dorsal	back	and	then	re-challenged	the	animals	32,	21,	7,	or	5	days	later	with	hapten	injections	in	the	ear.	We	found	that	inflammation	responses	measured	by	ear	swelling	were	significantly	higher	when	the	animal	had	previously	been	sensitized	by	the	agent	for	which	they	were	challenged,	exhibiting	supporting	evidence	of	a	memory	response.	Also	consistent	with	the	mice	literature,	NK	cells	from	the	liver	of	animals	that	have	been	sensitized	and	challenged	showed	a	heighted	activation	state	compared	to	NK	cells	in	the	peripheral	blood	of	the	same	animal	and	compared	to	separate	treatment	groups	(single	exposure,	and	vehicle	alone	control	pigs).	These	activated	liver	NK	cells	produced	higher	levels	of	perforin	and	IFN-g	(as	well	lysed	tumor	target	without	typically	required	additional	stimulation	(IL-2,	IL-12/IL-18)).	Collectively	we	established	that	hapten	specific	CHS	is	detectable	in	swine	and	associated	with	the	activation	of	hepatic	NK	cells.	In	a	preliminary	look	at	the	T-	B-	NK+	SCID	environment,	we	saw	results	contrary	to	the	SCID	mice	literature,	in	that	the	SCID	pig	NK	cells	did	not	show	evidence	of	NK	specific	education.	Although	there	was	present	an	inflammation	response	to	hapten	challenges,	it	was	not	specific	to	treatment	groups	and	there	was	no	statistical	interaction	between	back	sensitization	and	ear	treatment.	However,	this	offers	valuable	and	interesting	insight	into	NK	cell	training	and	suggests	the	Artemis	SCID	pig	lacks	or	is	impaired	in	a	crucial	component	of	the	NK	cell	memory	mechanism.		An	animal	model	with	the	absence	of	a	major	component	of	the	immune	system	is	valuable	for	studying	specific	immune	cell	subsets,	and	their	response	to	disease,		as	well	as	
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therapeutic	strategies	for	cancer	and	stem	cell	transplants	due	to	the	inability	to	reject	xenografts	(Huang	et	al.	2014).	The	pig	is	physiologically	similar	to	the	human	(Meurens	et	al.	2012),	and	initial	work	suggests	the	Artemis	defective	SCID	pig	is	more	similar	to	that	of	the	human	Artemis	defect	in	both	phenotype	and	mutation	(Waide	et	al.	2015).	The	success	of	the	SCID	mouse	for	regenerative	disease,	xenotransplantation,	cancer	therapy,	human	specific	disease	modeling,	and	stem	cell	therapies	is	well	documented	(Bility	et	al.	2012;	Chen	et	al.	2009;	Ito	R	et	al.	2012)	and	can	be	expanded	with	a	swine	model	more	similar	to	the	human.		Our	naturally	occurring	swine	SCID	model	offers	insight	into	the	SCID	disease,	and	holds	vast	potential	for	development	as	a	biomedical	model	for	SCID	and	cancer	therapies.		The	objectives	of	this	thesis	were:	1) Report	the	successful	rescue	of	the	ISU	SCID	phenotypes	through	bone	marrow	transplantation,	and	the	instances	of	lymphoma	and	leukemia	identified	in	two	of	these	cases.	2) Describe	the	unique	facilities	and	protocols	developed	for	the	creation	and	maintenance	of	an	ISU	SCID	colony.	3) Determine	the	in	vitro	functionality	of	NK	cells	present	within	the	ISU	SCID	pigs.		4) Assess	the	capabilities	of	the	porcine	immune	system	to	mount	a	hapten	specific	contact	hypersensitivity	memory	response	and	explore	innate	cell	training.	
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Thesis	Organization	
Four	manuscripts	were	prepared	for	publication	in	scientific	journals	and	are	included	as	Chapters	in	this	thesis.	I,	Ellis	Powell,	was	the	major	contributor	and	writer	of	each	of	the	four	manuscripts;	Christopher	Tuggle	supervised	the	research	presented.	A	review	of	literature	relevant	to	this	research	can	be	found	in	Chapter	2	which	is	composed	in	part,	of	a	published	mini-review.	Chapter	7	includes	general	conclusions	of	this	research,	as	well	as	the	applicability	of	the	findings	to	the	biomedical	community.	An	appendix	is	also	included	describing	preliminary	work	done	in	SCID	piglets	regarding	the	contact	hypersensitivity	described	in	Chapter	6.		
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CHAPTER 2. LITERATURE REVIEW 	 This	chapter	includes	sections	from	a	mini-review	published	in	the	Journal	of	Rare	Disease	
Research	and	Treatment	(see	below),	and	is	supplemented	to	expand	on	relative	topics	to	this	thesis	not	included	in	the	published	mini-review.		 This	Mini-Review	was	published	in	the	Journal	of	Rare	Disease	Research	and	Treatment	2017.	2(3):1-6.		
SCID	Pigs:	An	emerging	large	animal	NK	model		Ellis	J	Powell1,	Joan	E	Cunnick2,	and	Christopher	K	Tuggle1*			
Author	Contributions		EJP	wrote	the	initial	draft	of	the	manuscript	and	JEC	and	CKT	contributed	to	design	of	information	presentation	and	edited	the	manuscript.		
		1Genetics	and	Genomics	Graduate	Program	1Department	of	Animal	Science	Iowa	State	University,	Ames,	IA		50011	2Interdepartmental	Microbiology	Program	Department	of	Animal	Science	Iowa	State	University,	Ames,	IA		50011		*Corresponding	Author	Department	of	Animal	Science	806	Stange	Road	2255	Kildee	Hall	Iowa	State	University	Ames,	IA		50011	cktuggle@iastate.edu		
Mini-Review	Abstract	
	Severe	Combined	ImmunoDeficiency	(SCID)	is	defined	as	the	lack	or	impairment	of	an	adaptive	immune	system.	Although	SCID	phenotypes	are	characteristically	absent	of	T	and	B	cells,	many	such	SCID	cellular	profiles	include	the	presence	of	NK	cells.	In	human	SCID	patients,	functional	NK	cells	may	impact	the	engraftment	success	of	life	saving	procedures	such	as	bone	marrow	transplantation.		However,	in	animal	models,	a	T	cell-,	B	
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cell-,	NK	cell+	environment	provides	a	valuable	tool	for	asking	specific	questions	about	the	extent	of	the	innate	immune	system	function	as	well	as	emerging	NK	targeted	therapies	against	cancer.	Physiologically	and	immunologically	the	pig	is	more	similar	to	the	human	than	common	rodent	research	animals.	This	review	discusses	why	the	T-	B-	NK+	SCID	pig	may	offer	a	more	relevant	model	for	development	of	human	SCID	patient	therapies	as	well	as	provide	an	opportunity	for	systematic	exploration	of	the	role	of	NK	cells	in	artiodactyl	immunity.				
Severe	Combined	Immunodeficiency:	Mutations	and	Cellular	Profiles	
	SCID	is	naturally	found	in	humans,	mice,	horses,	dogs,	and	recently	pigs	(Bosma	et	al.	1983,	Cossu	2010;	Meek	et	al.	2001;	Perryman	et	al.	2004;	Cino	Ozuna	et	al.	2012).	It	is	characterized	chiefly	by	lymphopenia	(absence	of	T	cells	and	often	B	cells),	but	also	by	a	lack	of	thymocytes,	a	missing	or	small	thymus,	abnormalities	to	additional	immune	tissues	(Buckley	et	al.	1997),	and	in	some	case	species,	growth	defects	(Meek	et	al.	2009).		Although	the	SCID	condition	is	defined	by	the	central	phenotype	of	lacking	T	and	B	cells,	SCID	causative	mutations	can	affect	different	stages	along	the	lymphoid	development	or	function	pathway.	These	include	alterations	that	affect	developmental	cytokine	signaling,	lymphocyte	precursors,	and/or	inhibit	the	creation	of	the	T	cell	receptor	(TCR)	and	B	cell	receptor	(BCR)	complexes.	NK	cells	are	innate	lymphocytes	and	develop	from	common	lymphoid	precursors	shared	by	T	and	B	cells.	Since	NK	cells	do	not	make	receptors	requiring	somatic	recombination,	they	can	be	unaffected	by	causative	SCID	mutations	that	inhibit	such	steps	required	in	production	of	TCRs	and	BCRs.	Thus,	the	stage	
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of	development	that	a	causative	SCID	mutation	affects	will	determine	the	presence	or	absence	of	NK	cells.	SCID	defects	and	phenotypes	are	well	described	in	an	excellent	review	by	Cossu	(2010),	but	we	will	briefly	describe	some	broad	differences	in	cellular	profiles,	emphasizing	mutations	that	lead	to	the	presence	or	absence	of	NK	cells.		The	most	common	form	of	human	SCID	is	an	X-linked	defect	in	the	common	gamma	chain	(CD132),	which	is	present	in	the	interleukin-2	(IL-2),	IL-4,	IL-7,	IL-9,	IL-15	and	IL-21	receptors	and	encoded	by	the	IL2RG	gene	(Buckley	et	al.	1997;	Cossu	2010).	Without	the	common	gamma	chain	for	the	IL-7	and	IL-15	receptors,	neither	T	cells	nor	NK	cells	can	develop.	However,	B	cell	development	is	independent	of	the	common	gamma	chain,	thus	a	mutation	in	this	gene	creates	a	T	cell-,	B	cell+,	NK	cell-	(T-B+NK-)	phenotype	(Buckley	et	al.	1997;	Cossu	2010).	A	defect	in	Janus	Kinase	3	(JAK3),	which	alters	intracellular	signaling	from	the	IL2RG	common	γ	chain,	also	causes	a	T-B+NK-	SCID	phenotype	(Cossu	2010).	Another	classic	form	of	SCID	with	a	different	cellular	deficiency	comes	from	mutations	in	the	Recombination	Activation	Genes	(RAG)	1	or	2.		RAG	genes	are	lymphoid	specific	and	their	gene	products	form	a	complex	that	binds	to	recombination	signal	sequences	flanking	V	(variable),	D	(diversity),	and	J	(joining)	segments	(Notarangelo	et	al.	2016).	The	functional	RAG1/2	complex	induces	double	stranded	breaks	(DSB)	in	the	DNA	and	creates	an	inter-strand	hairpin	loop.	In	RAG1	or	RAG2	defective	individuals,	this	cleavage	is	inhibited,	and	T	or	B	lymphocyte	cannot	produce	a	TCR	or	BCR,	respectively	(Notarangelo	et	al.	2016).	However,	as	somatic	recombination	is	not	required	for	development	of	NK	cells,	most	RAG	deficient	patients	are	T-B-NK+.	Mutations	in	the	Artemis	gene	have	been	found	naturally	in	humans	and	pigs,	and	causes	a	T-B-NK+	phenotype	(Cossu	2010;	Waide	et	al.	2015).		The	Artemis	gene	encodes	an	endonuclease	that	cleaves	the	hairpin	loop	left	
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by	RAG	complex,	an	essential	next	step	in	rearrangement	to	create	the	TCR	and	BCR	(Powell	et	al.	2016,	Schuetz	et	al.	2014).	Due	to	this	role	of	Artemis	in	DNA	repair	of	DSB	involving	non-homologous	end	joining,	Artemis-defective	patients	and	animal	models	are	sensitive	to	radiation	(radiosensitive)	(Cossu	2010;	Ma	et	al.	2002;	Watanabe	et	al.	2013).	Also	radiosensitive	and	sharing	a	T-	B-	NK+	cellular	profile	are	SCID	patients	with	defects	of	the	DNA-dependent	kinase	catalytic	subunit	(DNA-PKcs)	protein.	After	cleavage	by	RAG	proteins	and	hairpin	loop	repair	by	Artemis,	DNA-PKcs	proteins	are	activated	by	DNA	ends	and	are	critical	components	of	DNA	repair	during	non-homologous	end	joining	(NHEJ)	(Maher	et	al.	2002;	Meek	et	al.	2001;	Waide	et	al.	2015).	DNA-PKcs	mutations	were	initially	identified	as	causative	defects	of	SCID	phenotypes	in	Arabian	horses,	Jack	Russell	terrier	dogs,	and	mice	before	such	mutations	were	recognized	in	humans	(Bosma	et	al.	1983,	Cossu	2010;	Meek	et	al.	2001;	Perryman	et	al.	2004).	Other	types	of	naturally	occurring	SCID	have	been	documented	including	a	defect	in	adenosine	deaminase	(ADA),	IL7Rα	(IL-7	receptor)	as	well	as	defective	CD3γ,	CD3δ,	CD3ζ,	and/or	CD3ε,	all	subunits	of	the	mature	TCR	on	the	cell	surface	(Cossu	2010).			
The	Iowa	State	University	SCID	Pig	
	The	SCID	phenotype	was	initially	identified	in	Iowa	State	University’s	residual	feed	intake	inbred	lines	of	Yorkshire	pigs	after	an	unexpected	reaction	to	a	Porcine	Reproduction	and	Respiratory	Syndrome	Virus	(PRRSV)	challenge	study	in	collaboration	with	Kansas	State	University	(KSU)	(Cino	Ozuna	et	al.,	2012).	A	Genome-Wide	Association	Analysis	identified	a	5.6	Mb	region	on	sus	scrofa	chromosome	10	that	contained	the	Artemis	
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(DCLRE1C)	gene	(Waide	et	al.	2015).	Further	genetic	analyses	of	this	region	revealed	two	independent	mutations	that	caused	the	SCID	phenotype,	which,	when	present	in	a	homozygous	or	compound	heterozygous	state,	have	a	Mendelian	recessive	mode	of	inheritance.	Although	several	classes	of	SCID	exist,	the	Artemis	defect	applies	to	the	mechanism	of	recombination	of	the	antigen	specific	regions	of	the	T	Cell	Receptor	(TCR)	and	B-Cell	Receptor	(BCR)	complexes	(Cossu,	2010).	Although	one	mutation	affects	a	splice	site	at	exon	8	and	the	other	creates	a	stop	codon	after	exon	10,	there	does	not	appear	to	be	a	severity	or	phenotype	difference	between	our	haplotypes	(termed	haplotype	12	(H12)	and	16(H16)).	Consistent	with	Artemis	SCID	human	patients,	the	SCID	pig	has	a	T-B-NK+	cellular	phenotype	confirmed	by	flow	cytometry	and	additionally	by	qPCR	which	showed	significantly	lower	expression	of	CD3e	(T-cell)	and	CD79A	(B-cell)	cell	markers,	but	the	presence	of	NCR1/NKp46	NK	cells	in	SCID	pigs	compared	to	non-SCID	littermates	(Ewen	et	al.	2014;	Powell	et	al.	2016;	Waide	et	al.	2015).	Also	consistent	with	the	phenotype	of	Artemis	patients,	fibroblasts	from	SCID	piglets	are	also	radiosensitive	(Waide	et	al.	2015).	A	study	conducted	with	the	USDA	labs	of	Amy	Vincent	and	Crystal	Loving	examined	the	role	of	the	innate	immune	system	in	SCID	pigs	when	challenged	with	the	pandemic	H1N1	influenza	virus.	The	SCID	pigs	were	not	able	to	control	viral	replication	as	seen	in	the	Bronchial	Alveolar	Lavage	Fluid	(BALF)	viral	titers	of	the	lung.	Interestingly,	upon	necropsy	seven	days	post	infection,	challenged	SCID	piglets	had	significantly	reduced	lung	lesions	(Rajao	et	al.	2017).	Also	found	in	the	BALF	analysis	were	significantly	increased	levels	of	IFN-a	in	the	challenged	SCID	animals.	The	SCID	pigs	were	not	able	to	clear	the	H1N1	virus,	despite	the	presence	of	NK	cells	contradicting	mouse	work	where	NK+	SCID	mice	were	capable	of	clearing	HSV	from	the	lung	(Reading	et	al.,	2006).	
  
15 
As	biomedical	models,	SCID	animals	are	often	coveted	for	their	lack	of	rejection	of	xenotransplantation.	Basel	et	al.	(2012)	injected	two	cancer	cell	lines	PANC-1	(pancreatic	carcinoma)	and	A375-SM	(melanoma)	into	the	ear	of	SCID	and	non-SCID	piglets	at	approximately	six	weeks	of	age.	The	piglets	were	monitored	for	up	to	22	days	post	injection	(animals	were	necropsied	once	health	began	to	decline).	Visible	tumors	developed	around	the	injection	site	of	SCID	animals.	Tumors	did	not	develop	in	injected	non-SCID	littermates.	Confirmation	of	cancerous	engraftment	was	confirmed	with	a	human	mitochondrial	stain	on	slides	taken	from	necropsied	animals	on	days	6,	14,	and	22	(Basel	et	al.	2012).		Presence	of	PANC-1	and	A375-SM	tumors	was	confirmed	in	all	injected	SCID	pigs	by	histology	and	immunohistochemistry	(Basel	et	al.	2012).		Thus,	SCID	pigs	were	not	able	to	reject	human	xenografted	A375-SM	or	PANC-1	tumor	cells.		Interestingly,	the	ISU	SCID	pig	may	also	be	a	natural	cancer	model.	To	create	genetically	SCID	but	phenotypically	normal	animals	that	would	have	better	chances	of	maintaining	high	health	in	a	breeding	role,	bone	marrow	transplantations	were	performed	on	nine	SCID	piglets	with	full	MHC	matched,	opposite	sex,	donor	littermates.	Four	animals	achieved	successful	engraftment	confirmed	by	the	generation	of	normal	numbers	of	lymphocytes	(Complete	Blood	Counts	(CBC)s	over	time),	confirmed	circulating	donor	cells	(detection	of	SRY	gene	(Y	chromosome)),	and	response	to	vaccination	(ability	to	form	an	antibody	response).	Of	those	four	animals	three	were	euthanized	at	11-13	months	of	age	after	failing	health.	Unexpectedly,	all	three	were	diagnosed	with	cancer;	both	homozygous	H16	animals	were	diagnosed	with	T	cell	lymphomas,	one	with	an	additional	leukemia,	and	the	other	H12/H16	heterozygote	with	a	nephroblastoma	(Powell	et	al.	Submitted).	Lymphomas	have	been	identified	in	association	with	hypomorphic	Artemis	mutations	in	
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human	SCID	patients	(Moshous	et	al.	2003).	The	SCID	pig	requires	further	characterization	to	determine	the	status	of	a	possible	‘leaky’	syndrome.		The	fourth	animal	had	a	successful	career	as	breeding	boar	until	he	succumbed	to	heart	failure	at	four	years	of	age.			Although	the	T-B-	SCID	environment	still	includes	the	presence	of	NK	cells	which	are	recognized	for	anti-viral	and	anti-tumor	activity,	it	allowed	for	growth	of	human	tumor	cell	lines.	However,	from	Basel’s	work	there	is	no	direct	evidence	the	NK	cells	were	responsible	for	tumor	clearance	in	the	challenged	non-SCID	animals.	To	test	whether	porcine	NK	cells	could	kill	human	cancer	cell	targets,	PBMCs	were	collected	from	SCID	and	non-SCID	pigs	and	incubated	in	the	presence	or	absence	of	recombinant	human	IL-2	as	well	as	a	combination	of	IL-12	and	IL-18.	IL-2	is	a	common	activator	of	NK	cells	(Mori	et	al.	1998);	it	is	a	T-cell	derived	cytokine	(which	may	not	be	within	normal	levels	within	T-	SCID	pigs).	IL-12	and	IL-18	is	a	cytokine	combination	produced	by	macrophages	and	dendritic	cells	(Pintarič	et	al.	2008)	and	was	selected	because	these	proteins	are	likely	present	within	normal	levels	within	the	SCID	pig.	In	vitro,	swine	NK	cells	required	cytokine	activation	to	kill	the	tumor	cell	lines	(A375-SMs,	PANC-1s,	and	K562s	(chronic	myelogenous	leukemia))	(Powell	et	al.	2016).	Whole	blood	was	collected	at	approximately	4,	11,	24,	and	35	days	of	age.	Peripheral	Blood	Mononuclear	Cells	(PBMCs)	from	SCID	pigs	were	found	to	have	higher	cytotoxicity	compared	to	PBMCs	from	unaffected	pigs	of	the	same	age	when	activated	with	IL-2	or	IL-12/IL-18.	Although	percent	cytotoxicity	is	higher	for	SCID	pigs	across	all	days,	the	SCID	animals	also	had	higher	percent	NK	cell	concentrations	in	PBMCs	across	all	days	(Powell	et	al.	2016).	Average	percent	NK	cells	in	PBMCs	from	SCID	animals	is	26.6%	compared	to	4.0%	in	non-SCIDs.	Though	the	SCID	NK	cells	can	be	activated	to	kill,	the	comparative	killing	activity	per	NK	cell	(calculated	as	
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tumor	targets	killed	per	NK	cell)	shows	non-significant	differences	between	SCID	and	non-SCID	animals	(Powell	et	al.	2016).			
Natural	Killer	Cells		
	
NK	Cell	Receptor	Repertoire,	Immune	Function	NK	cells	were	first	identified	in	1972	as	large	granular	lymphocytes	that	appeared	to	kill	tumor	targets	“naturally”	without	the	activation	typically	associated	with	T	cytotoxic	cells	(Rosenberg	et	al.	1972).	In	a	porcine	system,	there	is	a	relatively	low	abundance	of	NK	cells	in	circulating	periphery.	NK	cells	only	represent	5-10%	of	lymphocyte	population	within	normal	swine	(Toka	et	al.	2009).	NK	cells	are	thought	to	largely	differentiate	from	CD34+	stem	cells	in	the	bone	marrow	but	in	vitro	work	also	confirmed	NK	cells	can	mature	from	CD34+	cells	isolated	from	the	thymus,	liver,	cord	blood,	and	peripheral	blood	(Montaldo	et	al.	2013).	Phenotypic	differences	and	appearance	of	different	development	markers	may	exist	between	NK	cells	that	develop	in	various	tissues.	Integrin	DX5	(CD49a)	was	found	to	be	absent	on	a	population	of	mature	liver	derived	NK	cells,	but	present	in	nearly	all	of	the	bone	marrow	derived	counterparts	(Gotthardt	et	al.	2015).	Another	example	shows	that	integrin	Mac-1hi	(specific	to	NK	lymphocytes)	is	expressed	by	80-95%	of	peripheral,	spleen,	and	lung	NK	cells	but	only	10-60%	in	bone	marrow	and	liver	NK	cells	(Kim	et	al.	2002).	NK	cells	mature	and	are	influenced	by	their	environment	to	differentiate	into	complex	subsets	with	various	activating	and	inhibitory	signal	repertoires	that	are	summarized	here.	Broadly,	a	review	by	Montaldo	et	al.	(2013)	defines	three	classes	of	cells	in	NK	development	including	NK	cell	precursors,	immature	NK	cells,	and	mature	NK	cells.	
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Although	all	three	classes	are	usually	present	together	in	the	periphery	and	immune	tissues,	there	are	certain	surface	markers	associated	within	each	stage,	as	well	as	differences	in	cytokine	secretions.	The	early	precursors	lack	highly	specific	NK	cell	markers	but	express	CD122	(IL2-Rb	chain)	and	CD117	(c-kit,	which	recognizes	stem	cell	factor)	and	secrete	granulocyte	macrophage	colony	stimulating	factor	(GM-CSF),	IL-5,	and	IL-13	(Gotthardt	et	al.	2015;	Montaldo	et	al.	2013).	Immature	NK	cells	can	secrete	CXCL8,	and	start	to	express	CD56,	CD11	(lymphocyte	function	associated	antigen	(LFA-1)),	as	well	as	activation	and/or	inhibition	receptors	such	as	NKp44,	NKG2A	(Kim	et	al.	2002;	Montaldo	et	al.	2013).	Lastly,	mature	NK	cells	express	CD16,	NKp46,	NKp30,	NKG2D	and	produce	IFN-g	(Montaldo	et	al.	2013;	Gotthardt	et	al.	2015).		NK	cells	have	many	cell	surface	markers	in	common	with	cytotoxic	T-cells	such	as	CD8a+(glycoprotein	associated	with	cell-cell	interactions),	and	CD2+(T	cell	linage	surface	antigen),	but	are	externally	CD3-	(Eguizabal	et	al.	2014;	Kim	et	al.	2010;	King	et	al.	1998;	Orange	2013).	Unlike	porcine	T	cell	subsets,	NK	cell	populations	do	not	change	dramatically	during	early	piglet	development	(Talker	et	al.	2013).	One	of	the	first	markers	discovered	to	be	specifically	associated	with	NK	lymphocytes	is	the	CD16	(Fc-γ	IIIA	receptor)	which	binds	antibody–bound	cells	which	are	impaired	and	thus	targeted	for	cytotoxic	“killing”	through	Antibody	Dependent	Cellular	Cytotoxicity	(ADCC)	(He	et	al.	2013).	Another	important	common	surface	receptor	associated	with	mature	NK	cells	includes	CD56	(neural	cell	adhesion	molecule).	Interestingly,	although	pig	reagents	are	still	developing,	in	the	human	it	has	been	established	that	nearly	90%	of	peripheral	NK	cells	are	CD56dim	while	the	other	10%	are	CD56bright	(Montaldo	et	al.	2013).	A	human	defect	in	NK	cell	maturation	helped	determine	that	CD56bright	NK	cells	are	actually	precursors	of	CD56dim	
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NK	cells	(Domaica	et	al.	2012).	Broadly,	CD56dim	NK	cells	have	more	of	a	cytotoxic	and	effector	role	while	CD56bright	cells	tend	to	produce	more	cytokines	(Montaldo	et	al.	2013).	This	is	not	a	unique	principle,	many	subsets	of	NK	cells	exist	and	their	receptor	profile	may	dictate	distinctive	functional	roles.	Another	example	comes	from	NKp46/CD335	positive	and	negative	subsets.	NKp46	is	an	activating	receptor	that	binds	Hemagglutinin	(HA)	proteins	and	is	a	“hot-spot”	of	current	NK	literature	(Jost	et	al.	2011).	Although	it	was	widely	thought	that	all	NK	cells	expressed	NKp46,	Mair	et	al.	(2012)	has	shown	two	distinct	subtypes	of	NKp46+	versus	NKp46-	NK	cells.	Recent	papers	shows	that	NKp46	NK	cell	subsets	also	may	have	differentiated	function	such	as	effector	and	migration	response	roles	(Forberg	et	al.	2014).	Part	of	immune	protection	is	being	able	to	find	your	target.	Though	the	precise	mechanism	of	NK	cell	trafficking	is	not	well	documented,	there	are	several	examples	that	it	occurs.	Siddiqui	and	Hope	(2013)	has	shown	that	NK	cells	can	receive	chemokine	signals	associated	with	trafficking	capabilities,	and	the	recent	paper	by	Forberg	et	al.	(2014),	supplies	evidence	that	NKp46+	NK	cells	infiltrated	the	lung	tissue	during	the	early	stages	of	infection.	One	example	of	relevance	is	the	recent	work	involving	the	functional	differences	of	NKp46	positive	and	negative	NK	cell	subsets,	which	shows	evidence	that,	following	an	influenza	challenge,	more	NKp46+	NK	cells	appear	to	infiltrate	the	lung	tissue	(Forberg	et	al.	2014).	Similar	lung	recruitment	was	seen	in	RAG1	null	mice,	where	despite	lacking	B	and	T-cells,	mice	were	able	to	clear	Herpes	Simplex	Virus	type	1	(HSV-1)	from	the	lung	(Reading	et	al.	2006).	NK	cells	exhibiting	immune	training	from	an	exposure	of	hapten	induced	contact	hypersensitivity	also	have	shown	specific	migration	and	accumulation	in	sites	of	re-challenge	(O’Leary	et	al.	2006).		
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Unlike	cytotoxic	T	cells,	NK	cells	do	not	require	activation	by	specific	antigens	presented	by	MHC	complexes,	but	rather	can	lyse	targets	based	on	cells	lacking	or	down	regulating	self	MHC	class	I	molecules,	which	can	provide	protection	against	virally	infected	or	cancer	cells	(Orange	2013;	Vivier	et	al.	2011).	NK	cell	function	is	commonly	measured	against	target	cells	(cytotoxicity)	but	can	also	be	analyzed	through	cytokine	production	and	response	to	activation	signals	(Fehniger	et	al.	2007;	Pintarič	et	al.	2008;	Powell	et	al.	2016).	NK	cell	lysis	of	target	cells	can	be	accomplished	by	cell	to	cell	binding	of	FAS	or	TRAIL	‘death’	ligands,	ADCC,	or	receptor	activating	granule	exocytosis	of	proteins	such	as	perforin	and	granzyme	B,	both	of	which	can	also	be	measured	as	an	indication	of	NK	cell	activation	(Eguizabal	et	al.	2014;	Maher	et	al.	2002;	O’Leary	et	al.	2006).	In	swine,	piglets	are	born	with	perforin	containing	NK	cells	expected	to	be	capable	of	effector	function	(Talker	et	al.	2013).	In	addition	to	cytotoxic	roles,	activated	NK	cells	are	a	major	producer	of	cytokines	such	as	IFN-γ	(Eguizabal	et	al.	2014;	Paust	et	al.	2011;	Pintarič	et	al.	2008).	NK	cell	production	of	IFN-γ	enables	communication	and	activation	among	NK	cells	and	other	immune	cells	including	macrophages,	dendritic	cells,	T-cells,	and	B-cells	(Duluc	et	al.	2009;	Vivier	et	al.	2011).	Activation	of	NK	cells	has	been	demonstrated	in	vitro	using	individual	or	combinations	of	cytokines,	including	interleukin	(IL)-2	and	IFN-	a	(Mori	et	al.	1998)	as	well	as	IL-15,	IL-12,	and/or	IL-18	(Fehniger	et	al.	2007;	Pintarič	et	al.	2008;	Powell	et	al.	2016).	In	specific	combinations	or	collectively,	these	attributes	have	been	used	to	measure	the	activity	of	NK	cells	in	various	SCID	backgrounds.					
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As	Engraftment	Inhibitors,	and	As	Cancer	Therapy	Targets		 Though	NK	cells	in	a	T-B-	environment	may	offer	some	immune	protection	to	the	host,	for	some	SCID	patients	the	presence	of	functional	NK	cells	may	negatively	impact	the	success	of	critical	procedures	such	as	bone	marrow	transplantation	(BMT).	NK-	type	SCID	individuals	have	enhanced	survival	with	allogeneic	stem	cell	transplantations	compared	with	NK+	SCID	patients	(Hassan	et	al.	2014),	while	the	presence	or	absence	of	B	cells	did	not	impact	success	in	such	patients.	In	addition,	33%	of	NK+	SCID	stem	cell	recipients	required	additional	procedures,	including	pre-transplant	myeloablation	and/or	radiation,	while	only	8%	of	NK-	recipients	required	such	procedures	(Hassan	et	al.	2014).	Moreover,	SCID	patients	that	are	NK+	and	radiosensitive	(Artemis,	DNA-PKcs),	may	be	dangerously	sensitive	to	commonly	utilized	pre-transplant	radiation	treatments,	further	decreasing	BMT	success	rates	(Cossu	2010;	Hassan	et	al.	2014).		However,	in	the	context	of	NK	immunology	and	SCID	research,	a	circulating	lymphocyte	environment	composed	only	of	NK	cells	can	be	a	valuable	tool.	NK	cells	are	recognized	for	their	anti-tumor	activity	and	thus	methods	for	activating	such	cells	in	the	patient	or	in	providing	NK	cells	as	therapeutics	is	a	very	active	area	of	cancer	research	(Eguizabal	et	al.	2014).	For	example,	T-,	B-,	NK+	environments	are	valuable	for	development	of	NK	specific	therapies	including	IL-2	and	IFN-a	supplementation.	Supplementation	of	IL-2	therapy	is	intended	to	elicit	an	increased	response	(proliferation,	increased	cytotoxicity)	from	NK	cells	(Skrombolas	et	al.	2014).	In	addition	to	increased	cytotoxic	activity,	IL-2	stimulation	can	result	in	increased	cytokine	production,	such	as	IFN-
g	which	has	important	immune	signaling	implications	(Burns	et	al.	2003).	Intraperitoneal-injected	human	NK	cells	activated	with	IL-2	show	significantly	greater	anti-tumor	activity	
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(decreased	tumor	burden)	in	ovarian	cancer	mouse	models	compared	with	non-activated	NK	cells	(Geller	et	al.	2013).	IFN-	a	is	associated	with	viral	defense	and	anti-tumor	activity	and	thus	IFN-a	activation	of	NK	cells	has	become	a	potential	focus	for	cancer	and	viral	therapy	(Liang	et	al.	2003).	Stimulation	of	IFN-a	production	results	in	increased	cytotoxicity	of	human	NK	cells	and	increased	perforin	gene	expression	(Liang	et	al.	2003).		As	well,	T-B-NK+	systems	can	offer	opportunities	to	develop	mechanistic	insight	into	innate	immune	function.	Interestingly,	recent	studies	used	contact	hypersensitivity	in	SCID	mice	to	show	immune	memory	localized	to	liver-resident	NK	cells	(Majewska-Szczepanik	et	al.	2013;	O’Leary	et	al.	2006;	Paust	et	al.	2010;	Paust	et	al.	2011).	Adoptive	transfer	studies	in	SCID	mice	showed	that	educated	NK	cell	populations	are	responsible	for	such	memory,	and	that	these	cells	were	found	in	the	liver	(Majewska-Szczepanik	et	al.	2013;	O’Leary	et	al.	2006).	Upon	a	second	exposure,	NK	cells	exhibiting	memory-like	behavior	accumulated	in	the	site	of	re-challenge	and	show	a	heightened	activation	state	as	measured	by	IFN-g	production	and	upregulation	of	activation	receptors	(Majewska-Szczepanik	et	al.	2013;	O’Leary	et	al.	2006).	Importantly,	such	NK	memory	can	also	be	elicited	by	vaccines	for	different	viruses,	and	transfer	of	these	memory	NK	cells	into	naïve	mice	can	provide	protection	against	re-infection	without	the	presence	of	the	adaptive	immune	system	(Paust	et	al.	2010;	Paust	et	al.	2011).	A	better	understanding	of	innate	memory	mechanisms	can	enhance	our	understanding	of	vaccine	response	mechanisms	and	aid	in	vaccine	development.		In	summary,	understanding	the	cellular	profile	of	any	given	SCID	environment	is	important	for	focusing	therapy	efforts	in	human	SCID	patients	as	well	as	for	utilizing	the	full	potential	of	research	animals	lacking	an	adaptive	immune	system.		
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Hapten	Contact	Hypersensitivity	(CHS):	in	the	Context	of	Immune	Memory	
	Contact	Hypersensitivity	(CHS)	can	be	measured	with	an	immune	response	to	hapten	exposure.	Common	haptens	include	urushiol,	fluorescein,	nickel,	oxazolone	(OXA),	phosphorylcholine,	and	dinitrofluorobenzene	(DNFB)(Erkes	et	al.	2014).	Most	of	the	current	research	on	memory	CHS	has	been	done	with	rodent	models	or	human	cell	lines	(Grandclément	et	al.	2016).	Although	topical	application	of	a	hapten	alone	elicit	an	immune	response,	immune	memory	responses	can	be	measured	with	multiple	exposures	to	a	hapten.	Haptens	themselves	are	small	(less	than	one	kDa)	and	covalently	bind	to	protein	residues	to	create	haptenized	antigens	(Erkes	et	al.	2014).	Initial	sensitization	is	typically	applied	on	the	back	or	abdomen	of	mouse	or	model	animal	while	a	secondary	‘challenge’	is	applied	to	a	separate	location	(such	as	the	ear,	where	inflammation	swelling	can	easily	be	recorded).	The	first	cell	responders	to	a	cutaneous	hapten	exposure	are	langerhans	cells	(LCs),	dendritic	cells	(DCs),	and	keratinocytes	(KCs)	(Erkes	et	al.	2014).	Interestingly,	the	role	of	LCs	in	the	CHS	response	seems	to	be	time	conditional.	If	depleted	three	days	prior	to	haptenation	LCs	had	no	effect	on	CHS	response	but	a	single	day	prior	CHS	response	was	reduced.	LC	involvement	also	varied	in	the	flank	compared	to	the	ear	(Erkes	et	al.	2014).	As	these	first	responders	become	activated,	KCs	produce	IL-1b,	TNFa,	IL-18,	and	GM-CSF,	and	DCs	migrate	to	draining	lymph	nodes	where	they	can	interact	with	T	cells	(Erkes	et	al.	2014).		The	adaptive	immune	response	to	CHS	is	well-documented.	Antigen	presenting	cells	(APCs)	such	as	the	dermal	DCs	and	LCs	migrate	to	the	draining	lymph	node	where	they	can	
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present	the	hapten	antigen	to	naïve	T	cells	(Erkes	et	al.	2014).	Haptenized	protein	can	be	presented	on	the	cell’s	surface	or	internalized	where	they	interact	with	T	cells	or	invariant	NK	T	cells	(iNKTs)	through	MHCI/II	or	CD1d	respectively	(Erkes	et	al.	2014).	This	education	of	T	cells	results	in	hapten	specific	effector	CD4+	and	CD8+	cells.	The	iNKT	cells	play	more	of	a	regulatory	role,	producing	IL-4	and	IL-13	which	historically	regulate	and	suppress	effector	T	cells	(Erkes	et	al.	2014).	B	cells	also	respond	to	haptenization.	After	receiving	circulating	signals,	naïve	B	cells	home	to	draining	lymph	nodes	where	they	produce	hapten	specific	immunoglobulin	(Ig)M	(Erkes	et	al.	2014).	As	anticipated,	upon	secondary	exposure,	the	hapten	specific	IgM	and	hapten	antigen	in	circulation	will	activate	a	classical	pathway	complement	response,	and	the	production	of	important	recruitment	signals	including	serotonin,	P	selectin,	E	selectin,	TNFa,	CXCL-2,	CXCL-10	produced	by	resident	dermal	and	endothelial	cells	as	well	as	mast	cells	(Erkes	et	al.	2014).	These	signals	help	recruit	both	CD8+	and	CD4+	T	cells	to	the	hapten	challenge	site.	Both	CD8+	and	CD4+	T	cells	produce	cytokines	as	well	as	activate	production	of	additional	signals;	commonly	produced	are	TNFa,	IL-2,	IL-12,	IL-17,	and	IFN-g	(Erkes	et	al.	2014).	It	is	important	to	note	that	specific	CHS	response	are	different	between	acute	and	chronic	hapten	exposures.		Much	of	the	discussion	above	describes	memory	behavior	driven	by	cells	utilizing	antigen	specific	receptors	that	were	created	through	Recombination	Activating	Genes	(RAG)	dependent	recombination.	More	recent	advances	in	CHS	memory	has	expanded	some	of	these	principles	of	immune	memory	to	innate	cells	such	as	NK	cells	and	macrophages	which	do	not	produce	RAG	dependent	surface	receptors.	The	murine	Immgen	project	looked	at	unique	gene	profiles	of	NK	cells	in	different	activation	states	(Bezman	et	al.	2012).	Similar	to	other	long	lived	memory	cells	(primarily	ab	T	cells)	the	transcriptome	
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of	the	NK	signature	included	genes	unique	to	cells	able	to	develop	memory	responses	including	Casp1,	Fasl,	Ly6c1,	Itgal,	Hopx	(Bezman	et	al.	2012).	Consistent	with	investigating	these	parameters,	much	of	this	work	has	been	performed	in	T-B-NK+	SCID	mouse	models	including	Rag-/-	knockout	mice,	or	defective	DNA-dependent	kinase	catalytic	subunit	(DNA-PKcs)	mice	with	controls	of	wild	type,	double	knockout	IL2AG/RAG	mice,	or	beige	mice	with	non-functional	NK	cells	(O’Leary	et	al.	2006;	Paust	et	al.	2010;	Majewska-Szczepanik	et	al.	2013).	Although	the	mechanism	of	NK	cell	memory	is	not	fully	established,	some	characteristics	are	defined.	For	example,	trained	NK	cells	are	found	in	the	liver,	which	is	well	established	with	tracking	of	adoptive	transfer	cells	as	well	as	comparisons	to	peripheral	and	splenic	NK	cells	(O’Leary	et	al.	2006;	Majewska-Szczepanik	et	al.	2013).	Work	done	in	mouse	and	human	NK	cell	lines	has	shown	that	calcium	(Ca)2+	fluxes	through	plasma	permeable	membrane	channels	could	be	an	important	driver	for	certain	hapten	responses	(Grandclément	et	al.	2016).	Uniquely,	these	Ca2+	changes	are	documented	in	response	to	some	haptens	but	not	all	(NK	cells	responded	to	OXA	and	DNFB	but	not	dinitrobenzene	sulfonic	acid	(DNBS)	nor	trinitrobenzene	sulfonic	acid	(TNBS))	(Grandclément	et	al.	2016).	Consistent	with	T	cell	recruitment	to	the	site	of	re-challenge,	if	P	and	E	selectins	were	blocked,	SCID	mice	had	a	greatly	reduced	CHS	response	(O’Leary	et	al.	2006).	In	an	effort	to	explore	why	educated	NK	cells	seem	to	be	restricted	to	the	liver,	Paust	et	al.	(2010)	investigated	the	CXCR6	receptor	found	on	hepatic	NK	cells	whose	ligand,	CXCL16,	is	markedly	expressed	on	liver	endothelial	cells	(Paust	et	al.	2010).	Adoptive	transfer	comparisons	of	CXCR6-/+	(vs	CXCR6-/-),	-/-	NK	cell	subsets	into	NK-	mice	demonstrated	that	although	CXCR6+	status	alone	does	not	mediate	NK	cell	memory,	CHS	
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memory	responses	were	greatly	reduced	in	CXCR6-/-	transferred	NK	cells	(Paust	et	al.	2010).	The	maturation	and	activation	of	NK	cells	involves	various	receptor	developments	and	expression	profiles.	Specific	receptors	may	be	associated	with	certain	functions	or	roles	in	hapten	memory	education	or	migration.	One	receptor	that	may	play	a	contributing	role	in	trained	NK	recognition	of	targets	is	Ly49C-1	which	is	important	inhibitory	receptor	in	the	interaction	of	the	NK	cell	and	self-protein	(O’Leary	et	al.	2006).	If	haptenized,	the	self-protein	may	be	altered	in	a	way	that	the	NK	cells	then	recognizes	it	as	foreign	(Erkes	et	al.	2014);	additionally	Ly49C	+	NK	cell	subsets	tend	to	have	higher	effector	activity	and	conferred	higher	CHS	responses	when	educated	Ly49C+	NK	cells	were	adoptively	transferred	into	naïve	mice	(O’Leary	et	al.	2006).	Unsurprisingly,	there	is	evidence	for	a	role	for	NK	cell	activating	receptors	in	NK	cell	training	and	CHS	response.	One	such	example	is	NKG2D,	which	NK	cells	may	use	to	detect	and	sample	injury	and	damage	cell	signals	or	a	distressed	environment	(O’Leary	et	al.	2006).		Establishing	the	mechanism	of	NK	cell	memory	may	shed	some	light	on	some	of	the	more	controversial	aspects	of	NK	cell	mediated	memory.	Although	it’s	clear	memory	T	cell	and	trained	NK	cells	respond	to	hapten	CHS,	their	roles	and	mechanism	for	interacting	with	hapten	signals	are	likely	different	as	are	their	roles	in	the	immune	system	and	will	require	additional	analysis	to	unravel.							
  
27 
Large	Animal	Models	
	
Swine	Research	Models	One	of	the	largest	challenges	in	raising	biomedical	pigs	is	controlling	disease.	This	significantly	emphasized	when	rearing	immune	compromised	pigs,	especially	SCID	pigs.	Lee	et	al.	(2014)	reports	failure	to	thrive	phenotypes	in	his	engineered	RAG	deficient	SCID	pigs,	which	had	to	be	terminated	before	30	days	of	age.	The	best	option	for	raising	SCID	pigs	to	larger	sizes	(for	research	involving	parameters	like	organ	size	or	joint	stress)	or	ages	of	sexual	maturity,	is	to	source	them	from	disease	free	sows	and	rear	them	in	a	controlled	environment.	Specific	Pathogen	Free	(SPF)	colonies	of	immune	competent	swine	have	been	formed	from	founder	animals	sourced	from	hysterectomy,	raised	in	isolators,	and	subsequently	bred	to	produce	additional	generations	of	pigs	(Pan	et	al.	2015).	To	date,	ISU	is	the	only	home	of	an	SPF	SCID	producing	colony	(naturally	occurring)	(Powell	et	al	submitted).		Due	to	high	resource	requirement	of	SPF	founder	breeding	animals,	research	has	been	done	to	identify	methods	to	obtain	SPF	piglets	from	non-SPF	sows.	Most	of	the	exposure	to	disease	comes	from	contact	with	the	sow.	Some	of	the	more	common	methods	to	overcome	this	hurdle	include	cesarean	derived,	colostrum	deprived	(CDCD)	piglets	(Madson	et	al.	2016)	or	snatch	farrowed	piglets	(Huang	et	al.	2013).	Of	concern	with	these	methodologies	is	colostrum	deprivation	of	the	piglets.	In	swine,	the	lack	of	maternal	transfer	of	antibody	in	utero	leaves	piglets	relying	heavily	on	colostrum	consumption	immediately	after	natural	farrowing	for	acquisition	of	passive	immunity	(Ogawa	et	al.	2016).	Colostrum	includes	maternal	antibody,	immune	cells,	and	additional	immune	
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proteins	(Ogawa	et	al.	2016).	Colostrum	deprived	piglets	have	increased	mortality	and	decreased	immunity	both	measured	specifically	in	parameters	such	as	low	hematocrit	and	hemoglobin	levels,	and	broadly	by	increased	risk	of	disease	(Gomez	et	al.	1998;	Blanco	et	al.	2004;	Varley	et	al.	1985).	By	contrast,	colostrum	consumption	is	an	crucial	factor	contributing	to	piglet	survival,	immune	protection,	and	overall	growth	(Devillers	et	al.	2011).	In	response,	many	groups	supplement	CDCD	or	snatch	farrowed	piglets	with	milk	replacer,	bovine	colostrum,	or	pig	IgG	(Gomez	et	al.	1998;	Huang	et	al.	2013).	In	one	study	comparing	all	three,	milk	replacer	alone	resulted	in	70%	morality	of	piglets,	while	porcine	IgG	and	bovine	colostrum	supplementation	saw	100%	survival	rates	(Gomez	et	al.	1998).	Worth	noting,	no	supplementation	method	mentioned	achieved	the	levels	of	circulating	IgG	of	naturally	suckling	piglets	(Gomez	et	al.	1998).	Although	the	availability	of	the	SCID	pig	model	is	a	new	development	in	the	animal	resource	toolbox,	these	principles	of	limited	disease	exposure,	prenatal	colostrum	and/or	supplementation,	and	general	creation	of	SCID	SPF	colonies	will	become	increasingly	important.		
	
The	Opportunities	of	the	SCID	Pig	As	a	research	model,	SCID	systems	offer	insight	into	the	mechanism	of	SCID	disease,	offer	valuable	tools	for	development	of	biomedical	therapies,	and	present	a	unique	opportunity	to	explore	the	capabilities	of	the	innate	immune	system.	In	an	effort	to	harness	this	model	potential,	the	SCID	condition	has	been	introduced	into	mice,	rats,	and	recently	swine	using	transgenic	technology	(Huang	et	al.	2014;	Ito	T	et	al.	2014;	Kang	et	al	2016;	Lee	et	al.	2014;	Lei	et	al.	2016;	Suzuki	et	al.	2012;	Suzuki	et	al.	2016;	Watanabe	et	al.	2013).	
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The	pig	offers	a	large	animal	model	with	more	similar	genetics,	anatomy,	and	physiology	to	humans.	For	example,	the	porcine	immune	system	resembles	that	in	the	human	for	80%	of	analyzed	parameters,	compared	to	a	human,	mouse	parameters	match	for	only	10%	(Dawson	et	al.	2008;	Meurens	et	al.	2012).	This	suggests	an	advantage	for	pigs	as	a	biomedical	model	for	immunology	and	biomedical	research	and	therapy	development.		Though	the	SCID	phenotype	is	artificially	achievable	by	a	variety	of	genetic	manipulations,	swine	researchers	have	focused	on	targeting	IL2RG	and/or	the	RAG	1/2	knockouts	(Huang	et	al.	2014;	Ito	T	et	al.	2014;	Kang	et	al	2016;	Lee	et	al.	2014;	Lei	et	al.	2016;	Suzuki	et	al.	2012;	Watanabe	et	al.	2013).	Engineered	IL2RG	SCID	pigs	have	been	created	using	serial	nuclear	transfer	(Suzuki	et	al.	2012),	zinc	finger	nucleases	(ZFNs)(Watanabe	et	al.	2013),	or	the	clustered	regularly	interspaced	short	palindromic	repeats	(CRISPR)/cas9	system	(Kang	et	al	2016)	technologies.	Similar	to	human	SCID	patients,	IL2RG	SCID	pigs	have	shown	an	X	linked	heritability	(Suzuki	et	al.	2012;	Watanabe	et	al.	2013)	and	also	display	the	typical	T-B+NK-	cellular	phenotype	(Suzuki	et	al.	2012;	Watanabe	et	al.	2013).	More	suitable	for	NK	specific	research	questions	are	the	RAG	targeted	SCID	pig	models	which	have	been	achieved	using	transcription	activator-like	effector	nucleases	(TALENs)	and/or	somatic	cell	nuclear	transfer	(SCNT)	(Huang	et	al.	2014;	Ito	T	et	al.	2014;	Lee	et	al.	2014).	As	described	above,	RAG	knockouts	typically	result	in	a	T-B-NK+	phenotype;	however,	the	NK(+)	RAG	knockout	in	combination	with	the	NK	(-)	common	γ	chain	IL2RG	knockout	produces	T-B-NK-	SCIDs	(Ito	T	et	al.	2014;	Lei	et	al.	2016).	Interestingly,	NK	cells	from	RAG-SCID	mice	display	a	different	surface	marker	profile,	increased	cytotoxic	activity,	and	proliferation	deficiencies	compared	to	NK	cells	
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from	wild	type	mice	(Karo	et	al.	2014,	34).	To	date,	no	such	defect	has	been	reported	in	the	RAG-SCID	pig	models	(Huang	et	al.	2014;	Ito	T	et	al.	2014;	Lee	et	al.	2014).		The	only	naturally	occurring	SCID	pig	has	two	different	recessive	mutations	within	the	Artemis	gene;	these	mutations	cause	a	SCID	phenotype	in	the	homozygous	or	compound	heterozygous	state	(Waide	et	al.	2015).	These	SCID	pigs	have	a	phenotype	very	similar	to	human	Artemis	SCID	patients,	as	they	lack	B	and	T	cells	but	have	a	functional	population	of	NK	cells	capable	of	cytotoxic	lysis	of	numerous	tumor	target	cells	lines,	perforin	production,	and	response	to	activating	cytokines	(Powell	et	al.	2016).	As	seen	in	human	Artemis	patients,	fibroblasts	from	Artemis	SCID	pigs	are	also	radiosensitive	(Waide	et	al.	2015).	Also,	consistent	with	classic	characteristic	of	SCID	models,	the	Artemis	SCID	pigs	are	able	to	host	xenotransplants.	The	Artemis	SCID	pig	failed	to	reject	human	melanoma	(A375-SM)	and	pancreatic	carcinoma	(PANC-1)	cell	lines	injected	subcutaneously	into	the	ear	(Basel	et	al.	2012).		Given	the	substantial	differences	in	animal	models,	including	SCID	models,	it	is	useful	to	have	additional	such	models	for	regenerative	and	cancer	medicine.		We	propose	that	this	and	other	SCID	pig	models	may	be	more	physiologically	similar	to	SCID	humans,	and	such	newly	discovered	or	created	models	offer	a	valuable	research	model	for	clinical	testing,	procedure	improvement,	as	well	as	therapeutics.		One	of	the	landmark	uses	of	SCID	mice	models	has	been	the	creation	of	“humanized”	mouse	models	in	which	human	hematopoietic	stem	cells	(HSCs)	are	introduced	to	a	given	SCID	host	and	allowed	to	differentiate	into	components	of	the	immune	system	(Ito	R	et	al.	2012).	Coveted	for	the	lack	of	xenograft	rejection	and	capacity	for	human	tissue	differentiation,	humanized	mice	can	provide	the	environment	to	harbor	and	allow	
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differentiation	of	human	HSC	(Ito	R	et	al.	2012),	allowing	a	model	of	human	immune	response	to	host	species-restricted	pathogens	such	as	HIV	or	hepatitis	C	virus	(Ito	R	et	al.	2012;	Bility	et	al.	2012).	Early	research	on	humanization	using	various	strains	of	mice	identified	that	potential	mouse	cell	to	human	cell	interactions	were	interfering	with	engraftment	success.	Evidence	showed	mouse	phagocytes	could	directly	kill	developing	human	NK	cell	precursors	and/or	human	NK	precursors	were	not	binding	murine	cytokines	necessary	for	NK	cell	lineage	development	(Li	et	al.	2016).	Although	specific	B-cell	and	T-cell	responses	could	be	measured,	these	humanized	mice	presented	weak	or	non-significant	NK	and	myeloid	cell	compartment	development.	Phagocytosis	by	host	macrophages	is	largely	influenced	by	the	interaction	of	host	SIRPa	on	macrophages	and	monocytes	and	CD47	on	donor	cells,	which	initiates	an	anti-phagocytosis	signal	in	the	SIRPa+	phagocyte	and	increasing	survival	of	CD47	expressing	cells	(most	nucleated	cells	including	human	stem	cell	and	human	NK	cell	precursors)	(Li	et	al.	2016).	The	phagocytosis	problem	was	largely	corrected	with	the	original	Non-Obese	Diabetic	(NOD)	mouse,	which	is	recognized	as	a	gold	standard	of	engraftment	modeling,	due	mostly	to	its	modified	SIRPa	which	has	an	increased	affinity	for	donor	human	CD47	compared	even	to	human	SIRPa,	thus	encouraging	survival	of	donor	stem	cells	and	their	descendants	(Li	et	al.	2016).		It	is	well	documented	that	the	“rescue”	of	NK	and	myeloid	cell	differentiation	and	replication	can	also	be	accomplished	with	supplementation	of	combinations	of	human	IL-15,	erythropoietin,	G-CSF,	IL-3,	and/or	IL-4	through	direct	injection	or	through	transgenesis	(Chen	et	al.	2009).	Although	attempts	at	humanization	of	available	pig	has	not	yet	been	published,	mature	teratomas	developed	after	injection	of	human	pluripotent	stem	cell	injection	into	RAG	mutant	SCID	pigs	(Lee	et	al.	2014).	The	success	of	the	SCID	mouse	
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for	xenotransplantation,	cancer	therapy,	human	specific	disease	modeling,	and	stem	cell	therapies	is	well	documented	(Bility	et	al.	2012,	Chen	et	al.	2009;	Ito	R	et	al.	2012)	and	can	be	expected	to	extend	to	swine	models.	Swine	immune	parameters	more	similar	to	the	human,	as	described	above,	and	in	addition,	the	swine	immune	gene	component	or	“immunome”	is	very	similar	to	humans	(Dawson	et	al.	2013).	Another	advantage	of	the	pig	model	is	the	anatomical	similarity	to	the	human,	which	is	especially	valuable	for	pharmacological	reasons	such	as	establishing	drug	and	therapy	dosages.	Above	we	discuss	the	use	of	IL-2	supplementation	as	cancer	therapy	by	activating	anti-tumor	cytotoxic	cells	such	as	NK	cells	(and	if	present,	CD8+	T	cells).	IL-2	injections	have	been	responsible	for	complete	regression	(all	measurable	tumor	cleared)	in	7%	of	renal	cancer	and	melanoma	patients,	and	an	additional	10%	saw	partial	regression	(clearance	of	at	least	50%	of	tumor	burden)	(Skrombolas	et	al.	2014).	However,	IL-2	supplementation	is	extremely	dose	sensitive;	too	much	IL-2	will	have	toxic	effects,	including	the	development	of	Vascular	Leak	Syndrome	(VLS)	(Wagner	et	al.	2014).	VLS	can	be	fatal	and	in	severe	cases	causing	cardiac	and	pulmonary	failure	(Wagner	et	al.	2014).	In	work	observing	human	cancer	patients	receiving	IL-2	therapy,	65%	had	to	adjust	or	stop	treatment	due	to	VSL	complications	(Wagner	et	al.	2014);	therefore,	it	is	imperative	to	establish	a	safe	yet	efficient	dosage.	IL-2	supplementation	therapy	is	already	being	established	in	pigs	and	has	also	been	shown	to	be	beneficial	for	decreased	Graft	versus	Host	Disease	(GvHD)	following	a	mismatched	bone	marrow	transplant	in	miniature	swine	(Kozlowski	et	al.	2000).		 In	conclusion,	there	are	useful	SCID	pig	models	available	that	may	further	advance	the	work	accomplished	in	SCID	mice	in	a	system	more	similar	to	a	human	environment.	
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The	T-B-NK+	SCID	pig	model	provides	a	new	opportunity	for	advancement	of	NK	cell	biology.	The	presence	of	functional	NK	cells	in	a	deficient	immune	system	enables	the	exploration	of	challenges	faced	by	NK+	SCID	human	patients	and	potential	procedural	improvements,	the	development	of	NK	cell	specific	therapies,	and	the	exploration	of	mechanisms	independent	of	the	adaptive	immune	system.			
General	Summary	
	Recognizing	the	capacity	of	the	SCID	natural	killer	cell	remains	a	crucial	component	in	understanding	the	innate	immunity	present	in	any	given	SCID	environment.	The	presence	of	NK	cells	influences	engraftment	and	stem	cell	transplantation	in	SCID	patients.	In	addition,	characterizing	SCID	resident	NK	cells	is	important	for	animal	model	development	and	may	define	how	current	models	can	be	best	utilized	for	biomedical,	cancer,	and	therapy	uses.	Given	the	physiological	similarities	of	swine	to	humans,	pigs	as	immune-deficient	models	have	notable	advantages	and	vast	potential	as	a	tool	for	immunologic,	therapy	advancement,	and	biomedical	research.			
Acknowledgements	
	The	authors	thank	the	entire	ISU	SCID	pig	team,	especially	members	of	the	Tuggle	and	Cunnick	laboratories,	the	Iowa	State	University	Laboratory	Animal	Resources	department,	and	the	staff	at	Lauren	Christian	Swine	Breeding	farm.	EP	gratefully	recognizes	funding	from	a	USDA	National	Needs	Fellowship	Grant	(2012-38420-	19286).	
  
34 
Work	discussed	in	this	paper	performed	at	Iowa	State	University	was	supported	by	Iowa	State	University	Office	of	the	Vice	President	for	Research	and	NIH	5R24OD019813-03.		 	
  
35 
	
Literature	Cited		Basel	MT,	Balivada	S,	Beck	AP,	Kerrigan	MA,	Pyle	MM,	Dekkers	JC,	Wyatt	CR,	Rowland	RR,	
 Anderson	DE,	Bossmann	SH	et	al:	Human	xenografts	are	not	rejected	in	a	naturally	occurring	immunodeficient	porcine	line:	a	human	tumor	model	in	pigs.	Biores	Open	Access.	2012.	1(2):63-68.			Bezman	N,	Kim	CC,	Sun	JC,	Min-Oo	G,	Hendricks	DW,	Kamimura	Y,	Best	JA,	Goldrath	AW,	Lanier	LL.	The	Immunological	Genome	Project	Consortium:	Molecular	definition	of	the	identity	and	activation	of	natural	killer	cells.	nature	immunology	.2012;	13(10):	1000-1008.		Bility	M,	Zhang	L,	Washburn	M,	Curtis	A,	Kovalev	G,	Su	L.	Generation	of	a	humanized	mouse	model	with	both	human	Immune	system	and	liver	cells	to	model	hepatitis	C	virus	infection	and	liver	Immunopathogenisis.	Published	online.	Nature	America.	2012.	7(9):1608-17.		Blanco	I,	Galina-Pantoja	L,	Oliveira	S,	et	al.	Comparison	between	Haemophilus	
parasuis	infection	in	colostrum-deprived	and	sow-reared	piglets.	Vet	Microbiol.	2004;	103:21–27.		Bosma	BC,	Custer	PR,	Bosma	M.	A	severe	combined	immunodeficiency	mutation	in	the	mouse.	Nature.	1983.	301(5900),	527	–	530.			Buckley	R,	Schiff	R,	Schiff	S,	Market	L,	Williams	L,	Harville	T,	Roberts	J,	Puck	J.	Human	severe	combined	immunodeficiency:	Genetic,	phenotypic,	and	functional	diversity	in	one	hundred	eight	infants.	The	Journal	of	Pediatrics.		1997.	130(3):1264-8.		Burns	LJ,	Weisdorf	DJ,	DeFor	TE,	Vesole	DH,	Repka	TL,	Blazar	BR,	Burger	SR,	Panoskaltsis-Mortari	A,	Keever-Taylor	CA,	M-JZhang,	and	Miller	JS.	IL-2-based	immunotherapy	after	autologous	transplantation	for	lymphoma	and	breast	cancer	induces	immune	activation	and	cytokine	release: a	phase	I/II	trial	Bone	Marrow	Transplantation.	Nature	2003.	32,	177–186.		Chen	Q,	Khoury	M,	Cherr	J.	Expression	of	human	cytokines	dramatically	improves	reconstitution	of	specific	human-blood	lineage	cells	in	humanized	mice.	PNAS.	2009.	106(51).	21783-21788.		Cossu	F.	Genetics	of	SCID.	Italian	Journal	of	Pediatrics.	2010.	36(76).		Cino	Ozuna	A.G.,	R.R.R.	Rowland,	J.C.	Nietfeld,	M.A.	Kerrigan,	J.C.M.	Dekkers,	and	C.R.	Wyatt.	Preliminary	findings	of	a	previously	unrecognized	porcine	primary	immunodeficiency	disorder.	Vet	Pathol.	2012.	50(1):144-146.			Dawson,	H.	A	comparative	assessment	of	the	pig,	mouse,	and	human	genomes:	structural	and	functional	analysis	of	genes	involved	in	immunity	and	inflammation.	The	Minipig	in	
  
36 
Biomedical	Research	(McAnulty,	P.A.,	ed.),	CRC	Press,	Taylor	&	Francis	Group.	2011.	321–341.	 	Dawson	HD,	Loveland	JE,	Pascal	G,	et	al.	Structural	and	functional	annotation	of	the	porcine	immunome.	BMC	Genomics.	2013.	(14)332.			Devillers	N,	Dividich	JL,	Prunier	A.	Influence	of	colostrum	intake	on	piglet	survival	and	immunity.	Animal.	2011;	5:1605–1612.			Domaica	CI,	Fuertes	MB,	Uriarte	I,	et	al.	Human	Natural	Killer	Cell	Maturation	Defect	Supports	In	Vivo	CD56bright	to	CD56dim	Lineage	Development.	Ahlenstiel	G,	ed.	PLoS	ONE.	2012;7(12):e51677.	doi:10.1371/journal.pone.0051677.		Duluc	D,	Tan	F,	Scotet	M,	Blanchard	S,	Frémaux	I,	Garo	E,	Horvat	B,	Eid	P,	Delneste	Y,	and	Jeannin	P.	PolyI:C	plus	IL-2	or	IL-12	induce	IFN-γ	production	by	human	NK	cells	via	autocrine	IFN-β.	Eur.	J.	Immunology	2009.	39.	2877–2884.			Eguizabal	C,	Zenarruzabeitia	O,	Monge	J,	Santos	S,	Vesga	MA,	Maruri	N	et	al.	Natural	Killer	Cells	for	Cancer	Immunotherapy:	Pluripotent	Stem	Cells-Derived	NK	Cells	as	an	Immunotherapeutic	Perspective.	Frontiers	in	Immunology.	2014.	5(439).			Erkes	DA,	Selvan	SR.	Hapten-Induced	Contact	Hypersensitivity,	Autoimmune	Reactions,	and	Tumor	Regression:	Plausibility	of	Mediating	Antitumor	Immunity.	Journal	of	
Immunology	Research.	2014;2014:175265.	doi:10.1155/2014/175265.		Ewen	CL,	Cino-Ozuna	AG,	He	H,	Kerrigan	MA,	Dekkers	JC,	Tuggle	CK,	Rowlan	RR,	Wyatt	CR.	Analysis	of	blood	leukocytes	in	a	naturally	occurring	immunodeficiency	of	pigs	shows	the	defect	is	localized	to	B	and	T	cells.	Veterinary	Immunology	and	Immunopathology	
Immunopathology	2014.	162(3-4)	2014.			Fehniger	TA,	Cai	SF,	Cao	X,	Bredemeyer	AJ,	Presti	RM,	French	AR,	Ley	TJ.	Acquisition	of	murine	NK	cell	cytotoxicity	requires	the	translation	of	a	pre-existing	pool	of	granzyme	B	and	perforin	mRNAs.	Immunity.	2007.	26(6):798-811.			Forberg,	H.,	Hauge,	A.	G.,	Valheim,	M.,	Garcon,	F.,	Nunez,	A.,	Gerner,	W.,	…	Storset,	A.	K.	Early	Responses	of	Natural	Killer	Cells	in	Pigs	Experimentally	Infected	with	2009	Pandemic	H1N1	Influenza	A	Virus.	PLoS	ONE.	2014.	9(6),	e100619.	doi:10.1371/journal.pone.0100619		Geller	MA,	Knorr	DA,	Hermanson	DA,	et	al.	Intraperitoneal	delivery	of	human	natural	killer	cells	for	treatment	of	ovarian	cancer	in	a	mouse	xenograft	model.	Cytotherapy.	2013.	15(10):1297-1306.			Gomez	GG,	Phillips	O,	Goforth	RA.	Effect	of	immunoglobulin	source	on	survival,	growth,	and	hematological	and	immunological	variables	in	pigs.	J	Anim	Sci.	1998;	76:1–7.		
  
37 
Gotthardt	D,	Prchal-Murphy	M,	Seillet	C,	Glasner	A,	Mandelboim	O,	Carotta	S,	Sexl	V,	Putz	EM.	NK	cell	development	in	bone	marrow	and	liver:	site	matters.	Genes	Immun.	2014	Dec;15(8):584-7.		Grandclément	C,	Pick	H,	Vogel	H,	Held	W.	NK	Cells	Respond	to	Haptens	by	the	Activation	of	Calcium	Permeable	Plasma	Membrane	Channels.	Obukhov	AG,	ed.	PLoS	ONE.	2016;11(3):e0151031.	doi:10.1371/journal.pone.0151031.		Hassan	A,	Lee	P,	Maggina	P,	et	al.	Host	natural	killer	immunity	is	a	key	indicator	of	permissiveness	for	donor	cell	engraftment	in	patients	with	severe	combined	immunodeficiency.	The	Journal	of	Allergy	and	Clinical	Immunology.	2014.	133(6):1660-1666.			He	X,	Li	D,	Luo	Z,	et	al.	Compromised	NK	Cell-Mediated	Antibody-Dependent	Cellular	Cytotoxicity	in	Chronic	SIV/SHIV	Infection.	Ahlenstiel	G,	ed.	PLoS	ONE.	2013.	8(2).			Huang	J,	Guo	X,	Fan	N,	Song	J,	Zhao	B,	Ouyang	Z,	Liu	Z,	Zhao	Y,	Yan	Q,	Yi	X,	Schambach	A,	Frampton	J,	Esteban	MA,	Yang	D,	Yang	H,	and	Liangxue	L.	RAG1/2	Knockout	Pigs	with	Severe	Combined	Immunodeficiency.	J	Immunology.	2014.	193:1496-1503.		Huang	Y,	Haines	DM,	Harding	JCS.	Snatch-farrowed,	porcine-colostrum-deprived	(SF-pCD)	pigs	as	a	model	for	swine	infectious	disease	research.	Can	J	Vet	Res.	2013;	77(2):81-88.		Ito	R,	Takahashi	T,	Katano	I,	et	al.	Current	advances	in	humanized	mouse	models”	Central	Institute	for	Experimental	Animals,	Kawasaki,	Japan.	Cellular	&	Molecular	Immunology.	2012.	9(3).	208–214.			Ito	T,	Sendai	Y,	Yamazaki	S,	et	al.	Generation	of	Recombination	Activating	Gene-1-Deficient	Neonatal	Piglets:	A	Model	of	T	and	B	Cell	Deficient	Severe	Combined	Immune	Deficiency.	Di	Noia	JM,	ed.	PLoS	ONE.	2014.	9(12).			Jost	S,	Reardon	J,	Peterson	E,	et	al.	Expansion	of	2B4+	natural	killer	(NK)	cells	and	decrease	in	NKp46+	NK	cells	in	response	to	influenza.	Immunology.	2011;	132(4):516-526.		doi:10.1111/j.1365-2567.2010.03394.x.		Kang	J-T,	Cho	B,	Ryu	J,	et	al.	Biallelic	modification	of	IL2RG	leads	to	severe	combined	immunodeficiency	in	pigs.	Reproductive	Biology	and	Endocrinology :	RB&E.	2016.14(74).			Karo	JM,	Schatz	DG,	Sun	JC.	The	RAG	recombinase	dictates	functional	heterogeneity	and	cellular	fitness	in	natural	killer	cells.	Cell.	2014;159(1):94-107.				
Kim S, Iizuka K, Kang HS, Dokun A, French AR, Greco S, Yokoyama WM. In vivo 
developmental stages in murine natural killer cell maturation. Nat Immunol. 2002;3(6):523-8. 	
  
38 
Kim	TJ,	Kim	N,	Kim	EO,	Choi	JR,	Bluestone	JA,	&	Lee	KM.	Suppression	of	human	anti-porcine	natural	killer	cell	xenogeneic	responses	by	combinations	of	monoclonal	antibodies	specific	to	CD2	and	NKG2D	and	extracellular	signal-regulated	kinase	kinase	inhibitor.	Immunology.	2010.	130(4).	545–555.			King	A,	Gardner	L,	Sharkey	A,	Loke	YW.	Expression	of	CD3	epsilon,	CD3	zeta,	and	RAG-1/RAG-2	in	decidual	CD56+	NK	cells.	Cell	Immunology.	1998.	183(2).	99-105.		Kozlowski	T,	Sablinski	T,	Basker	M,	Kitamura	H,	Spitzer	HR,	Fishman	J,	Sykes	M,	Cooper	DKC,	Sachs	DH.	Decreased	graft-versus-host	disease	after	haplotype	mismatched	bone	marrow	allografts	in	miniature	swine	following	interleukin-2	treatment.	Bone	Marrow	
Transplantation.	2000.	25(1).	47–52.		Lee	K,	Kwon	D-N,	Ezashi	T,	et	al.	Engraftment	of	human	iPS	cells	and	allogeneic	porcine	cells	into	pigs	with	inactivated	RAG2	and	accompanying	severe	combined	immunodeficiency.	Proceedings	of	the	National	Academy	of	Sciences	of	the	United	States	of	
America.	2014.	111(20).	7260-7265.			Lei	S,	Ryu	J,	Wen	K,	et	al.	Increased	and	prolonged	human	norovirus	infection	in	RAG2/IL2RG	deficient	gnotobiotic	pigs	with	severe	combined	immunodeficiency.	Scientific	
Reports.	2016.	27(6).			Li	Y,	Di	Santo	JP.	Probing	Human	NK	Cell	Biology	Using	Human	Immune	System	(HIS)	Mice.	
Current	Topics	in	Microbiology	and	Immunology.	2016.	395.	191–208.		Liang	S,	Shujuan	Liang	A	,	Haiming	Weia	,	Rui	Suna,b,	Zhigang	Tian.	IFNa	regulates	NK	cell	cytotoxicity	through	STAT1	pathway.	Cytokine.	2003.	23(6).190–199.		Ma	Y,	Pannicke	U,	Schwarz	K,	Lieber	MR.	Hairpin	opening	and	overhang	processing	by	an	Artemis/DNA-dependent	protein	kinase	complex	in	nonhomologous	end	joining	and	V(D)J	recombination.	Cell.	2002.	108(6)	781-94.		Madson	DM,	Arruda	PH,	Magstadt	DR,	et	al.	Characterization	of	Porcine	Epidemic	Diarrhea	Virus	Isolate	US/Iowa/18984/2013	Infection	in	1-Day-Old	Cesarean-Derived	Colostrum-Deprived	Piglets.	Vet	Pathol.	2016;	53(1):44-52.			Maher	KJ,	Klimas	NG,	Hurwitz	B,	Schiff	R,	Fletcher	MA.	Quantitative	Fluorescence	Measures	for	Determination	of	Intracellular	Perforin	Content.	Clinical	and	Diagnostic	Laboratory	
Immunology.	2002.	9(6).1248-1252.			Mair	KH,	Essler	SE,	Patzl	M,	Storset	AK,	Saalmüller	A,	and	Gerner	W.	NKp46	expression	discriminates	porcine	NK	cells	with	different	functional	properties.	Eur.	J.	Immunology.	2012.	42:	1261–1271.	doi:	10.1002/eji.201141989		
  
39 
Majewska-Szczepanik	M,	Paust	S,	Andrian	UH,	Askenase	PW,	Szczepanik	M.	Natural	killer	cell-mediated	contact	sensitivity	develops	rapidly	and	depends	on	interferon-α,	interferon-γ	and	interleukin-12.	Immunology.	2013.	140(1).98-110.			Meek	K,	Kienker	L,	Dallas	C,	Wang	W,	Dark	MJ,	Venta	PJ,	Huie	ML,	Hirschhorn	R,Bell	T.	2001	SCID	in	Jack	Russell	terriers:	a	new	animal	model	of	DNA-PKcs	deficiency.	Journal	of	
Immunology.	2001.	167(4):2142-50.		Meek	K,	Jutkowitz	A,	Allen	L,	et	al.	SCID	Dogs:	Similar	Transplant	Potential	but	Distinct	Intra-Uterine	Growth	Defects	and	Premature	Replicative	Senescence	Compared	with	SCID	Mice.	Journal	of	immunology	(Baltimore,	Md :	1950).	2009;183(4):2529-2536.	doi:10.4049/jimmunol.0801406.		Meurens	F,	Summerfield	A,	Nauwynck	H,	Saif	L,	Gerdts	V:	The	pig:	a	model	for	human	infectious	diseases.	Trends	Microbiol.	2012.	20(1).50-57.		Montaldo	E,	Del	Zotto	G,	Della	Chiesa	M,	Mingari	MC,	Moretta	A,	De	Maria	A,	Moretta	L.	Human	NK	cell	receptors/markers:	a	tool	to	analyze	NK	cell	development,	subsets	and	function.	Cytometry	A.	2013;83(8):702-13.		Mori	S,	Jewett	A,	Cavalcanti	M,	Murakami-Mori	K,	Nakamura	S,	Bonavida	B.	Differential	regulation	of	human	NK	cell-associated	gene	expression	following	activation	by	IL-2,	IFN-a	and	PMA/ionomycin.	International	Journal	of	Onocolgy.	1998.	12(5).	1165-1170.		Moshous	D,	Pannetier	C,	Chasseval	R	de,	Deist	F	le,	Cavazzana-Calvo	M,	Romana	S,	…	Villartay	J-P	de.	Partial	T	and	B	lymphocyte	immunodeficiency	and	predisposition	to	lymphoma	in	patients	with	hypomorphic	mutations	in	Artemis.	Journal	of	Clinical	
Investigation,	2003;	111(3),	381–387.	http://doi.org/10.1172/JCI200316774		Notarangelo	LD,	Kim	MS,	Walter	JE,	Lee	YN.Human	RAG	mutations:	biochemistry	and	clinical	implications.	Nature	Reviews:	Immunology.	2016.	16(4).	234-46.			O’Leary	J,	Goodarzi	M,	Drayton	DL,	von	Adrian	UH.	T	cell-	and	B	cell-independent	adaptive	immunity	mediated	by	natural	killer	cells.	Nature	immunology.	2006.	7(5).	507-516.			Ogawa	S,	Tsukahara	T,	Imaoka	T,	Nakanishi	N,	Ushida	K,	Inoue	R.	The	effect	of	colostrum	ingestion	during	the	first	24	hours	of	life	on	early	postnatal	development	of	piglet	immune	systems.	Anim	Sci	J.	2016;87(12):1511-1515.		Orange	JS.	Natural	killer	cell	deficiency.	The	Journal	of	allergy	and	clinical	
immunology	2013.	132(3).515-526.			Pan	J,	Min	F,	Wang	X,	et	al.	Establishment	of	a	special	pathogen	free	Chinese	Wuzhishan	Minipigs	Colony.	Journal	of	Animal	Science	and	Technology.	2015;57:7.	doi:10.1186/s40781-015-0046-4.		
  
40 
Rajao	DS,	Loving	CL,	Waide	EH,	Gauger	PC,	Dekkers	JC,	Tuggle	CK,	Vincent	AL.	Pigs	with	Severe	Combined	Immunodeficiency	Are	Impaired	in	Controlling	Influenza	A	Virus	Infection.J	Innate	Immun.	2017;9(2):193-202.		Rosenberg	EB,	Herberman	RB,	Levine	PH,	Halterman	RH,	McCoy	JL,	Wunderlich	JR.	Lymphocyte	cytotoxicity	reactions	to	leukemia-associated	antigens	in	identical	twins.	Int	J	
Cancer.	1972.	15;9(3):648-58.		Paust	S,	Gill	HS,	Wang	B-Z,	et	al.	Critical	role	for	CXCR6	in	NK	cell-mediated	antigen-specific	memory	to	haptens	and	viruses.	Nature	immunology.	2010.	11(12):1127-1135.			Paust	S,	von	Adrian	UH.	Natural	killer	cell	memory.	Nature	immunology	review.	2011.	12,	500–508.			Perryman,	LE.		Molecular	pathology	of	severe	combined	immunodeficiency	in	mice,	horses,	and	dogs.	Vet	Pathol.	2004.	41(2).	95-100.		Pintarič	M,	Gerner	W,	Saalmüller	A.	Synergistic	effects	of	IL-2,	IL-12	and	IL-18	on	cytolytic	activity,	perforin	expression	and	IFN-γ	production	of	porcine	natural	killer	cells.	Veterinary	
Immunology	and	Immunopathology	2008.	121(1-2).		Powell	EJ,	Cunnick	JE,	Knetter	SM,	Loving	CL,	Waide	EH,	Dekkers	JCM,	Tuggle	CK.	NK	cells	are	intrinsically	functional	in	pigs	with	Severe	Combined	Immunodeficiency	(SCID)	caused	by	spontaneous	mutations	in	the	Artemis	gene.	Veterinary	Immunology	and	
Immunopathology.	2016.	175.	1–6.			Powell	EJ,	Graham	J,	Ellinwood	NM,	Hostetter	J,	Yaeger	M,	Ho	S,	Gault	L,	Norlin	V,	Snella	EN,	Jens	J,	Waide	EH,	Boettcher	AN,	Kerrigan	M,	Rowland	RRR,	Ross	J,	Dekkers	JCM,	Tuggle	CK.		T-cell	lymphoma	and	leukemia	in	Severe	Combined	Immunodeficiency	(SCID)	pigs	following	bone	marrow	transplantation:	A	Case	Report.	Submitted.	Frontiers	in	
Immunology.			Powell	EJ,	Charley	S,	Boettcher	A,	Varley	L,	Schroyen	M,	Adur	MK,	Dekkers	S,	Isaacson	D,	Sauer	M,	Cunnick	JE,	Ellinwood	NM,	Ross	JW,	Dekkers	JCM,	Tuggle	CK.	Creating	Effective	BioContainment	Facilities	and	Maintenance	Protocols	for	Raising	Specific	Pathogen	Free,	Severe	Combined	ImmunoDeficient	(SCID)	Swine.	Submitted.	Laboratory	Animals.			Reading	PC,	Whitney	PG,	Barr	DP,	Smyth	MJ,	Brooks	AG.	NK	cells	contribute	to	the	early	clearance	of	HSV-1	from	the	lung	but	cannot	control	replication	in	the	central	nervous	system	following	intranasal	infection.	Eur.	J.	Immunol.	2006;	36(4):897-905.		Schuetz	C,	Neven	B,	Dvorak	CC,	Leroy	S,	Ege	MJ,	Pannicke,	U.,	…	Cowan	MJ.	SCID	patients	with	ARTEMIS	vs	RAG	deficiencies	following	HCT:	increased	risk	of	late	toxicity	in	ARTEMIS-deficient	SCID.	Blood.	2014.	123(2),	281–289.			
  
41 
Siddiqui,	N.	and	Hope,	J.	Differential	recruitment	and	activation	of	natural	killer	cell	sub-populations	by	Mycobacterium	bovis-infected	dendritic	cells.	Eur.	J.	Immunol.	2013.	43:	159–169.	doi:	10.1002/eji.201242736		Skrombolas	D,	Frelinger	JG.	Challenges	and	developing	solutions	for	increasing	the	benefits	of	IL-2	treatment	in	tumor	therapy.	Expert	review	of	clinical	immunology.	2014.	10(2):207-217.	doi:10.1586/1744666X.2014.875856.		Suzuki	S,	Iwamoto	M,	Saito	Y,	Fuchimoto	D,	Sembon	S,	Suzuki	M,	Mikawa	S,	Hashimoto	M,	Aoki	Y,	Najima	Y,	Takagi	S,	Suzuki	N,	Suzuki	E,	Kubo	M,	Mimuro	J,	Kashiwakura	Y,	Madoiwa	S,	Sakata	Y,	Perry	AC,	Ishikawa	F,	Onishi	A.,	Frelinger	JG.	Il2rg	gene-targeted	severe	combined	immunodeficiency	pigs.	Cell	Stem	Cell.	2012.	10(6):753-8.			Suzuki	S,	Iwamoto	M,	Hashimoto	M,	Suzuki	M,	Nakai	M,	Fuchimoto	D,	Sembon	S,	Eguchi-Ogawa	T,	Uenishi	H,	Onishi,	A.	Generation	and	characterization	of	RAG2	knockout	pigs	as	animal	model	for	severe	combined	immunodeficiency.Vet	Immunol	
Immunopathol.	2016.	178.	37-49.			Talker	SC1,	Käser	T,	Reutner	K,	Sedlak	C,	Mair	KH,	Koinig	H,	Graage	R,	Viehmann	M,	Klingler	E,	Ladinig	A,	Ritzmann	M,	Saalmüller	A,	Gerner	W.	Phenotypic	maturation	of	porcine	NK-	and	T-cell	subsets.	Dev	Comp	Immunol.	2013.	40(1):51-68.			Toka	FN,	Nfon	C,	Dawson	H,	Golde	W.	Natural	Killer	Cell	Dysfunction	during	Acute	Infection	with	Foot-and-Mouth	Disease	Virus.	Clinical	and	Vaccine	Immunology	2009.	16(12).	1738-1749.		Varley	MA,	Fowler	VR,	Maitland	A.	A	rearing	system	for	colostrum-deprived	neonatal	piglets.	Lab	Anim.	1985;	19(4):290-296		Vivier	E,	Raulet	DH,	Moretta	A,	Caligiuri	MA,	Zitvogel	L,	Lanier	LL,	Yokoyama	WM,	Ugolini	S.	Innate	or	Adaptive	Immunity?	The	example	of	Natural	Killer	Cells.	Science.	2011.	331	(44);	44–49.		Wagner	SC,	Markosian	B,	Ajili	N,	et	al.	Intravenous	ascorbic	acid	as	an	adjuvant	to	interleukin-2	immunotherapy.	Journal	of	Translational	Medicine.	2014.	13(12).127.			Waide	EH,	Dekkers	JCM,	Ross	JW,	Rowland	RRR,	Wyatt	CR,	Ewen	C,	Thekkoot	DM,	Boddicker	NJ,	Tuggle	CK.	Not	all	SCID	pigs	are	created	equally:	Two	independent	mutations	in	Artemis	gene	found	to	cause	Severe	Combined	Immunodeficiency	(SCID)	in	pigs.	Journal	
of	Immunology.	2015.	195(7):3171-9.		Watanabe	M,	Nakano	K,	Matsunari	H,	et	al.	Generation	of	Interleukin-2	Receptor	Gamma	Gene	Knockout	Pigs	from	Somatic	Cells	Genetically	Modified	by	Zinc	Finger	Nuclease-Encoding	mRNA.	PLoS	ONE.		2013.	8(10).			 	
  
42 
CHAPTER	3.		
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Abstract	
After	the	discovery	of	naturally	occurring	Severe	Combined	Immunodeficiency	(SCID)	within	a	selection	line	of	pigs	at	Iowa	State	University	(ISU),	we	found	two	causative	mutations	in	the	Artemis	gene:	haplotype	12	(ART12)	and	haplotype	16	(ART16).	Bone	
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marrow	transplants	(BMTs)	were	performed	to	create	genetically	SCID	and	phenotypically	immune	competent	breeding	animals	to	establish	a	SCID	colony	for	further	characterization	and	research	utilization.	Of	nine	original	BMT	transfer	recipients,	only	four	achieved	successful	engraftment.	At	approximately	eleven	months	of	age,	both	animals	homozygous	for	the	ART16	mutation	were	diagnosed	with	T-cell	lymphoma.	One	of	these	ART16/ART16	recipients	was	a	male	who	received	a	transplant	from	a	female	sibling;	the	tumors	in	this	recipient	consist	primarily	of	Y	chromosome-positive	cells.	The	other	ART16/ART16	animal	also	presented	with	leukemia	in	addition	to	T-cell	lymphoma,	while	one	of	the	ART12/ART16	compound	heterozygote	recipients	presented	with	a	nephroblastoma	at	a	similar	age.	Human	Artemis	SCID	patients	have	reported	cases	of	lymphoma	associated	with	a	‘leaky’	Artemis	phenotype.	The	naturally	occurring	Artemis	SCID	pig	offers	a	large	animal	model	more	similar	to	human	SCID	patients	and	may	offer	a	naturally	occurring	cancer	model	and	provides	a	valuable	platform	for	therapy	development.	 		Case	Presentation	
	After	the	discovery	of	the	SCID	phenotype	in	pigs	at	ISU,	the	phenotype’s	genetic	cause	was	determined	to	be	two	independent	mutations	originally	segregating	from	independent	founders.	To	further	characterize	the	SCID	pig	and	to	maintain	a	research	population,	bone	marrow	transplantations	(BMTs)	were	performed	on	select	individuals.	Interestingly,	of	four	successful	transplants,	three	developed	hematological	malignancies	with	possible	implications	from	their	different	genetic	background	as	described	herein.		
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	Matings	between	heterozygous	dams	and	a	sire	for	either	ART12	or	ART16	produced	litters	from	which	25%	of	piglets	had	the	SCID	phenotype	and	required	BMT	to	rescue.	This	would	result	in	genetically	SCID	animals,	but	phenotypically	competent	immune	systems.	If	fertile,	these	animals	would	allow	SCID	to	carrier	matings	producing	litters	of	50%	SCID	piglets,	which	would	be	advantageous	for	experimental	and	characterization	work.		After	farrowing,	tissues	samples	were	tested	for	Artemis	genotype	and	MHC	haplotype.	Between	four	litters	across	two	rounds	of	transplantation,	nine	SCID	piglets	were	transplanted	with	unfractionated	bone	marrow	from	100%	matched	MHC,	opposite	sex	donors,	by	intravenous	injection.	Of	the	nine	recipients,	five	were	euthanized	due	to	degrading	health	within	the	first	three	months	post	transplantation.	While	not	studied	in	detail,	these	five	had	cutaneous	clinical	signs	(skin	rash)	similar	to	Graft	versus	Host	Disease	(GvHD),	which	lessened	with	the	use	of	topical	and/or	systemic	steroid	treatments	(details	not	shown).	Since	the	purpose	of	the	BMT	experiments	were	to	create	fertile	adults,	diagnostics	to	confirm	GvHD	were	not	performed	and	the	continuous	use	of	steroids	was	felt	to	be	incompatible	with	this	purpose.	Only	the	four	recipients	that	were	free	of	these	symptoms	were	carried	forward.			These	four	transplant	recipients,	consisting	of	two	ART16/ART16	pigs	from	the	first	round	of	transplants	and	two	ART12/ART16	pigs	from	the	second,	achieved	successful	engraftment.	We	monitored	lymphocyte	numbers,	production	of	specific	antibodies	in	response	to	vaccination,	and	presence	of	Y	chromosome	as	engraftment	parameters.	Lymphocyte	numbers	were	evaluated	using	complete	blood	counts	(CBC)	every	two	weeks	
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after	BMT	and	found	that	lymphocytes	reached	a	near	normal	level	around	approximately	8-10	weeks	post	BMT	(Fig	1A).	As	the	capability	to	mount	an	antibody	response	to	vaccination	would	be	a	strong	indicator	of	engraftment	success,	both	ART16/ART16	animals	were	injected	with	killed	porcine	circovirus	type	2	(PCV2)	vaccine	10-11	weeks	post	BMT	and	again	14-15	weeks	post	BMT.	Serum	was	analyzed	every	two	weeks	for	immunoglobulin	(Ig)G	or	IgM	against	PCV2.	As	seen	in	Fig	1B	for	IgG,	and	in	Fig	1C	for	IgM,	both	animals	mounted	successful	antibody	responses.	Of	note,	in	Fig	1B,	initial	levels	of	IgG	that	decreased	during	the	first	12-14	weeks	of	life	are	consistent	with	maternal	antibody	decay.	Finally,	because	donors	were	opposite	sex	to	recipients,	we	measured	the	amount	of	
SRY	DNA	(Y	chromosome)	content	in	the	female	BMT	recipients,	which	as	expected	with	successful	engraftment,	increased	over	time	in	both	peripheral	blood	mononuclear	cells	(PBMCs)	and	whole	blood	(Fig	1D,	1E).			Three	of	the	four	successful	bone	marrow	transplants	were	euthanized	from	11-13	months	of	age,	and	the	last	one	at	four	years	of	age,	due	to	deteriorating	health.	The	significant	pathology	findings	are	described	below.	Descriptions	of	pathology	follow	veterinary	medicine	standards	of	scoring	and	grading	for	neoplasm	classification.			Pig	one	(BMT1)	was	a	13-month	old	ART16/ART16	male	that	presented	with	a	thoracic	mass.		This	was	a	30cm	tan	solid	mass	located	immediately	rostral	to	the	heart.	This	mass	had	infiltrated	the	thoracic	aorta,	cranial	mediastinum,	and	pericardium.		Similar	masses	1-6	cm	in	diameter	were	observed	within	the	lungs,	and	on	the	parietal	pleural	of	the	chest	wall	(Fig	2A)	and	diaphragm.		Microscopically	these	masses	were	composed	of	
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densely	packed	sheets	of	small	to	medium	sized	lymphocytes	(Fig	3A).	Immunohistochemistry	on	the	mediastinal	mass	with	CD3	(T	cell)	and	CD79	(B	cell)	specific	antibodies	demonstrated	that	neoplastic	cells	stained	uniformly	for	CD3	and	were	negative	for	CD79	(Fig	3B)	(Fig	3C).	This	staining	profile	indicates	that	the	neoplastic	lymphocytes	had	a	T	cell	phenotype.	A	QPCR	analysis	of	the	SRY	gene	for	three	separate	16/16	male	tumor	samples	assaying	for	the	Y	chromosome	showed	that	the	tumors	were	derived	from	cells	of	the	recipient	male	rather	than	from	female	donor	bone	marrow	cells	(see	Table	1).	While	the	variation	in	male	cell	percentage	is	unclear,	we	speculate	that	variable	amounts	of	female	donor	cells	were	present	in	the	immune	tissue	as	part	of	the	biopsy,	explaining	the	variation	of	SRY	presence	from	the	tumor	sections	seen	in	Table	1.			Pig	two	(BMT2),	an	11-month	old	ART16/ART16	female	had	a	5	cm	tan	cranial	mediastinal	mass	(Fig	2B).	Microscopically	the	mass	was	composed	of	densely	packed	uniform	sheets	of	small	to	medium	sized	neoplastic	lymphocytes	similar	to	those	seen	in	Fig	3A	for	BMT1.	Neoplastic	lymphocytes	had	scant	to	moderate	amounts	of	cytoplasm	with	a	small	round	nucleus.	The	mitotic	rate	was	low.	Neoplastic	lymphocytes	were	also	identified	microscopically	in	the	bone	marrow,	lymph	node,	thymus,	lung,	colon,	and	small	intestine.	Antemortem	CBCs	demonstrated	abnormally	high	numbers	of	circulating	lymphocytes	suggesting	extension	of	neoplastic	lymphocytes	into	circulation.	Neoplastic	lymphocytes	were	diffusely	positive	for	CD3	and	negative	for	CD79	as	seen	in	Fig	3B	and	3C.	These	findings	are	consistent	with	a	diagnosis	of	T	cell	lymphoma.	Based	on	the	morphology	and	phenotype	of	neoplastic	lymphocytes	and	their	distribution	in	tissues	and	
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blood	a	diagnosis	of	chronic	lymphocytic	leukemia	was	made,	though	multicentric	T	cell	lymphoma	with	a	leukemic	blood	profile	could	not	be	definitively	excluded.			Pig	three	(BMT3),	ART12/ART16	male	lived	until	four	years	of	age.	He	had	severe	distention	of	the	pericardium	by	clear	fluid	and	there	was	~2	liters	of	clear	fluid	in	the	abdominal	cavity.	The	epicardial	surface	was	covered	in	a	friable	dark	brown	exudate.	Microscopically	this	exudate	consisted	of	immature	fibrous	connective	tissue	that	was	infiltrated	by	macrophages	and	lymphocytes.	In	the	subendocardium	there	was	myocyte	loss	and	fibrosis.	Additional	microscopic	changes	were	present	in	the	liver	where	there	was	congestion	of	centrilobular	sinusoids	and	necrosis	of	centrilobular	hepatic	cords.	Together	these	gross	and	microscopic	changes	indicate	right-sided	heart	failure.	An	underlying	etiology	was	not	identified.	However	bacterial	agents	such	as	Mycoplasma	hyorhinis	and	
Haemophilus	parasuis	would	be	possible.	No	evidence	of	a	neoplastic	process	was	identified	in	BMT3.			Pig	four	(BMT4)	was	a	ART12/ART16	female	12	months	of	age	that	had	a	20x30	cm	irregular	mass	in	the	retroperitoneal	space	which	compressed	the	right	kidney.		The	right	kidney,	caudal	vena	cava,	and	a	loop	of	duodenum	were	attached	to	the	mass	via	firm	fibrous	adhesions.	Microscopically	the	mass	was	composed	of	a	population	of	neoplastic	epithelial	cells	arranged	into	irregular	tubular	structure	separated	by	densely	packed	streams	of	spindle	shaped	cells.		The	mitotic	rate	was	high	in	both	the	epithelial	and	mesenchymal	populations	with	1-2	mitoses	per	400x	field.		The	location	of	the	neoplasm,	and	its	gross	and	microscopic	features	were	consistent	with	a	diagnosis	of	nephroblastoma.		
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	BMT1,	the	first	male,	was	fertile	and	a	number	of	doses	of	semen	were	collected,	which	have	been	used	subsequently	to	successfully	create	litters.	The	second	male,	BMT3,	lived	four	years	as	a	successful	breeding	boar,	having	created	over	eight	litters	in	that	time,	and	for	which	semen	was	also	collected	and	frozen	and	is	being	used	for	additional	litters.			
Background	
	Severe	Combined	Immunodeficiency	(SCID)	is	defined	as	the	lack	or	impairment	of	the	adaptive	immune	system	and	can	be	caused	by	over	30	gene	defects	(Cossu,	2010).	In	addition	to	humans,	SCID	is	naturally	occurring	in	the	horse	(Perryman	et	al.	2014),	dog	(Meek	et	al.	2001),	mouse	(Barthels	et	al.		2013),	and	as	of	2012,	the	pig	(Cino-Ozuna	et	al.		2012).	This	SCID	pig	was	serendipitously	discovered	during	a	virus	challenge	study	in	collaboration	with	Kansas	State	University	with	ISU	Yorkshire	pigs	that	had	been	divergently	selected	for	feed	efficiency	(Cai	et	al.	2011).	Four	pigs	died	unexpectedly	early	in	the	trial	and	during	routine	necropsy	presented	with	symptoms	consistent	with	SCID:	virtually	absent	of	antibodies,	lacked	or	had	an	unusually	small	thymus,	and	presented	additional	underdeveloped	immune	tissues	(Cino-Ozuna	et	al.		2012).	A	genome-wide	association	study	(GWAS)	identified	a	strong	correlation	between	the	SCID	phenotype	and	a	candidate	peak	on	chromosome	10,	which	contains	the	Artemis	(DCLRE1C)	gene	(Waide	et	al.	2015).	During	Variable	(V),	Diversity	(D),	and	Joining	(J)	segment	recombination,	the	endonuclease	Artemis	cleaves	open	the	hairpin	loop	created	by	recombination	activating	genes	(RAG)1	and	RAG2	(Cossu	2010)(Schuetz	et	al.	2014).	Thus	individuals	with	severe	
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Artemis	defects	cannot	create	mature	lymphocytes	with	B	Cell	Receptors	(BCR)s	or	T	Cell	Receptors	(TCR)s,	causing	an	Artemis	SCID	phenotype	(Schuetz	et	al.	2014).	Although	genetically	engineered	SCID	pigs	exist	for	modified	interleukin-2	receptor	g	gene	(IL2RG)	(Suzuki	et	al.	2012)(Watanabe	et	al.	2013)	as	well	as	for	RAG1	and/or	2	(Huang	et	al.	2014)(Lee	et	al.	2014),	the	ISU	SCID	pig	is	the	only	naturally	occurring	SCID	pig.	Consistent	with	human	SCID	Artemis	patients,	the	ISU	SCID	pig	is	radiosensitive,	and	has	a	T	cell-,	B	cell-,	Natural	Killer	(NK)	cell+	phenotype	(Waide	et	al.		2015)	(Powell	et	al.		2016)	(Ewen	et	al.	2015).		Interestingly,	two	separate	point	mutations	within	the	Artemis	gene	are	responsible	for	the	SCID	phenotype	(Waide	et	al.	2015).	Termed	ART12	and	ART16,	these	alleles	travel	in	a	Mendelian	recessive	mode	of	inheritance	in	either	homozygous	(ART12/ART12,	ART16/ART16	)	or	compound	heterozygous	(ART12/ART16)	states	(Waide	et	al.	2015).	The	ART12	allele	has	a	point	mutation	in	exon	10	that	creates	a	frameshift	and	premature	stop	codon,	which	results	in	less	than	40%	of	the	Artemis	protein	produced:	thus	animals	carrying	homozygous	ART12	mutations	are	expected	to	have	no	Artemis	activity	(Waide	et	al.	2015).	The	ART16	mutation	abrogates	a	5’	splice	site	signal	sequence	in	intron	8	that	alters	a	splice	signal	sequence,	and	causes	the	deletion	of	141	nucleotides	and	exon	8.	As	this	deletion	does	not	compromise	the	reading	frame,	it’s	possible	the	transcripts	could	result	in	a	partially	functional	Artemis	protein	(Waide	et	al.	2015).	While	Artemis	VDJ	recombination	or	DNA	repair	activity	assays	for	a	collection	of	human	Artemis	patient	allele-encoded	proteins	have	been	performed	(Pannicke	et	al.,	2010,	Felgentreff	et	al.	2015),	there	are	no	reported	assays	involving	exon	8-only	deletions	or	missense	point	
  
50 
mutants.	It	is	interesting	that	such	assays	have	shown	partial	activity	for	point	mutants	in	exon	7	and	9,	(Felgentreff	et	al.	2015),	thus	the	swine	allele	with	the	ART16	mutation	affecting	exon	8	only	may	encode	a	partially	active	protein.	However,	transcripts	isolated	from	fibroblasts	derived	from	16	homozygous	pigs	show	many	different	structures,	with	only	a	minority	containing	a	deleted	exon	8	only.			
Discussion		In	summary,	both	ART16/ART16	BMT	pigs	(BMT1,	BMT2)	were	diagnosed	with	neoplastic	disease	of	T	lymphocytes,	one	with	T	cell	lymphocytic	leukemia	and	each	with	T	cell	lymphoma.	The	third	successful	BMT	pig	was	found	to	have	chronic	heart	failure	(BMT3),	and	a	nephroblastoma	was	found	in	the	last	BMT	pig,	BMT4;	both	were	of	the	ART12/ART16	heterozygous	genotype.				Although	the	ISU	SCID	pigs	have	a	T-B-NK+	environment,	we	showed	successful	bone	marrow	engraftment	increased	lymphocytes	to	within	normal	ranges,	a	positive	antibody	response	to	vaccination,	and	in	female	recipients	who	received	male	donor	cells,	an	increase	in	Y	chromosome	(SRY	gene)	detection	over	time	after	transplantation.	The	presence	of	functional	NK	cells	in	the	SCID	environment	has	been	known	to	affect	engraftment	success	of	BMT	procedures	as	well	as	the	likelihood	of	Graft	versus	Host	Disease	(Hassan	et	al.	2014).	This	is	an	obstacle	for	human	SCID	patients	that	we	may	be	able	to	model	and	improve	therapies	by	using	the	NK+	ISU	SCID	pig.			
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The	ISU	SCID	pig	is	well-poised	as	a	biomedical	cancer	model.	The	SCID	pig	does	not	reject	xenotransplants,	as	growth	of	human	pancreatic	carcinoma	and	human	melanoma	cells	was	established	in	the	ears	of	SCID	piglets	but	not	in	non-SCID	littermates	(Basel	et	al.	2012).	The	ability	of	SCID	pigs	to	allow	growth	of	human	cells	creates	a	potential	model	for	investigating	stability	and	efficacy	of	stem	cell-derived	therapies	for	many	medical	conditions.	Such	pigs	also	provide	a	disease	model	to	study	and	improve	therapies	for	human	SCID	patients.	One	such	example	would	include	the	improvement	of	BMTs,	which	is	a	common	therapy	to	rescue	the	SCID	phenotype	(Hassan	et	al.	2014).	The	size	and	anatomical	similarities	between	pigs	and	humans	compared	to	classic	rodent	models	also	facilitates	novel	approaches	to	pharmacology	and	drug	dosing	research	important	to	improving	human	patient	therapies.	Although	several	versions	of	SCID	mice	have	been	genetically	engineered	as	biomedical	models,	the	pig	is	more	physiologically	similar	in	anatomy	and	size	to	a	human	than	is	the	mouse	(Meurens	et	al.	2011)	in	addition	to	having	a	more	similar	“immunome”	(Dawson	et	al.	2013),	which	may	make	research	therapy	progress	in	pigs	more	directly	applicable	to	the	human	patient.			Furthermore,	‘leaky’	behavior	of	some	Artemis	defects	has	been	shown	to	exist	in	human	Artemis	patients	and	can	be	associated	with	lymphoma	(Moshous	et	al.	2003).	SCID	causing	mutations	that	are	hypomorphic	can	sometimes	result	in	low	level	development	of	circulating	T	cells	described	as	leaky	SCID	(LS)	(Moshous	et	al.	2003),	and	a	LS	mouse	model	has	recently	been	developed	for	Artemis	(Humblet-Baron	et	al.	2017).	LS	SCID	patients	are	still	severely	at	risk	from	pathogen	threat	and	often	have	additional	autoimmune	complications	caused	by	a	lack	of	appropriate	immune	signaling	of	existing	T	
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cells	(Moshous	et	al.	2003).	Along	with	the	increased	risk	of	lymphoma	in	leaky	human	Artemis	patients	(Moshous	et	al.	2003),	Artemis	patients	are	at	much	higher	risk	for	late-stage	infection	following	BMT	procedures	and	for	repeat	of	such	BMT	(Schuetz	et	al.	2014).	In	a	2013	review	describing	14	SCID	patients	affected	by	a	hypomorphic	Artemis	mutations,	three	patients	presented	with	lymphoma	(associated	with	Epstein	Barr	virus),	six	were	successfully	rescued	by	transplantation,	and	three	that	received	transplants	died	due	to	complications	(Lee	et	al.	2013).	It	is	conceivable	that	the	homozygous	ART16	SCID	pig	could	produce	a	partial	Artemis	protein	demonstrating	a	leaky	phenotype.	More	characterization	and	long-term	analysis	of	ART16/ART16	would	be	necessary	to	confirm	this	pathogenesis.	Regardless,	especially	considering	the	dearth	of	lymphoma	large	animal	biomedical	models,	the	naturally	occurring	SCID	pig	offers	a	relevant	model	for	treatment	and	therapy	research.			
Concluding	Remarks		 The	pig	is	more	similar	immunologically	and	physiologically	to	the	human	than	the	mouse.	Thus	a	porcine	model	without	adaptive	immunity	is	valuable	for	studying	immune	cell	subsets,	regenerative	medicine,	and	therapeutic	strategies	for	cancer	treatment.	The	repeated	occurrence	of	cancer	within	such	a	limited	number	of	animals	and	the	unique	cases	of	lymphoma	and	leukemia	herein	suggest	the	ART16/ART16	homozygous	SCID	pig	may	be	a	valuable	tool	to	study	specific	forms	of	cancer,	and	potentially	model	treatments	for	human	lymphoma/leukemia	patients.		
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Materials	and	Methods		All	animal	work	was	conducted	in	accordance	with	USDA	guide	to	large	animal	requirements	in	the	Animal	Welfare	Act	and	approved	by	the	Institutional	Animal	Care	and	Use	Committee	(IACUC).		
Creation	of	SCID	Litters:	Carrier	x	carrier	matings	were	conducted	to	produce	litters	expected	to	contain	25%	SCID	affected	piglets.	DNA	was	isolated	from	ear	or	tail	tissue	after	piglet	processing	and	shipped	to	Gift	of	Life	Michigan	for	MHC	typing.	SCID	status	was	determined	through	PCR	testing	as	described	in	Waide	et	al.	2015.		
	
Swine	leukocyte	antigen	(SLA)	genotyping:	SLA	genotyping	of	three	class	I	(SLA-1,	SLA-2,	
SLA-3)	and	three	class	II	(DRB1,	DQB1,	DQA)	genes	was	performed	using	PCR-based	assays	with	sequence-specific	typing	primers	as	previously	described	[Ho	et	al.	2009)(Ho	et	al.	2010).	Modifications	were	made	to	the	typing	primer	panels	to	broaden	the	allele	coverage	with	the	increasing	number	of	SLA	alleles.	Parental	SLA	haplotypes	and	allele-level	resolution	were	assigned	based	on	published	data	(Smith	et	al.	2005	(1))	(Smith	et	al.	2005	(2))	(Ho	et	al.	2008),(Lunney	et	al.	2009)	and	confirmed	by	inheritance	and	segregation	in	the	offspring.	
	
Bone	Marrow	Preparation:	Donor	femurs	were	aseptically	removed,	washed	in	ethanol,	and	moved	to	a	sterile	biological	safety	cabinet.	Bone	ends	were	cut	to	expose	the	marrow.	Using	a	syringe	and	needle,	marrow	was	flushed	with	HBSS	(Sigma	cat#	H6648)	into	a	sterile	beaker.	Bone	marrow	particles	were	aspirated/triturated	and	spun	at	1500	rpm	for	
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5	min.		Supernatant	was	removed	and	cells	resuspended	in	100	ml	ACK	(Lonza	No.:10548E)	and	incubated	at	RT	for	10	minutes.	The	marrow	suspension	was	filtered	through	a	cell	strainer	(Falcon,	Cat#	352350).	The	supernatant	was	removed	and	resuspended	in	10	ml	HBSS	and	spun	at	1500	rpms	for	5	min.	The	wash	was	repeated	and	cell	suspension	was	counted	for	live	cells	prior	to	injection	using	a	hemocytometer.			
Bone	Marrow	Transplants:	BMTs	were	performed	via	intravenous	injection	of	unfractionated	bone	marrow	cells	from	100%	MHC	matched,	opposite	sex	full	or	half-sib	donors	so	that	sex	chromosome	assays	could	be	used	for	tracking	donor	cells.	All	available	cells	from	donor	piglet	were	injected	into	the	MHC	matched	recipient	(typically	between	1-8	x	109	cells/kg).				
Monitoring	of	Engraftment:	Engraftment	was	determined	through	monitoring	complete	blood	counts	(CBC)	for	lymphocytes,	Y	chromosome	detection	via	quantitative	PCR	(QPCR)	of	the	SRY	gene,	and	response	to	vaccination.		
Complete	Blood	Counts:	CBCs	were	performed	on	EDTA	treated	blood	samples	at	various	dates	with	an	automated	cell	counter	at	the	Clinical	Pathology	Laboratory	in	the	College	of	Veterinary	Medicine	at	Iowa	State	University.			
Y	Chromosome	Detection:	Y	Chromosome	presence	was	determined	through	PCR	detection	of	the	SRY	gene	(RefSeq	assembly	accession:	GCF_000003025.5)	in	whole	blood,	PBMCs,	and	tissue	DNA	samples	prepared	using	standard	Phenol-Chloroform	isolation.		
  
55 
Initial	primer	sequences	were	from	Pomp	et	al.	1995	but	were	modified	to	increase	efficiency	to	a	final	assay	utilizing	the	following	primers:	Forward	primer	5’-GAGGGCACAGAATTTGCTTC-3’	Reverse	primer	5’-GGCTTTCTGTTCCTGAGCAC-3’	Conditions	were	taken	from	the	Pomp	et	al.	paper	(1995).	This	protocol	was	modified	to	increase	PCR	efficiency	by	changing	to	a	two-step	amplification.	There	was	a	95°C	degree	ramp	up	for	5	min	followed	by	40	cycles	of	95°C	for	2	min	then	62°C	for	1	min.	For	quantitative	PCR,	a	Bio-Rad	MyIQ	Real	Time	Thermal	Cycler	was	used	with	a	melting	curve	to	determine	PCR	product	specificity.		
Response	to	Vaccination:	The	ability	to	mount	an	antibody	response	to	vaccination	was	measured	to	test	the	existence	of	a	functionally	recovered	adaptive	immune	response	after	BMT.	Animals	were	vaccinated	with	Circumvent	(Merck	Animal	Health	product	103904)	against	porcine	Circovirus	type	2	(PCV2)	10-11	weeks	post	BMT	and	again	14-15	weeks	post	BMT.	Serum	samples	were	collected	every	two	weeks	and	analyzed	via	Fluorescent	Microsphere	ImmunoAssay	(FMIA)	for	total	immunoglobulin	(Ig)	as	well	as	IgM	against	PCV2	(Stephenson	et	al.	2015).			
Immunohistochemistry	staining:	Unstained	3µm	thick	slides	were	prepared	from	formalin	fixed	paraffin	embedded	tissues.	The	CD79	(DAKO	monoclonal	mouse	anti-human,	B-cell	clone	HM57)	primary	antibody	was	used	at	a	concentration	of	200µg/ml	and	the	CD3	primary	antibody	(DAKO	monoclonal	mouse	anti-human,	F7.2.38)	was	used	at	a	concentration	of	0.60µg/ml.	CD3	antibody	was	incubated	for	90min	and	CD79	for	60min	at	
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room	temperature.	Appropriate	secondary	antibodies	were	used	for	15	min	with	multilink	(1.25mg/ml)	HRP	(2.5mg/2ml)	detection	system.		
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Figures	
	
	
	Figure	1.	Engraftment	parameters	of	SCID	pigs	after	opposite	sex,	100%	MHC	
matched	donor	bone	marrow	transplantation.	A)	Recovery	of	lymphocyte	numbers	to	within	a	normal	range	of	BMT	SCID	pigs	(dashed	line)	compared	to	non-SCID	littermates	(solid	line)	monitored	by	CBC	counts	ever	two	weeks	after	transplant.	B)	Antibody	response	to	vaccination	for	Circumvent	(against	circovirus)	for	both	ART16/ART16	pigs	(BMT1,	BMT2)	for	total	IgG	and	C)	IgM.	Only	applicable	to	female	recipients	of	male	donor	cells,	pig	SRY	gene	expression	(detection	of	Y	Chromosome)	was	determined	as	a	percentage	of	sample	from	D)	isolated	PBMC’s	and	E)	whole	blood	from	BMT2,	BMT4.	
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	Figure	2.	Gross	Pathology	images	of	two	separate	ART16/ART16	pigs	(BMT1,	BMT2)	
diagnosed	with	T	cell	Lymphoma.	A)	Multiple	smooth	tan	nodules	1-6	cm	in	diameter	in	the	lung	from	BMT1	and	similar	B)	tan	cranial	mediastinal	mass	of	thymic	origin	from	BMT2.					
		Figure	3.	Histologic	staining	documenting	characteristic	T	cell	lymphoma.		A)	An	
example	of	the	neoplastic	sheets	collected	from	thoracic	tumor.	B)	Stained	tumor	mass	showing	CD3+	T	cell	positive	phenotype.	C)	Stained	tumor	mass	showing	CD79-	B	cell	negative	tissue	staining.			 	
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Tables		Table	1.	Y	Chromosome	Detection	in	Tumor	Samples:	Percent	male	(concentration	of	
SRY	Y	chromosome	detection)	of	various	tumor	samples	of	BMT1,	the	homozygous	ART16	male,	diagnosed	with	T	cell	lymphoma.		Tumor	Sample	 Percent	Male	(%)	Neoplastic	I		 46.20%	Neoplastic	II	 60.24%	Neoplastic	III	 97.68%		
  
63 
CHAPTER 4. 
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Abstract		 Severe	Combined	ImmunoDeficiency	(SCID)	is	defined	by	the	lack	of	an	adaptive	immune	system.	Mutations	causing	SCID	are	found	naturally	in	humans,	mice,	horses,	dogs,	and	recently	in	pigs,	with	the	serendipitous	discovery	of	the	Iowa	State	University	SCID	pigs.	As	research	models,	SCID	animals	are	naturally	tolerant	of	xenotransplantation	and	offer	valuable	insight	into	research	areas	such	as	regenerative	medicine,	cancer	therapy,	as	well	as	immune	cell	signaling	mechanisms.	Large	animal	biomedical	models,	particularly	swine,	are	increasingly	essential	to	advance	the	efficacy	and	safety	of	novel	regenerative	therapies	on	human	disease.		Thus	there	is	need	to	create	practical	approaches	to	maintain	hygienic	severe	immunocompromised	swine	models	for	exploratory	medical	research.	Such	research	often	requires	stable	genetic	lines	for	replication	and	survival	of	healthy	SCID	animals	for	months	post	treatment.	A	further	hurdle	in	the	development	of	the	ISU	SCID	pig	as	a	biomedical	model	involved	the	establishment	of	facilities	and	protocols	necessary	to	obtain	clean	SPF	piglets	from	the	conventional	swine	farm	on	which	they	were	discovered.		A	colony	of	homozygous	SCID	boars	and	SPF	carrier	sows	has	been	created	and	maintained	through	selective	breeding,	bone	marrow	transplants,	innovative	husbandry	techniques	and	the	development	of	biocontainment	facilities.			
Introduction	
	 The	Iowa	State	University	Severe	Combined	ImmunoDeficiency	(SCID)	pigs	were	unexpectedly	discovered	during	a	viral	challenge	study	in	collaboration	with	Kansas	State	University	(Cino	Ozuna	et	al.	2012).	Animals	that	died	early	in	the	trial	revealed	a	complete	
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lack	of	antibodies	and	dysplastic	immune	tissues	(thymus,	spleen,	and	lymph	nodes).	Genetic	analysis	using	genome	wide	association	study	(GWAS)	revealed	a	significant	peak	on	chromosome	10	corresponding	to	the	location	of	the	Artemis	gene,	which	is	associated	with	human	SCID	(Waide	et	al.	2015;	Cossu	2010).	It	was	determined	that	two	separate	point	mutations	within	the	Artemis	gene	segregate	in	a	Mendelian	recessive	mode	of	inheritance	in	which	homozygotes	or	compound	heterozygotes	produce	the	SCID	phenotype	(Waide	et	al.	2015).	Consistent	with	human	Artemis	SCID	patients,	early	in	life	the	ISU	SCID	pig	is	devoid	of	B	and	T	cells,	but	have	a	population	of	natural	killer	(NK)	cells	that	demonstrate	normal	function	in	vitro	(Powell	et	al.	2016).		While	SCID	is	naturally	occurring	in	humans,	mice,	dogs,	horses	and	now	pigs	(Cossu	2010;	Bosma	et	al.	1983;	Perryman	et	al.	2004;	Cino	Ozuna	et	al.	2012)	it	has	also	been	introduced	into	rodent	and	swine	hosts	for	use	as	biomedical	models	through	targeted	genetic	modification	(Ito	et	al.	2012;	Huang	et	al.	2014;	Suzuki	et	al.	2012;	Lee	et	al.	2014	;	reviewed	in	Powell	et	al.	2017).	Both	SCID	mice	and	pigs	characteristically	accept	xenotransplants,	and	thus	make	excellent	test	subjects	for	cancer	research	and	cell-based	therapeutics	in	regenerative	medicine.	A	related	use	of	SCID	animals	is	‘humanization’	studies	with	the	engraftment	of	human	hematopoietic	stem	cells	into	an	immune	compromised	host	creating	a	human	immune	system	in	the	SCID	animal.	This	facilitates	a	non-human	research	model	to	explore	species-specific	pathogens	such	as	HIV	and	Hepatitis	C	(Ito	R	et	al.	2012).		The	ISU	SCID	pig	facilitates	the	growth	of	two	kinds	of	human	cancer	cell	lines	when	injected	into	the	ear	(Basel	et	al.	2012),	establishing	its	value	for	research	in	cancer	drug	testing.	The	ISU	SCID	pig	has	also	been	used	to	explore	the	roles	of	the	innate	and	adaptive	
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immune	system	during	disease	challenge,	contributing	to	research	focusing	on	mechanisms	of	disease	for	influenza	A	(Rajao	et	al.	2017).	Although	there	is	widespread	interest	in	developing	SCID	pigs	as	a	research	model,	little	research	is	available	on	the	care	of	large	animal	SCID	models.		 Specific	Pathogen	Free	(SPF)	SCID	mice	colonies	are	typically	cared	for	in	a	‘barrier	facility’	with	group	housing	boxes	under	HEPA	filtered	conditions	(Matsumoto	et	al.	1995).	Staff	interacting	with	animals	follow	strict	personal	protective	equipment	(PPE)	requirements	and	animals	are	maintained	with	autoclaved	feed	and	bedding	(Dietrich	et	al.	1996).	Large	animals	facilities	have	many	more	parameters	to	balance	considering	the	size	and	requirements	of	swine.	We	have	been	unable	to	keep	the	immune	compromised	SCID	pig	alive	for	more	than	80	days	in	a	conventional	pig	holding	facility	or	within	an	isolated	standard	animal	room.	Similar	viability	of	SCID	pigs	including	failure	to	thrive	phenotypes	were	described	after	engineering	defective	Recombination	Activating	Genes	(RAG)	SCID	pigs	who	had	to	be	terminated	before	30	days	of	age	(Lee	et	al.	2014).	To	improve	the	research	potential	of	the	SCID	pig	model	by	producing	longer-lived,	healthy	SCID	pigs,	development	of	biocontainment	facilities	and	appropriate	methodologies	to	raise	SPF	SCID	pigs	are	needed.			 Current	approaches	for	obtaining	SPF	piglets	from	non-SPF	sows	include	snatch	farrowing	with	milk	replacer	or	a	bovine	colostrum	alternative	supplementation	(Huang	et	al.	2013),	as	well	as	cesarean	derived,	colostrum	deprived	(CDCD)	practices	(Madson	et	al.	2016).		The	production	of	dried	replacement	bovine	colostrum	is	an	involved	process	(Chelack	et	al.	1993),	and	does	not	protect	the	piglet	from	swine-specific	pathogens	with	antibodies	they	would	normally	receive	from	their	vaccinated	sow.	The	risks	of	colostrum	
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deprivation	(CD)	are	well	understood,	and	include	mortality,	reduced	protection	from	clinical	disease,	and	significantly	lower	hematocrit	and	hemoglobin	levels	compared	to	naturally	sucking	piglets	(Lecce	1969;	Varley	et	al.	1985;	Meyer	et	al.	1964;	Blanco	et	al.	2004;	Gomez	et	al.	1998).	Colostrum	consumption	is	positively	associated	with	general	piglet	immunity,	survival,	and	growth	(Blanco	et	al.	2004;	Devillers	et	al.	2011).	An	interesting	study	(Gomez	et	al.	1998)	compared	circulating	IgG	levels	between	naturally	suckling	and	CD	piglets:	the	CD	piglets	were	fed	either	milk	replacer,	bovine	colostrum,	or	pig	immunoglobulin	(IgG).	Naturally	suckling	piglets	achieved	the	highest	levels	of	total	IgG,	while	supplementation	with	bovine	or	pig	IgG	was	sufficient	for	100%	survival	of	piglets.	However,	only	30%	of	the	CD	and	unsupplemented	piglets	survived	(Gomez	et	al.	1998).	While	much	of	the	CD	piglet	rearing	literature	was	developed	prior	to	the	availability	of	SCID	pigs,	these	results	indicate	that	various	options	may	be	available	to	rear	SCID	pigs	isolated	from	their	nursing	sow,	which	is	the	main	source	of	disease	transmission	to	the	piglet.			This	manuscript	describes	the	facilities	and	protocols	developed	to	remove	opportunities	for	contamination	and	raise	SPF	SCID	and	non-SCID	pigs	derived	from	non-SPF	sows.	This	work	also	provides	examples	of	facilities	and	protocols	to	produce	disease-naive	pigs,	which	may	be	important	for	disease	challenge	studies.	The	farrowing	protocols	herein	described	provide	means	for	creating	founding	SPF	SCID	carrier	dams,	methods	to	introduce	new	genetics	or	replace	animals	within	an	established	SPF	colony,	and	provide	recommended	guidelines	for	researchers	seeking	to	develop	a	SCID	pig	model	containment	facility.			
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Animals	
	
IACUC	Statement:	All	care	and	animal	procedures	were	approved	by	the	Institutional	Animal	Care	and	Use	Committee	(IACUC)	and	adhere	to	the	USDA	guide	to	Large	Animals	and	the	Animal	Welfare	Act.	Captive	bolt	or	intravenous	overdose	of	sodium	pentobarbital	euthanasia	was	performed	by	trained	staff.		
SCID	pigs	and	non-SCID	littermates:	SCID	carrier	dams	were	raised	at	the	ISU	Lauren	Christen	Swine	farm.		Pregnant	SCID	carrier	dams	with	potential	to	produce	SCID	affected	piglets	for	biomedical	use	were	farrowed	in	facilities	with	high	sanitation	clean	rooms	at	the	ISU	College	of	Veterinary	Medicine.		
BMT	Rescued	SCID	Sires:	To	create	litters	composed	of	50%	SCID	piglets,	we	rescued	SCID	boars	via	bone	marrow	transplantation	(BMT),	which	resulted	in	a	genetically	SCID,	phenotypically	normal	animal	that	could	be	used	for	breeding.	Since	successful	BMT	boars	have	intact	immune	systems,	they	can	be	housed	in	clean,	more	traditional	swine	facilities	at	lower	cost.	To	accomplish	this,	SCID	piglet	containing	litters	were	MHC	typed	to	identify	recipient	and	donor	littermate	matches	(Powell	et	al.	submitted).	SCID	recipients	received	unfractionated	bone	marrow	cells	(isolated	from	all	long	bones	of	the	donor)	intravenously	delivered	via	an	ear	vein.	Successful	engraftment	was	verified	by	CBC,	flow	cytometry	and	response	to	vaccination.		
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Materials	and	Methods	
	
Maintenance	and	Construction	of	facility:	
Bubble	fabrication:	Custom	design	of	bubbles	was	completed	with	expertise	from	ISU,	SCID	project	leadership,	LAR	supervisors,	and	Biobubble,	Inc.,	who	created	the	final	design,	fabricated	and	installed	the	main	isolation	equipment.	Incoming	conditioned	city	water	is	UV-irradiated	and	filtered	(5	micron	before	the	UV	irradiation	and	0.5	micron	after	UV	irradiation)	(Fig	1	D).		
Room	sterilization:	Prior	to	animal	occupation,	rooms	are	sterilized	using	a	‘Halo’	HaloMist™	Disinfectant	Fogging	Solution	(halosil.com/halo-disinfection-system),	which	entails	a	hydrogen	peroxide/silver	mixture	aerosolized	treatment	of	the	room	and	any	resident	equipment.		
	
Maintenance	and	Care	of	animals:	
SCID	Carrier	Dams:	Before	leaving	the	Lauren	Christian	Swine	farm,	pregnant	carrier	sows	are	tested	by	blood	draw	for	Porcine	Reproductive	and	Respiratory	Syndrome	(PRRS),	Porcine	CircoVirus	(PCV2),	and	Porcine	Epidemic	Diarrhea	Virus	(PEDV)	through	the	ISU	Veterinary	Diagnostic	Laboratory	(VDL).	Test-negative	sows	are	washed	at	the	farm,	delivered	by	pre-sanitized	truck	and	trailer,	washed	again,	and	housed	in	a	high	sanitation	room	with	other	separately	penned	gestating	sows	within	the	LAR	facility.	A	week	before	farrowing,	animals	are	transferred	to	a	recently	“Halo”	aerosolized	cleaned	room	containing	a	farrowing	crate,	and	sows	are	cleaned	with	chlorhexidine.	Once	piglets	are	removed	(delivered	for	snatch	farrowing	(see	below),	or	weaned	for	naturally	
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farrowing)	sows	are	transferred	back	to	the	sow	room.	If	sows	are	to	be	used	for	artificial	insemination,	they	are	monitored	for	behavioral	estrus	(standing	heat)	with	a	cloth	sprayed	with	boar	pheromones	(Part	#:	320506,	QC	Supply	state,	country).	Alternatively,	adjusting	the	estrous	cycle	in	preparation	for	insemination	of	sows	was	accomplished	by	administering	15	mg/day	altrenogest	(Matrix,	Merck,	NJ,	USA)	orally	for	18	days	followed	by	one	dose	of	PG600	(Merck,	Part	#:	147448)	administered	intramuscularly	24	hours	after	last	Matrix	dose,	and	single	dose	of	Ovugel	(JBS	United,	NDC	#:	51233-101-50)	administered	intravaginally	at	approximately	80	hours	after	PG600	injection.	Behavioral	estrus	was	detected	typically	24-48	hours	post	Ovugel	administration,	at	which	point	animals	are	artificially	inseminated	using	fresh	or	frozen	semen	from	the	desired	sire.	Frozen	semen	was	prepared	by	Swine	Genetics	International	(SGI,	Cambridge,	IA),	stored	in	liquid	nitrogen,	and	prepared	for	use	using	SGI	instructions.	
Neonatal	Piglet	Care:	Naturally	farrowed	piglets	are	monitored	to	ensure	they	are	suckling.	Snatch	farrowed	piglets	are	delivered	by	personnel	wearing	PPE	(see	below)	without	touching	the	floor	or	crate	using	sterile	towels	and	transferred	into	sterile	rodent	boxes	with	air	filtered	lids	(Innovive,	Part	#:	RS1-H)	for	transport	to	the	short	term	bubble	(STB)	where	they	are	dried	with	Mistral	micronized	clay	(Part	#:	541005,	QC	Supply,	NE,	USA),	weighed,	and	placed	in	heat	lamp-warmed,	piglet	housing	decks	(Birthright™,	Yellow	Sow,	Ralco,	MN,	USA).	Within	the	first	24	hours	of	life,	snatch-farrowed	piglets	were	fed	a	minimum	of	250	mL	(Quesnel	et	al.	2012)	pooled	pig	colostrum	collected	previously	by	hand	by	staff	at	the	Lauren	Christian	Swine	Farm	from	farrowing	sows,	which	was	then	pasteurized	at	the	ISU	dairy	farm	using	standard	bovine	practices.	Confirmation	of	pasteurization	was	accomplished	with	a	Bulk	Tank	Analysis/Standard	Plate	Count	at	the	
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ISU	VDL	which	includes	the	detection	of	Streptococcus	agalactiae,	Staphylococcus	aureus,	coliforms,	gram	negative	rods	(lactose	negative),	non-	agalactiae	Streptococci,	coagulase-negative	Staphylococci,	Corynebacterium,		and	Bacillus,	Mycoplasma,	among	others.	Pasteurization	of	colostrum	dramatically	decreases,	but	does	not	eliminate,	microbial	counts.	For	example,	one	unpasteurized	colostrum	sample	had	colony	forming	units	(CFU)	counts	of	3.9	x	105	CFU/mL	while	post	pasteurization	averages	3.8	x	103	CFU/mL.	Piglets	were	fed	with	a	60	mL	syringe	and	attached	sterile	tubing	(Part	#:	366.78750.4,	Midwest	Veterinary	Supply	MN,	USA).	After	250	mL	colostrum	consumption,	piglets	are	converted	to	irradiated	milk	replacer,	and	eventually	starter	feed.		
General	Piglet	Care:	All	litters	are	processed	24-48	hours	post	birth;	piglets	were	ear	notched,	their	needle	teeth	clipped	and	tails	docked,	and	given	1	mL	of	each	iron	(Iron	Dextran	cat#	DU3067,	Durvet,	MO,	USA)	and	EXCEDE	(ceftiofur	crystalline	free	acid,	Zoetis,	NJ,	USA).	Piglets	are	weighed	daily	until	achieving	a	body	weight	of	20	kg,	and	weekly	thereafter	up	to	100	kg.	All	piglets	are	weaned	from	the	sow	or	from	milk	replacer	at	day	24-35	days	of	age	and	transitioned	to	an	irradiated	starter	feed.	All	feed	given	to	pigs	other	than	colostrum	(gestation,	starter,	and	milk	replacer	powder)	is	gamma-irradiated	(5kGy,	Iotron,	Inc).		Long	term	carrier	animals	are	vaccinated	following	standard	swine	farm	practices	including	Circumvent	PCV-M	(Intervet),	FarrowSure	Gold	B	(Pfizer),	LitterGuard	LT-C	(Pfizer).	To	aid	in	the	safety	and	efficiency	of	animal	handling,	as	well	as	increase	animal	enrichment,	pigs	in	our	facility	are	clicker	trained	with	marshmallow	rewards	for	regular	care	such	as	weighing,	toe	clipping,	vaccinations,	snaring,	and	additional	sample	collection.		
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IgG	ELISA:		A	sandwich	Enzyme	Linked	Immunosorbent	Assay	(ELISA)	was	used	to	quantify	pig	serum	IgG	concentration.	The	protocol	was	adapted	from	Bethyl	laboratories	Porcine	IgG	ELISA	protocols.	Briefly,	plate	wells	are	coated	with	polyclonal	goat	antibody	(Bethyl	labs	#A100-104A,	10	µg/mL).	Rinsed	plates	are	blocked	with	1%	Fetal	Bovine	Serum	(FBS)	in	phosphate	buffered	saline	(PBS)	and	capture	the	Fc	region	of	unconjugated	pig	IgG	reference	serum	(Bethyl	labs	#RS10-107)	or	serially	diluted	serum	sample.	After	washing,	secondary	horseradish	peroxidase	(HRP)	conjugated	antibodies	to	pig	IgG-Fc	(Bethyl	labs	#A100-104P,	1:15,000	dilution)	is	applied.	After	incubation	with	2,2'-azino-bis	(3-ethylbenzothiazoline-6-sulphonic	acid)	(ABTS)	substrate	buffer	in	citric	acid,	the	reaction	is	stopped	with	5%	Sodium	Dodecyl	Sulfate	(SDS)	and	the	plate	read	at	an	absorbance	of	405	nm	(SynergyHI,	BioTek,	Winooski,	VT).	Absorbance	data	is	collected	and	calculated	using	a	four	parameter	fit	curve	of	the	standard	curve	(Gen5	Software,	BioTek).		
Monitoring	for	disease	and	SPF	Testing:	
Biosecurity,	staff,	and	PPE:	Our	facility	features	different	levels	of	biosecurity,	and	PPE	guidelines	are	dependent	on	the	level	of	biosecurity	required.	Staff	interacting	with	animals	cannot	travel	from	one	level	to	a	higher	biosecurity	area	without	24	hours	down	time	and	at	least	one	shower	and	change	of	clothing.	To	enter	the	highest	biosecurity	region	(either	the	long	term	bubble	(LTB)	or	STB),	staff	must	have	not	been	into	contact	with	outside	swine	for	at	least	seven	days	and	a	minimum	of	five	showers.	Staff	remove	outer	clothing,	change	into	freshly	laundered	scrubs	and	socks,	then	don	protective	disposable	outer	shoe	covers,	zip-up	full-body	long-sleeved	plastic	suit	(Part	#:	4902,	
  
73 
Valumax,	PA,	USA),	surgical	mask,	hair	net,	a	pair	of	long	cuffed	gloves,	and	a	second	pair	of	short	cuffed	gloves.	Although	gloves	are	non-sterile,	gloved	hands	are	then	sprayed	with	a	hydrogen	peroxide	disinfectant	and	staff	immediately	enter	the	high	biosecurity	area.	For	staff	moving	between	animal	housing	areas,	innermost	scrubs	are	protected	within	full-body	plastic	suits	in	hallways	and	new	suits	are	donned	before	entering	a	new	animal	room.	Rubber	slip-on	shoes	are	worn	between	animal	containing	units,	and	changed	for	rubber	boots	that	remain	inside	pig	residing	areas.			
Monitoring	swine	health:	All	pigs	are	checked	by	staff	twice	per	day,	with	written	records	updated	daily.	In	accordance	with	biosecurity	management,	staff	enter	the	cleanest	LTB	first,	and	as	described	above	change	outer	suits	and	gloves	before	entering	the	STB.	Only	outer	gloves	are	changed	for	entry	into	isolated	non-SCID	sow	rooms	(or	housed	naturally	farrowed	litters).	If	any	animal	in	any	given	location	is	not	Bright,	Alert,	Responsive	(BAR)	or	Quiet,	Alert,	Responsive	(QAR),	an	on-call	veterinarian	is	called.	Depending	on	the	symptoms	present	and	severity,	animals	are	closely	monitored	with	scheduled	veterinarian	check-ups,	and	if	necessary,	veterinarian	prescribed	treatments.		
Specific	Pathogen	Free	(SPF)	Testing:	Piglets	snatch	farrowed	into	the	STB	are	evaluated	for	SPF	status	at	one	and	two	months	of	age	and	must	be	completely	negative	for	all	pathogens	at	both	times	before	they	can	be	moved	to	the	LTB.	In	the	LTB	they	will	continue	to	be	tested	for	SPF	status	at	4,	8	and	12	months	of	age	and	at	six-month	intervals	thereafter.	Litters	produced	in	the	LTB	are	monitored	for	SPF	status	at	two	months	of	age.		For	SPF	testing	serum	blood	draws	are	collected	from	jugular	vein	bleeds,	nasal	swabs	(BD	BBL™	CultureSwab™	Transport	Systems:	Liquid	Amies,	Regular	Aluminum	Wire,	Fisher	Scientific,	Part	#:	B4320129),	and	fecal	samples	are	collected	into	sterile	50	mL	conical	
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tubes.	Samples	are	submitted	to	the	ISU	VDL	(see	Table	1)	and	Clinical	Pathology	Laboratory	(see	Table	2).		
Results	
	
Large	Animal	Biocontainment	bubbles:	The	novel	SCID	pig	‘Bubbles’	create	a	clean	environment	where	SCID	pigs	can	be	raised	free	of	pathogen	threat	(Fig	1A,B).		Air	sterility	is	maintained	by	a	Biobubble	containment	structure	consisting	of	a	positive	pressure	HEPA-filtered	airflow	system	(Fig	
1C)	and	UV	treated	water	system	(Fig	1D).	All	personnel	entering	the	bubbles	or	interacting	with	SCID	colony	animals	wear	PPE	that	minimizes	human	exposure	as	described	in	the	materials	&	methods	(Fig	1E).	Please	see	(https://vimeo.com/221432512)	or	contact	the	Tuggle	lab	for	more	information	or	detailed	standard	operating	procedures	(SOPs).		
Snatch	Farrow/Cesarean	Section:	Once	facilities	were	established,	protocols	for	obtaining	SPF	piglets	from	non-SPF	sows	were	developed	and	tested.	SCID	carrier	sows	were	sourced	from	a	traditional	non-SPF	swine	farm	environment.	Although	uncontaminated	piglets	can	be	obtained	by	cesarean	section,	future	reproductive	use	of	the	sow	can	be	lost,	and	she	is	commonly	terminated	(Daniel	et	al.		2008).	Additionally,	piglets	obtained	by	cesarean	section	are	not	exposed	to	maternal	microbiota	from	their	sow.	To	retain	a	reproductively	sound	carrier	sow	for	production	of	future	litters,	and	produce	piglets	with	non-pathogenic	microbiota,	
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we	developed	a	snatch	farrowing	technique	based	upon	prior	work	(Huang	et	al.	2013).	Farrowing	sows	were	moved	into	a	sterile	room,	washed,	and	monitored	for	signs	of	labor.	As	piglets	are	delivered,	they	are	caught	directly	from	the	vaginal	canal	in	sterile	towels	by	gowned	staff	and	immediately	have	their	cords	clamped	prior	to	being	placed	in	a	sterile	rodent	box	with	filter	tops	for	delivery	to	staff	in	the	bubble.		Upon	arrival	into	the	bubble,	piglets	have	cord	blood	collected	and	are	processed.	As	described	in	the	introduction,	because	of	the	substantial	documented	advantage	to	piglet	health	for	piglets	that	receive	porcine	colostrum	versus	those	that	are	deprived,	we	developed	a	unique	set	of	protocols	to	provide	as	safe	an	exposure	to	microbiota	as	possible.	Piglets	are	fed	pasteurized	pooled	pig	colostrum	that	was	collected	by	hand	from	farrowing	animals	at	the	farm	from	which	the	carrier	sows	are	originally	sourced.	To	date,	pooled	pasteurized	colostrum	has	been	administered	to	five	litters	and	approximately	27	snatch	farrowed	piglets.	Various	pools	included	samples	from	13-45	sows	and	had	an	average	total	IgG	concentration	of	5.56	(±	0.13)	mg/mL.	Since	conventional	human	bottles	are	inadequate	for	feeding	piglets,	are	expensive,	and	difficult	to	regularly	clean	in	the	bubble	environment,	we	feed	our	piglets	with	a	catheter	attached	to	60	mL	syringe	(Fig	
2A).	We	tape	the	tapered	end	of	the	tube	to	our	finger	and	allow	the	piglet	to	suckle	while	delivering	colostrum	with	the	syringe.	This	feeding	apparatus	is	disposable,	less	expensive	to	supply,	and	allows	us	to	carefully	monitor	and	record	colostrum	volumes	consumed	by	each	individual	(Fig	2B).	Piglets	are	fed	pasteurized	colostrum	every	three	hours	until	they	have	consumed	250	mL	at	which	point	they	are	fed	irradiated	milk	replacer	using	the	same	method.	Once	sufficient	colostrum	has	been	consumed	by	all	piglets	in	the	litter	(within	the	first	24	hours	of	life),	milk	replacer	is	also	provided	in	a	separate	feed	dish	inside	the	
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farrowing	decks.	Piglets	typically	require	supplemental	tube	feeding	for	the	following	48-72	hours	as	they	transition	to	dish	feeding.		To	confirm	we	were	delivering	antibody	in	pasteurized	colostrum	before	gut	closure	at	approximately	24	hours	of	age,	we	collected	serum	from	cord	blood	(pre-colostrum)	and	from	the	jugular,	cephalic,	or	ear	vein	during	the	first	1-4	days	of	life	to	determine	IgG	levels	by	ELISA	(Fig3A).	Non-SCIDs	and	SCIDs	that	were	naturally	farrowed	(NS_NF	and	S_NF,	respectively)	had	total	IgG	levels	of	13.06	±	3.63	(mg/mL)	and	19.05	±	4.78	(mg/mL),	while	non-SCID	and	SCID	snatch	farrowed	piglets	(NS_SF	and	S_SF	respectively)	had	7.19	±	0.51	(mg/mL)	and	11.36	±	4.23	(mg/mL)	(Fig3A).	To	further	compare	naturally	farrowed	versus	snatch	farrowed	piglets,	we	examined	growth	curves	for	the	first	50	days	of	life	from	SCID	and	non-SCID	piglets	(Fig	3B).	Although	tube-fed	piglets	weighed	less	for	the	first	30	days,	their	growths	curves	are	consistent	with	the	trend	of	naturally	suckling	piglets	and	weight	differences	are	not	noticeable	after	day	35,	when	weaned	from	dam	and	milk	replacer	(shown	as	vertical	line	in	Fig	3B).		
	
Animal	Flow:		To	further	reduce	the	risk	of	contamination,	we	established	a	time-	and	testing-based	quarantine	system	whereby	piglets	are	tested	for	SPF	status	before	changing	location	within	the	facility.	To	accomplish	this,	we	utilize	two	bubbles:	the	smaller	STB	that	receives	snatch	farrowed	or	cesarean	derived	piglets,	and	the	LTB	where	SPF	females	can	be	raised	to	sexual	maturity.	The	two	bubbles	are	located	in	adjacent	wings	of	the	same	building.	Snatch	farrowed	piglets	pass	through	the	vaginal	canal	during	farrowing	and	are	thus	exposed	to	maternal	microbiota	and	possible	contaminants	before	entering	the	STB.		
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They	are	tested	at	one	month	and	two	months	of	age	for	SPF	status	(see	materials	&	methods,	Table	1,	and	Table	2).	If	either	test	results	in	the	positive	identification	of	pathogen	in	an	individual,	litter,	or	pen	mate,	the	pig	cannot	progress	to	the	LTB.	If	SPF	status	is	achieved,	female	piglets	are	cleared	for	transfer	to	the	LTB	(Fig	4A).		The	environment	outside	the	positive	pressure	bubble	could	play	host	to	a	series	of	potential	contaminants,	including	the	hallways	between	our	STB	and	LTB.	To	overcome	this	obstacle,	we	designed	and	constructed	a	battery-operated	positive	pressure,	HEPA-filtered	transfer	cart	that	allows	us	to	wheel	a	pig	from	an	internal	pen	in	the	STB,	to	the	biocontainment	transfer	cart,	to	an	internal	pen	in	the	LTB	(Fig	4B).	
	
Disease	Prevalence:		Although	the	ISU	SCID	pig	is	susceptible	to	virtually	all	bacterial	and	viral	threats,	historically	the	two	most	common	infections	documented	in	our	colony	are	Streptococcus	
suis	and	Staphylcoccus	hyicus.	Although	antibiotic	treatment	is	effective	in	pigs	with	a	normal	immune	system,	we	have	not	observed	any	SCID	piglets	to	clear	the	infection,	and	infected	SCID	piglets	typically	fail	to	thrive	and	are	euthanized	for	humane	care	reasons.	The	development	of	the	bubble	and	farrowing	system	has	significantly	decreased	the	prevalence	and	severity	of	these	infections	in	snatch	farrowed	SCIDs.	While	71%	(5/7	litters)	of	naturally	farrowed	litters	have	presented	with	diagnosed	or	suspected	incidences	of	S.	hyicus	and/or	S.	suis,	we	have	only	identified	two	individual	cases	(2/27	or	8%	of	piglets)	of	infection	in	animals	snatch	farrowed	into	the	STB,	and	zero	events	of	infectious	disease	in	our	LTB	to	date.			
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Additional	evidence	that	high	levels	of	biocontainment	are	necessary	for	maximum	health	was	provided	by	two	healthy	SCID	females	that	were	snatch	farrowed	into	the	STB	and	maintained	SPF	status	at	one	and	two	months.	These	gilts	were	later	moved	out	of	biocontainment	into	non-bubble	clean	rooms,	where	they	were	cared	for	following	strict	clean	PPE	guidelines,	irradiated	feed,	and	aforementioned	monitoring	practices.	However,	within	two	months	after	transfer,	both	animals	had	positive	confirmation	of	S.	hyicus	and	one	additionally	was	positive	for	S.	suis.		
Discussion	
		 The	potential	contributions	of	a	large	animal	SCID	research	model	to	the	development	of	regenerative	medicine	and	cancer	therapies,	as	well	as	improving	our	understanding	of	the	mechanisms	of	immunity,	is	enormous.	The	practices	described	herein	focus	on	the	refinement	component	of	the	3R’s	(replacement,	reduction,	and	refinement)	with	an	emphasis	on	improving	the	overall	management,	health,	and	welfare	of	the	ISU	SCID	pig	model.	To	complete	future	biomedical	studies	utilizing	SCID	pigs,	we	have	developed	facilities	for	maintaining	a	SPF	SCID	swine	colony	and	concurrently	developed	methods	using	snatch	farrowing	to	produce	SPF	piglets	from	non-SPF	sows.	Our	snatch	farrowing	protocols	and	feeding	of	pasteurized	colostrum	successfully	delivered	IgG	to	neonatal	piglets,	for	which	growth	follows	normal	rates	seen	in	naturally	suckling	piglets.	Although	some	exposure	to	potential	contaminants	is	possible	through	contact	with	the	vaginal	canal	
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of	the	sow,	our	high	sanitation	practices	are	validated	by	observed	reduced	disease	incidence	and	severity.		For	the	long-term	SCID	pig	colony,	our	goal	is	to	raise	females	to	reproductive	age	in	the	LTB	where	they	can	be	artificially	inseminated	with	semen	from	our	BMT	SCID	boars	to	create	SPF	litters	with	50%	SCID	and	50%	non-SCID	piglets	for	further	research.	This	will	decrease	labor	and	the	use	of	resources	required	by	snatch	farrowing	and	raising	piglets	in	the	STB.	To	date,	we	have	successfully	raised	four	SCID	carrier	gilts	to	sexual	maturity	and	farrowed	a	litter	within	the	LTB.	The	snatch	farrowing	practices	and	unique	facilities	described	herein	allow	us	the	flexibility	of	introducing	new	genetics	into	our	herd	to	control	inbreeding,	and	provide	us	with	methods	to	readily	replace	animals	if	necessary	or	re-populate	the	LTB	in	the	event	of	contamination.	Furthermore,	the	development	of	protocols	that	couple	snatch	farrowing	with	biocontainment	facilities	provides	valuable	information	to	collaborators	who	do	not	have	access	to	full	scale	long-term	bubbles,	but	still	require	SCID	piglets	for	biomedical	research.			
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Figures	
	
	
Figure	1.	General	Bubble	Components.	A)	Entrance	of	long	term	bubble;	pigs	are	housed	on	either	side	while	middle	section	is	designated	for	dressing	in	PPE.	B)	Staff	shown	collecting	cord	blood	on	newly	snatch	farrowed	piglets	in	STB.	C)	HEPA	filtration	unit	filters	all	incoming	air	that	enters	bubble.	D)	Water	is	filtered	and	irradiated	before	entering	bubble.	E)	All	staff	don	PPE	prior	to	entering	either	bubble.			
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Figure	2.	Snatch	Farrowed	Piglet	feeding	apparatus.	A)	A	sterile	urinary	catheter	tube	is	taped	to	a	gloved	finger	and	attached	to	a	60	ml	tube	for	feeding.		B)	Swine	colostrum	or	milk	replacer	is	administered	as	piglets	suckle	on	the	tube	attached	finger.			 	
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Figure	3.	ELISA	IgG	and	Growth	Curve	Data	comparing	naturally	sucking	and	tube	fed	
piglets.	A)	The	box	and	whisker	plot	shows	serum	levels	of	IgG	(mg/mL)	from	cord	blood	of	SCID	(gray)	and	non-SCID(black)	piglets	prior	to	consumption	of	colostrum	compared	to	SCID	and	non-SCID	samples	post	colostrum	delivery	both	from	tube	fed	and	naturally	suckling	piglets.	(NS=	non-SCID,	S=	SCID,	NF=	Naturally	Farrowed,	SF=	Snatch	Farrowed	respectively).	B)	Weight	(kg)	over	time	for	average	of	combined	SCID	and	non-SCID	piglets	that	were	tube	fed	(gray)	or	naturally	suckled	(black)	is	shown.	The	gray	vertical	line	denotes	typical	35	day	wean	date	(from	sow	or	off	milk	replacer).	Shaded	region	shows	95%	confidence	interval.				 	
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Figure	4.	Animal	transfer	through	facilities.	A)	The	figure	shows	animal	flow	from	farrowing	through	short	(STB)	and	long	term	(LTB)	bubbles.	Litters	are	either	naturally	farrowed	where	SCID	males	are	BMT	rescued	and	used	for	subsequent	breeding,	or	naturally	farrowed	where	carrier	females	are	kept	SPF	clean	and	moved	to	the	LTB	to	sexually	mature	and	ultimately	be	bred	to	BMT	boars	to	produce	naturally	farrowed	SPF	litters	in	the	LTB.		B)	HEPA	filtered	transfer	cart	used	to	move	carrier	female	pigs	from	the	STB	into	the	LTB.			 	
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Tables	
		
Table	1:	Testing	for	Specific	Pathogen	Free	(SPF)	status	from	the	Veterinary	
Diagnostic	Lab.	Animals	are	tested	for	the	specific	porcine	pathogens	above.		
Pathogen		 Type	of	sample	Porcine	Reproductive	and	Respiratory	Syndrome	 Blood	Serum	Porcine	parvovirus	haemagglutination	inhibition	 Blood	Serum	Mycoplasma	hyorhinis	 Nasal	Swab	Mycoplasma	hyosynoviae	 Nasal	Swab	Lawsonia	intracellularis	 Fecal,	Blood	Serum	Fecal	Flotation	 Fecal	Swine	Influenza	Virus	NP	Elisa	 Blood	Serum	Actinobacillus	pleuropneumoniae	Antibody	1-2-9-11	 Blood	Serum	Actinobacillus	pleuropneumoniae	Antibody		4-5-7	 Blood	Serum	Actinobacillus	pleuropneumoniae	Antibody		3-6-8-15	 Blood	Serum	M.	hyopneumoniae	 Fecal,	Nasal	Swab	M.	floccularel	 Fecal,	Nasal	Swab	Porcine	Epidemic	Diarrhea	virus	N	gene	 Fecal,	Blood	Serum	Porcine	Epidemic	Diarrhea	Whole	Virus		 Fecal,	Blood	Serum	Ingezim	Circovirus	 Blood	Serum	Rota	Virus	A,	B,	C	 Fecal			 	
  
89 
	
Table	2:	Testing	for	Specific	Pathogen	Free	(SPF)	status	from	the	Clinical	Pathology	
Lab.	Animals	are	tested	for	the	specific	parameters	listed.	Testing	is	conducted	from	serum	or	EDTA	treated	whole	blood.			
Testing	Profile	 Sample	Type	Bilirubin	Urea	Nitrogen	(BUN)	 Blood	Serum	Creatinine	 Blood	Serum	Glucose	 Blood	Serum	Total	Protein	 Blood	Serum	Albumin	 Blood	Serum	Creatine	Kinase	 Blood	Serum	Aspartate	Aminotransferase	 Blood	Serum	Alkaline	Phosphatase	 Blood	Serum	Gamma-Glutamyl	Transferase	 Blood	Serum	Total	Bilirubin	 Blood	Serum	Calcium	 Blood	Serum	Phosphorus	 Blood	Serum	Magnesium	 Blood	Serum	Sodium	 Blood	Serum	Potassium	 Blood	Serum	Chloride	 Blood	Serum	Total	CO2		 Blood	Serum	Complete	Blood	Count	 Blood	EDTA						 	
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CHAPTER 5. 	
NK	CELLS	ARE	INTRENSICALLY	FUNCITONAL	IN	PIGS	WITH	SEVERE	COMBINED	
IMMUNODEFICIENCY	(SCID)	CAUSED	BY	SPONTANEOUS	MUTATIONS	IN	THE	
ARTEMIS	GENE				A	paper	published	in	the	Journal	of	Veterinary	Immunology	and	Immunopathology	2016			Ellis	J.	Powell1,	Joan	E.	Cunnick1,	Susan	M.	Knetter1,	Crystal	L.	Loving2,	Emily	H.	Waide1,	Jack	C.M.	Dekkers1,	Christopher	K.	Tuggle1	
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Abstract	
We	have	identified	Severe	Combined	Immunodeficiency	(SCID)	in	a	line	of	Yorkshire	pigs	at	Iowa	State	University.	These	SCID	pigs	lack	B-cells	and	T-cells,	but	possess	Natural	Killer	(NK)	cells.	This	SCID	phenotype	is	caused	by	recessive	mutations	in	the	Artemis	gene.	
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Interestingly,	two	human	tumor	cell	lines,	PANC-1	and	A375-SM,	survived	after	injection	into	these	SCID	pigs,	but,	as	we	demonstrate	here,	these	cells,	as	well	as	K562	tumor	cells,	can	be	lysed	in	vitro	by	NK	cells	from	SCID	and	non-SCID	pigs.	NK	cells	from	both	SCID	and	non-SCID	pigs	required	activation	in	vitro	with	either	recombinant	human	IL-2	or	the	combination	of	recombinant	porcine	IL-12	and	IL-18	to	kill	tumor	targets.	We	also	showed	that	SCID	NK	cells	could	be	activated	to	produce	perforin,	and	perforin	production	was	greatly	enhanced	in	NK	cells	from	both	SCID	and	non-SCID	pigs	after	IL-2	cytokine	treatment.	While	CD16+,	CD172-	NK	cells	constituted	an	average	of	only	4%	in	non-SCID	pigs,	NK	cells	averaged	27%	of	the	peripheral	blood	mononuclear	cell	population	in	SCID	pigs.	We	found	no	significant	differences	in	killing	activity	per	NK	cell	between	SCID	and	non-SCID	pigs.	We	conclude	that	survival	of	human	cancer	cells	in	these	SCID	pigs	is	not	due	to	an	intrinsic	defect	in	NK	cell	killing	ability.			
Introduction	
	 Severe	combined	immunodeficiency	(SCID)	can	be	caused	by	genetic	defects	in	over	30	genes	(Cossu,	2010).	Several	mouse	lines	have	been	developed	through	genetic	modification	to	model	known	SCID	phenotypes	in	humans	(Xiao	et	al.,	2008).	In	addition,	SCID-type	defects	have	been	identified	to	occur	spontaneously	in	several	animal	species,	including	the	dog	(Meek	et	al.,	2001),	mouse	(Barthels,	2013),	and	horse	(Perryman,	2004).		Recently,	a	novel	SCID	phenotype	was	serendipitously	discovered	in	a	line	of	Yorkshire	pigs	that	was	selected	for	increased	feed	efficiency	at	Iowa	State	University	(Cai	et	al.,	2008)	during	a	large-scale	Porcine	Reproductive	and	Respiratory	Syndrome	Virus	
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(PRRSV)	challenge	study	(Cino-Ozuna	et	al.,	2012).		Upon	necropsy	of	piglets	that	died	unexpectedly	early	in	the	study,	abnormal	lymph	node	and	thymus	structures	as	well	as	very	low	antibody	titers	were	detected,	indicating	a	SCID-like	phenotype.	A	genome-wide	association	analysis	of	172	pigs	within	the	selection	line	pedigree		that	was	segregating	the	SCID	phenotype	identified	a	5.6	Mb	region	on	Sus	scrofa	chromosome	10,	which	contains	the	Artemis	(DCLRE1C)	gene	(Waide	et	al.,	2015).	Defects	in	Artemis	are	known	to	specifically	affect	the	mechanism	of	recombination	of	the	T-Cell	Receptor	(TCR)	and	B-Cell	Receptor	(BCR)	complexes	(Cossu,	2010).	The	Artemis	gene	encodes	an	endonuclease	that	cleaves	the	hairpin	loop	created	by	the	RAG1	and	RAG2	proteins	during	somatic	rearrangement	of	these	two	complexes	(Schuetz	et	al.,	2014).	Due	to	the	clear	relevance	of	this	gene	for	the	SCID	phenotype	observed,	molecular	genetic	analyses	of	this	gene	was	performed,	revealing	two	independent	mutations	in	Artemis.	Both	alleles	have	a	Mendelian	recessive	mode	of	inheritance	and	cause	the	SCID	phenotype	in	either	the	homozygous	or	compound	heterozygous	state	(Waide	et	al.,	2015).	As	seen	in	other	species	with	a	defect	in	Artemis	(Schuetz	et	al.,	2014),	these	pigs	lack	B-lymphocytes	and	T-lymphocytes	but	produce	Natural	Killer	(NK)	cells	(Ewen	et	al.	2015;	Waide	et	al.,	2015).	NK	cells	are	innate	lymphocytes	cytolytic	to	cells	not	presenting	‘self’	Major	Histocompatibility	Complex	I	(MHC	class	I),	including	virally	infected	cells	or	tumor	cells	with	down-regulated	MHC	class	I	(Vivier	et	al.,	2011).	NK	cell	lysis	of	target	cells	can	be	accomplished	by	exocytosis	of	granular	proteins	perforin,	granzyme	B,	and	other	pro-apoptotic	proteins	(Maher	et	al,	2002).	The	NK	cell	recognizes	surface	changes	in	tumor	or	virally	infected	cells,	binds	via	activating	receptors	(for	review	see	Pegram	et	al.,	2010),	and	releases	granular	contents	including	perforin,	which	form	pores	in	the	target	
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cell.	Perforin	alone	can	result	in	osmotic	lysis	of	the	target	cell.		However,	perforin–induced	membrane	changes	can	allow	granzyme	B,	co-localized	in	the	granule,	to	enter	the	target	cell	and	induce	programmed	cell	death	or	apoptosis.	(Maher	et	al.,	2002;	Bolitho	et	al.,	2007).	Resting	murine	NK	cells	have	very	low	levels	of	perforin	and	granzyme	B,	but	exposure	to	an	activating	signal	increases	the	production	of	each	protein	(Fehniger	et	al.,	2007).	NK	cells	in	mice	deficient	for	granzyme	B	and	perforin	have	minimal	cytotoxic	activity,	even	if	activated	by	cytokines	in	vitro	(Fehniger	et	al.,	2007).	Activation	of	porcine	NK	cells	has	been	demonstrated	using	numerous	cytokines,	including	recombinant	human	IL-2	and	IFN-	a	(Mori	et	al.,	1998).	Activation	of	NK	cells	is	also	well	documented	with	IL-15,	IL-12,	and	IL-18	(Fehniger	et	al.,	2007)	(Pintarič	et	al.,	2008).	As	an	animal	model	for	human	research,	the	SCID	pig	may	be	more	advantageous	than	other	species,	as	the	domestic	pig	is	more	physiologically	and	immunologically	similar	to	humans	(Meurens	et	al.,	2012)	and	has	an	“immunome”	with	greater	homology	to	humans	than	mice	(Dawson	et	al.,	2013).	Basel	et	al.	(2012)	showed	that	the	SCID	pigs	did	not	reject	two	human	tumor	cell	lines,	PANC-1	(pancreatic	carcinoma)	and	A375SM	(melanoma).	As	these	immune-compromised	pigs	possessed	phenotypically	identifiable	NK	cells,	yet	failed	to	reject	cancer	target	cells,	the	authors	concluded	that	the	NK	cells	are	not	functional	due	to	lack	of	appropriate	cytokine	stimulation	from	absent	T-cells.	However,	no	studies	have	directly	measured	intrinsic	killing	activity	of	NK	cell	from	the	Artemis-mutated	SCID	pigs.	The	presence	or	absence	of	functional	NK	cells	in	SCID	patients	can	impact	the	success	of	clinical	procedures,	such	as	bone	marrow	transplantation,	and	likelihood	of	Graft	versus	Host	Disease	(Hassan	et	al.,	2014).	Since	SCID	models	with	detectable	NK	cells	have	been	predicted	(Lunn	et	al.,	1995)	or	reported	(Buckley	et	al.,	1997)	to	be	functionally	impaired	
  
94 
or	operative,	it	is	important	to	determine	the	functionality	of	the	NK	cells	within	the	porcine	Artemis	SCID	model.	This	information	will	be	relevant	to	the	utilization	of	the	SCID	pig	model	in	preclinical	studies.		This	paper	addresses	the	role	of	NK	cells	in	SCID	pigs	by	defining	their	cytolytic	activity,	responses	to	cytokine	activation	in	vitro,	and	production	of	perforin.		
Results	
	Peripheral	blood	mononuclear	cells	(PBMCs)	from	SCID	and	non-SCID	piglet	littermates	were	first	tested	for	their	ability	to	recognize	and	kill	several	types	of	human	tumor	targets,	including	those	previously	shown	to	survive	in	SCID	pigs	(Basel	et	al.	2012):		A375SM	(melanoma);	PANC-1	(pancreatic	carcinoma);	as	well	as	K562	(chronic	myelogenous	leukemia)	cells,	a	standard	target	cell	for	human	and	porcine	NK	cell	research.	Cells	were	plated	at	three	different	effector	to	target	(E:T)	ratios	(5:1,	10:1,	20:1)	with	effectors	of	PBMCs	(used	as	a	source	of	NK	cells)	and	the	three	cancer	cell	type	targets.	Percent	Cytotoxicity	in	PBMCs	required	cytokine	activation	(human	recombinant	IL-2)	to	kill	tumor	cells	in	vitro,	as	no	lysis	of	any	of	the	three	cell	types	tested	was	observed	for	cells		treated	with	medium	alone	at	any	E:T	ratio.	The	difference	in	killing	at	every	E:T	ratio	for	cells	treated	with	IL-2	versus	medium	alone	was	significant	(p-value	<	0.0001)	(Figure	1).	Activated	PBMCs	had	similar	levels	of	cytotoxicity	for	all	cancer	target	cells	across	all	E:T	ratios,	and	percent	cytotoxicity	was	not	significantly	different	between	cancer	target	cell	types		(p-value	=	0.065).		
  
95 
Flow	cytometric	analysis	of	PBMC’s	was	used	in	combination	with	these	assays	to	correlate	NK	cell	activity	directly	to	NK	cell	effector	concentration.	We	defined	NK	cells	as	PBMCs	that	were	CD16+(FcγR)	and	CD172-	(CD172;	monocyte/granulocyte).	Flow	cytometric	analysis	demonstrated	SCID	pigs	had	higher	concentrations	of	NK	cells	(percent	NK)	among	isolated	PBMCs	(26.6%	[SCID]	compared	to	4.0%	[non-SCID])	(p-value	<	0.0001)	across	all	days	(representative	data	is	shown	in	Figures	2a	(SCID)	and	2b	(non-SCID	littermate)).	By	normalizing	the	cytotoxicity	data	based	on	the	percent	NK	cells	in	the	PBMC	preparation	for	each	sample,	intrinsic	killing	ability	was	reported	as	the	number	of	tumor	targets	killed	per	NK	cell	(Figure	2c)	and	found	to	be	comparable	in	SCID	and	non-SCID	littermates.	Due	to	limitations	in	blood	volume	that	can	be	collected	from	young	animals,	subsequent	experiments	were	performed	using	only	the	K562	target	cell	line,	which	demonstrated	similar	trends	and	percent	cytotoxicity	to	all	cancer	cell	types.	To	test	for	differences	in	development	of	cytolytic	activity	of	NK	cells	from	SCID	pigs,	we	isolated	PBMCs	from	peripheral	blood	of	SCID	and	non-SCID	littermates	at	two	time	points	in	the	first	two	weeks	post-farrow	(approximately	4	and	11	days	of	age;	early)	and	twice	in	the	second	two	weeks	(approximately	22	and	31	days	of	age;	late)	(Figures	3b	and	4b).	Time	points	were	chosen	based	on	reported	differences	in	normal	porcine	NK	cell	activity	before	and	after	the	first	two	weeks	of	life	(Yang	et	al.,	1986).	In	contrast	to	the	work	by	Yang	et	al.	(1986),	we	did	not	find	significant	differences	in	percent	cytotoxicity	between	early	and	late	time	points	for	normal	piglet	samples	activated	with	IL-2	(p-value=	0.65;	Figure	3b),	nor	for	samples	activated	with	IL-12	and	IL-18	(p-value=	0.06;	Figure	4b).	Overall,	cytotoxicity	of	PBMCs	from	SCID	animals	was	statistically	higher	than	that	of	PBMCs	from	non-SCID	littermates	at	all	E:T	ratios	(p-value	<	0.01)	(Figure	3a).	This	was	
  
96 
also	true	for	PBMCs	from	SCID	piglets	compared	to	PBMCs	from	non-SCID	piglets	both	before	and	after	the	first	two	weeks	of	life	(p-values	<	0.01	for	data	at	the	10:1	E:T	ratio)	(Figure	3b).	By	accounting	for	the	percent	NK	cells	in	the	PBMC	fractions,	we	were	able	to	calculate	the	number	of	NK	cells	present	per	well	and	analyze	tumor	targets	killed	per	NK	cell.	We	thus	demonstrated	that	the	intrinsic	killing	activity	of	NK	cells	was	not	significantly	different	between	SCID	and	non-SCID	animals	(Figure	3c).	Averaged	across	all	time	points	and	over	the	5:1,	10:1,	20:1	E:T	ratios,	the	number	of	tumor	targets	lysed	per	NK	cell	was	similar	in	SCID	animals	(0.36	±	0.086)	and	non-SCID	animals	(0.33	±	0.089)	(p-value=	0.72)	(Figure	3c).	We	then	proceeded	to	test	cytotoxicity	of	SCID	and	non-SCID	NK	cells	when	activated	with	cytokines	that	are	produced	by	myeloid-derived	cells.	The	combination	of	recombinant	porcine	IL-12	and	recombinant	porcine	IL-18	(rpIL-12/rpIL-18)	has	been	shown	to	activate	porcine	NK	cells	(Pintarič	et	al.,	2008).	We	found	that	both	SCID	and	non-SCID	NK	cells	could	be	activated	to	lyse	K562	targets	with	a	combination	of	rpIL-12/rpIL-18	(Figure	4a).	Similar	to	the	results	with	IL-2	activation,	total	PBMCs	from	SCID	pigs	activated	by	rpIL-12/rpIL-18	demonstrated	a	higher	percent	cytotoxicity	across	most	E:T	ratios	than	PBMCs	from	non-SCID	pigs	(p-value	(5:1)	=	0.08,		p-value	(10:1)	<	0.03,		p-value	(20:1)	<	0.03)(Figure	4a).	As	seen	with	IL-2-stimulated	cells,	the	higher	cytotoxicity	trend	for	SCID	cells	was	demonstrated	for	each	of	the	two-week	periods	(Figure	4b).	However,	when	PBMC	cytotoxicity	was	normalized	based	on	the	percent	NK	cells,	there	was	no	significant	difference	in	cytotoxic	capability	between	SCID	and	non-SCID	NK	cells	activated	with	rpIL-12/rpIL-18	at	either	the	early	or	late	time	points	(p-values	>	0.87;	Figure	4c).		
  
97 
As	another	measure	of	function	of	SCID	NK	cells,	we	also	examined	the	ability	of	cells	from	SCID	and	non-SCID	animals	to	produce	perforin	in	vitro	in	response	to	activation	with	recombinant	human	IL-2.	PBMCs	incubated	with	rh	IL-2	for	three	days	were	stained	for	CD16	and	CD172	as	surface	‘NK’	cell	markers	(within	PBMCs)	and	intracellular	perforin.	Results	showed	CD16+	CD172-	NK	cells	from	SCID	or	non-SCID	pigs	responded	similarly	to	activation	with	increased	production	of	intracellular	perforin	(Figure	5).	In	Figure	5a,	we	demonstrate	that	perforin	production	was	increased	in	IL-2	activated	SCID	NK	cells	compared	to	non-activated	NK	cells,	and	in	Figure	5b	we	demonstrate	that	perforin	mean	fluorescence	response	to	activation	was	similar	in	cells	from	a	non-SCID	pig	(Figure	5b).		
Discussion		 This	study	answers	an	important	question	raised	by	the	results	of	the	Basel	et	al.	(2012);	whether	PANC-1	and	A375SM	cancer	cell	targets	can	be	killed	by	suitably	activated	NK	cells	from	SCID	pigs.	We	demonstrated	that	these	human	cancer	cells	could	be	recognized	and	killed	in	vitro	by	activated	NK	cells	from	both	non-SCID	and	SCID	pigs.		As	humans	and	other	species	with	naturally-occurring	SCID	have	variation	in	the	existence	and	functionality	of	NK	cells	(Buckley	et	al.,	1997),	it	was	important	to	determine	the	functional	status	of	NK	cells	from	the	defective	Artemis	SCID	pig.	In	the	work	presented	herein,	we	have	established	that	porcine	NK	cells	from	both	normal	and	SCID	pigs	can	be	activated	with	cytokines,	including	IL-2,	to	functionally	lyse	a	target	cell.	While	IL-2	is	a	well-documented	activating	agent	of	NK	cells	(Pintarič	et	al.,	2008),	it	is	produced	by	T-cell	lymphocytes,	which	are	not	detectable	in	the	blood	of	our	SCID	model	(Ewen	et	al.,	2015).	
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We	then	assessed	the	functionality	of	NK	cells	when	activated	with	cytokines	produced	by	myeloid-derived	cells,	such	as	macrophages	and	dendritic	cells.	Normal	levels	of	both	granulocytes	and	monocytes	have	been	detected	in	un-stimulated	SCID	animals	(Ewen	et	al.,	2015)	and	are	expected	to	be	capable	of	producing	IL-12	and	IL-18.	Further	investigations	will	explore	the	cytokine	producing	capabilities	and	natural	cytokine	profile	of	the	SCID	pig.	NK	cells	from	SCID	animals	were	able	to	kill	tumor	targets	when	activated	with	a	combination	of	IL-12	and	IL-18.	As	seen	with	IL-2	activation,	there	was	no	significant	difference	between	the	SCID	and	non-SCID	NK	cells	in	tumor	targets	killed	per	NK	cell	following	exposure	to	IL-12	and	IL-18	(Figure	3).	We	acknowledge	that	the	CD16+,	CD172-	NK	cell	population	in	non-SCID	pigs	includes	a	minor	proportion	of	CD16+,	CD3+	T-like	lymphocytes	that	may	have	cytolytic	capacity	(Denyer	et	al.,	2006).	In	order	to	portray	that	the	majority	of	killing	by	PBMCs	from	non-SCID	pigs	was	due	to	conventional	NK	cells,	we	used	flow	cytometry	to	show	that	less	than	2%	of	total	PBMCs	in	non-SCIDs	were	CD16+,	CD3+,	CD172-	(data	not	shown).	Thus,	it	is	unlikely	that	any	cytotoxicity	observed	from	this	minor	population	of	cells	in	non-SCID	pigs	impacts	the	main	findings	of	cytotoxic	capacity	of	SCID-derived	NK	cells.	We	also	demonstrated	that	SCID-derived	CD16+	CD172-	NK	cells	responded	to	IL-2	activation	to	produce	intracellular	perforin,	which	was	similar	between	cells	isolated	from	SCID	and	non-SCID	piglets.	Thus,	SCID	NK	cells	appear	to	be	intrinsically	functional	and	capable	of	killing	human	cancer	cells	and	of	producing	perforin	in	response	to	IL-2	activation	in	vitro.		These	results	indicate	that	the	survival	of	human	cancer	cells	in	SCID	pigs	shown	by	Basel	et	al.	(2012)	is	not	due	to	an	intrinsic	inability	to	respond	to	cytokines,	nor	to	a	defect	in	the	ability	to	lyse	the	tumor	target	cells.	Based	on	these	results,	two	possibilities	can	be	
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presented	for	the	survival	of	human	tumor	cells	in	the	SCID	pig	model;	1)	SCID	NK	cells	are	not	activated	in	vivo,	or	2)	migration	of	NK	cells	to	injected	target	cells	is	impaired.	Our	current	hypothesis	is	that	SCID	NK	cells	are	not	being	activated	in	vivo,	due	to	a	deficit	of	IL-2	due	to	the	absence	of	T	lymphocytes.	In	order	to	test	this	hypothesis	it	will	be	necessary	to	assay	activation	and	migration	of	circulating	NK	cells	in	SCID	pigs	through	direct	administration	of	cytokines	(IL2	or	IL12/18)	or	molecules	known	to	activate	NK	cells	in	
vivo	(Duluc	et	al.,	2009),	though	that	was	outside	the	scope	of	this	work.	A	large	animal	model	that	lacks	major	components	of	the	immune	system	is	valuable	for	studying	specific	immune	cell	subsets,	response	to	disease,	therapeutic	strategies	for	cancer,	and	stem	cell	transplantation	(Huang	et	al.,	2014).	Thus,	in	addition	to	improving	our	understanding	of	the	relationships	between	the	innate	and	adaptive	immune	systems	in	porcine	immunity,	our	characterization	of	NK	cell	functionality	in	this	swine	SCID	model	will	further	develop	it	as	a	large	animal	model	in	preclinical	testing	of	human	stem	cell	therapeutics	and	specific	treatments	for	Artemis	SCID	patients.			
Materials	and	Methods	
All	animal	experiments	were	performed	under	a	protocol	approved	by	the	Iowa	State	University	Institutional	Animal	Care	and	Use	Committee	(Ames,	Iowa).		
Creation	and	care	of	SCID	piglets	Six	litters	were	generated	from	matings	between	carrier	females	and	a	compound	heterozygous	SCID	affected	boar	that	was	rescued	by	littermate	bone	marrow	transfer	(BMT).	One	week	before	farrowing,	pregnant	sows	were	washed	and	transferred	from	the	
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Iowa	State	University	(ISU)	Lauren	Christian	Swine	Research	Center	to	an	environmentally-controlled,	clean	room	at	the	ISU	College	of	Veterinary	Medicine.	In	total,	33	piglets	were	processed	within	24	hours	of	farrowing	and	tissue	samples	were	collected	for	identification	of	the	SCID	affected	animals.	The	SCID	genotype	was	determined	through	a	PCR	test	(Waide	et	al.,	2015);	18	SCID	and	15	non-SCID	pigs	were	used	in	these	experiments.		All	animal	handling	protocols	and	standard	operating	procedures	(SOPs)	were	approved	by	and	met	all	IACUC	requirements.		
Cytotoxicity	Assay	
Maintenance	of	Tumor	Target	Cell	Lines:	Frozen	aliquots	of	PANC-1	and	A375SM	were	obtained	from	D.	Troyer	(Kansas	State	University,	Manhattan,	KS)	and	K562	cells	from	ATCC.	Cells	were	thawed,	washed,	and	grown	in	complete	RPMI	media	(RPMI-1640	supplemented	with	L-glutamine	(2	mM),	gentamicin	(50	ug/mL),	Hepes	(10	mM)	(all	from	Life	Technologies)	and	heat-inactivated	fetal	bovine	serum	(10%;	FBS;	Atlanta	Biologicals,	Inc,	Flowery	Branch,	GA)	at	37°C	with	7%	CO2	with	subculture	every	2-3	days	to	maintain	cells	in	log	growth	phrase.	
Isolation	of	PBMCs:	Data	was	produced	using	SCID	and	non-SCID	littermates	from	the	litters	described	above.	Heparinized	blood	(3-8	mL)	was	collected	into	vacutainer	tubes	(BD	#367874	Becton	Dickinson	and	Company,	Franklin	Lakes,	NJ).	Blood	was	diluted	in	Hanks’	Balanced	Saline	Solution	(HBSS;	Life	Technologies,	Grand	Island,	NY)	and	PBMCs	collected	using	Ficoll-paque	Plus	(GE	Healthcare	Bio-Sciences	Corp,	Piscataway,	NJ).	Mononuclear	cell	layers	were	washed	twice	with	HBSS	and	resuspended	in	complete	RPMI.	An	aliquot	of	cells	was	taken	to	the	ISU	Flow	Cytometry	Facility	and	enumerated	using	a	
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cell	viability	kit	to	determine	live	cell	counts	(BD	#349480).	Cell	suspensions	were	diluted	with	complete	RPMI	and	added	to	96-well	low	evaporation	culture	plates	(Costar,	Cambridge,	MA).	Recombinant	human	(rh)	IL-2	(Sigma-Aldrich-Cat#17908)	or	recombinant	porcine	IL-12	and	IL-18	(rpIL-12/IL-18;	912-PL/588-PL;	R&D	Systems,	Minneapolis,	MN)	was	used	at	a	concentration	of	2	ng/well,	or	complete	RPMI	alone	was	added	to	appropriate	wells.		PBMC	suspensions	were	diluted	to	2	x	106	cell/mL	suspensions	and	were	plated	to	create	5:1,	10:1,	and	20:1	effector	to	target	ratios.	Plates	were	incubated	overnight	at	37°C	with	7%	CO2.	
Chromium	Labeling	of	Targets	and	Application	to	PBMCs:	Following	overnight	incubation	of	PBMCs	prepared	as	described	above,	tumor	target	cell	lines	(A375SM,	PANC-1,	or	K562	cells)	were	washed	with	RPMI	and	labeled	with	200uCi	chromium	(Cr	51)	for	80	minutes	with	gentle	agitation	every	20	minutes.	Complete	media	was	used	to	wash	cells	and	remove	extracellular	Cr	51.	Tumor	cell	suspensions	were	diluted	to	2x105	cells/mL	and	1x104	cells	in	50uL	was	added	to	each	well	containing	PBMCs	or	control	media.	Controls	of	spontaneous	and	total	release	wells	were	also	prepared.	Plates	were	incubated	for	6	hours	at	37°C.			 Harvesting	of	Plates:	Triton-X	100	(10%)	was	added	to	total	release	wells	and	pipetted	up	and	down.	Plates	were	centrifuged	at	200	rpm	for	5	min.	An	equal	volume	of	supernatant	was	collected	from	each	well	into	individual	counting	tubes.	Radioactivity	of	supernatants	was	determined	using	a	gamma-counter	(Gamma	trac	1191,	TM	Analytic	Inc.,	ElkGrove	Village,	IL).	Results	were	reported	as	counts	per	minute	(CPM).	Percent	cytotoxicity	was	averaged	across	triplicates,	and	calculated	as:		
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Percent	Cytotoxicity	=	100	x	(CPM	experimental	average)-(CPM	spontaneous	release)												(CPM	total	release)-(CPM	spontaneous	release)		
Flow	cytometry		 Staining	for	CD16,	CD172:	We	enumerated	NK	cells	as	PBMCs	with	the	following	phenotype:	CD16+,	CD172	(SWC3a)-.	Isolated	PBMCs	(as	described	above)	were	diluted	in	Phosphate	Buffered	Saline	(PBS)-	Sodium	Azide	(0.05%)	solution	(PBS-Azide)	and	incubated	with	pre-titered	antibodies	in	an	ice	water	bath	for	45	minutes.	Primary	antibodies	included	a	cocktail	of	mouse	anti-pig	CD172-	(SWC3a;	IgG2b,	BD	Biosciences-Cat	#553640),	mouse	anti-pig	CD16	(IgG1,	AbD	Serotec-Cat#	MCA1971)	and	heat-inactivated	swine	serum	for	blocking.		After	washing	with	PBS-Azide,	a	cocktail	of	secondary	antibodies	was	added	and	incubated	in	an	ice	bath	for	an	additional	45	minutes.	The	secondary	antibodies	used	were	goat	anti-mouse	IgG2b-	FITC	(Southern	Biotech-Cat#1090-02)	and	goat	anti-mouse	IgG1-	PE	(Southern	Biotech-Cat#1072-09).	Samples	were	washed	with	PBS,	fixed	with	PBS/2%	formaldehyde	solution	and	submitted	within	7	days	of	fixation	to	the	ISU	Flow	Cytometry	Facility	for	analysis	on	a	BD	Biosciences	FACSCanto	II	(San	Jose,	CA).	
Intracellular	staining	for	perforin:	PBMCs	were	isolated	(as	reported	above)	and	plated	at	a	concentration	of	2	x	105	cells	per	well	in	a	96-well	plate	in	the	presence	and	absence	of	rhIL-2	and	complete	RPMI	media.	Cells	were	incubated	for	3	days	at	37	°C.	A	protein	transport	inhibitor	(BD	GolgiPlug,	Cat#	555029)	was	added	6	hours	prior	to	staining	(1	uL	per	106	cells).	An	equal	volume	of	supernatant	was	collected	from	each	well	into	counting	tubes	(two	wells	per	flow	tube).	Extracellular	proteins	(CD16,	CD172)	were	
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stained	as	described	above.	Cells	were	then	fixed	and	permeabilized	with	BD	Cytofix/Cytoperm	kit	as	directed	by	the	manufacturer	(Cat#	555028).	Directly	conjugated	PerCP-Cy5.5	primary	antibody	targeted	against	perforin	(BD	Pharmingen	Cat#	563762)	or	an	isotype	control	(BD	Pharmingen	Cat#	558304)	was	added	to	samples	and	incubated	on	ice	in	the	dark	for	30	min.	Cells	were	washed	with	BD	Perm	wash	buffer	(according	to	kit	instructions)	and	stored	until	flow	cytometric	acquisition.				 Flow	cytometry	data	was	analyzed	and	figures	were	created	with	BD	FACSDiva	Software	(5-3-6)	and	Flowjo	(V.10.1).		
Statistical	Analyses		Data	generated	on	SCID	and	non-SCID	pigs	was	analyzed	with	a	mixed	model	in	SAS	9.2	(SAS	Institute	Inc.,	Cary,	NC).	For	analysis	of	the	effect	of	IL-2	stimulation	of	NK	cell	cytotoxicity	against	the	three	tumor	targets	shown	in	Figure	1,	a	mixed	model	was	run	with	fixed	effects	of	treatment	(IL-2	presence	or	absence),	dilution,	SCID	status,	and	target	cell	type;	animal	was	fit	as	a	random	effect.	For	later	Figures,	phenotype	responses	of	percent	cytotoxicity	or	number	of	tumor	targets	killed	per	NK	cell	were	analyzed	with	a	repeated	measures	(by	animal)	mixed	model	with	fixed	effects	of	litter,	time	point,	dilution,	and	SCID	status.	Significance	was	set	at	a	p-value	≤	0.05.			
Acknowledgements	
	This	work	was	funded	by	Iowa	State	University	Office	of	Vice	President	for	Research,	and	grant	1R24OD019813-01	from	NIH.	EJP	gratefully	acknowledges	support	from	a	USDA	
  
104 
National	Needs	Fellowship	Grant	(2012-38420-19286).	We	thank	the	Lauren	Christian	Swine	Breeding	farm	staff	and	Iowa	State	University	Laboratory	Animal	Research	staff	for	excellent	professional	care	of	the	SCID	pigs.	We	thank	Dr.	Deryl	Troyer	for	the	A375-SM	and	PANC-1	cell	lines,	and	give	tremendous	thanks	to	Dr.	Martine	Schroyen,	the	ISU	Cytometry	Flow	Facility,	and	Dr.	Shawn	Rigby	for	all	the	help	and	advice.	We	also	thank	Sam	Humphrey	for	assistance	with	flow	cytometric	software.		 	
  
105 
Literature	Cited	
Basel,	M.T.,	Balivada,	S.,	Beck,	A.P.,	Kerrigan,	M.A.,	Pyle,	M.M.,	Dekkers,	J.C.,	Wyatt,	C.R.,	Rowland,	R.R.,	 Anderson,	D.E.,	Bossmann,	S.H.,	et	al.	2012.	Human	xenografts	are	not	rejected	in	a	naturally	occurring	immunodeficient	porcine	line:	a	human	tumor	model	in	pigs.	Biores	Open	Access.	1,	63-68.			Barthels,	C.,	Puchalka,	J.,	Racek,	T.,	Klein,	C.,	Brocker,	T.,	2013.	Novel	Spontaneous	Deletion	of	Artemis	Exons	10	and	11	in	Mice	Leads	to	T-	and	B-Cell	Deficiency.	Moser	M,	ed.	PLoS	ONE.	8(9):e74838.	doi:10.1371/journal.pone.0074838.		Bolitho,	P.,	Voskoboinik,	I.,	Trapani,	J.A.,	Smyth,	M.J.,	2007.	Apoptosis	induced	by	the	lymphocyte	effector	molecule	perforin.	Curr	Opin	Immunol.	19(3),	339-47.		Buckley,	R.,	Schiff,	R.,	Schiff,	S.,	Market,	L.,	Williams,	L.,	Harville,	T.,	Roberts,	J.,	Puck,	J.,	1997.	Human	severe	combined	immunodeficiency:	Genetic,	phenotypic,	and	functional	diversity	in	one	hundred	eight	infants.	J	Pediatr.		130,	378-387.		Cai,	W.,	Kaiser,	M.S.,	Dekkers,	J.C.,	2011.	Genetic	analysis	of	longitudinal	measurements	of	performance	traits	in	selection	lines	for	residual	feed	intake	in	Yorkshire	swine.	J	Anim	Sci.	89,	1270-80.			Cino-Ozuna,	A.G.,	Rowland,	R.R.R.,	Nietfeld,	J.C.,	Kerrigan,	M.A.,	Dekkers,	J.C.M.,	Wyatt,	C.R.,	2012.	Preliminary	findings	of	a	previously	unrecognized	porcine	primary	immunodeficiency	disorder.	Vet	Pathol.	50,	144-146.			Cossu,	F.,	2010.	Genetics	of	SCID.	Ital	J	Pediatr.		36(76).		Dawson,	H.D.,	Loveland,	J.E.,	Pascal,	G.,	et	al.	2013.	Structural	and	functional	annotation	of	the	porcine	immunome.	BMC	Genomics.	14,	332.		Denyer,	M.S.,	Wileman,	T.E.,	Stirling,	C.M.A.,	Zuber,	B.,	Takamatsu,	H.	2006.	Perforin	expression	can	define	CD8	positive	lymphocyte	subsets	in	pigs	allowing	phenotypic	and	functional	analysis	of	Natural	Killer,	Cytotoxic	T,	Natural	Killer	T	and	MHC	unrestricted	cytotoxic	T-cells.	Vet	Immunol	Immunopathol.	110,	279-292.		Duluc,	D.,	Tan,	F.,	Scotet,	M.,	Blanchard,	S.,	Frémaux,	I.,	Garo,	E.,	Horvat,	B.,	Eid.	P.,	Delneste,	Y.,	and	Jeannin,	P.,	2009.		PolyI:C	plus	IL-2	or	IL-12	induce	IFN-γ	production	by	human	NK	cells	via	autocrine	IFN-β.	Eur.	J.	Immunology.	39,	2877–2884.		Ewen,	C.L.,	Cino-Ozuna,	A.G.,	He,	H.,	Kerrigan,	M.A.,	Dekkers,	J.C.M.,	Tuggle,	C.K.,	Rowland,	R.R.R.,	Wyatt,	C.R.,	2014.	Analysis	of	blood	leukocytes	in	a	naturally	occurring	immunodeficiency	of	pigs	shows	the	defect	is	localized	to	B	and	T	cells.	Vet	Immunol	Immunopathol.	162,	174-179.			
  
106 
Fehniger	TA,	Cai	SF,	Cao	X,	Bredemeyer	AJ,	Presti	RM,	French	AR,	Ley	TJ.	Acquisition	of	murine	NK	cell	cytotoxicity	requires	the	translation	of	a	pre-existing	pool	of	granzyme	B	and	perforin	mRNAs.	Immunity.	2007	;	(6):798-811.			Hassan,	A.,	Lee,	P.	Maggina,	P.,	Xu,	J.H.,	Moreira,	D.,	Slatter,	M.,	et	al.	2014.	Host	Natural	Killer	Immunity	Is	a	Key	Indicator	of	Permissiveness	for	Donor	Cell	Engraftment	in	Patients	with	Severe	Combined	Immunodeficiency.	J	Allergy	Clin	Immunol.	133,	1660–1666.			Huang,	J.,	Guo,	X.,	Fan,	N.,	Song,	J.,	Zhao,	B.,	Ouyang,	Z.,	Liu,	Z.,	Zhao,	Y.,	Yan,	Q.,	Yi,	X.,	Schambach,	A.,	Frampton,	J.,	Esteban,	M.A.,	Yang,	D.,	Yang,	H.,	and	Liangxue,	L.,	2014.			RAG1/2	Knockout	Pigs	with	Severe	Combined	Immunodeficiency.	J	Immunol.		193,	1496-1503.		Leber,	R.,	Wiler,	R.,	Perryman,	L.E.,	Meek,	K.,	1998.	Equine	SCID:	Mechanistic	analysis	and	comparison	with	murine	SCID.	Vet	Immunol	Immunopathol.	65,	1-9.			Lunn,	D.P.,	McClure,	J.T.,	Schobert,	C.S.,	Holmes,	M.A.,	1995.	Abnormal	patterns	of	equine	leucocyte	differentiation	antigen	expression	in	severe	combined	immunodeficiency	foals	suggests	the	phenotype	of	normal	equine	natural	killer	cells.	Immunol.	84,	495-499.		Maher	KJ,	Klimas	NG,	Hurwitz	B,	Schiff	R,	Fletcher	MA.	Quantitative	Fluorescence	Measures	for	Determination	of	Intracellular	Perforin	Content.	Clinical	and	Diagnostic	Laboratory	Immunology.	2002;9(6):1248-1252.	doi:10.1128/CDLI.9.6.1248-1252.2002.		Meek	K.,	Kienker	L.,	Dallas	C.,	Wang	W.,	Dark	M.J.,	Venta	P.J.,	Huie	M.L.,	Hirschhorn	R.,	Bell	T.	2001.	SCID	in	Jack	Russell	terriers:	a	new	animal	model	of	DNA-PKcs	deficiency.	J	Immunol.	167,	2142-50.		Meurens,	F.,	Summerfield,	A.,	Nauwynck,	H.,	Saif,	L.,	Gerdts,	V.,	2011.	The	pig:	a	model	for	human	infectious	diseases.	Trends	Microbiol.	20(1):50-7.	doi:	10.1016/j.tim.2011.11.002.	Epub			Mori,	S.,	Jewett,	A.,	Cavalcanti,	M.,	Murakami-Mori,	K.,	Nakamura,	S.,	Bonavida,	B.	Differential	regulation	of	human	NK	cell-associated	gene	expression	following	activation	by	IL-2,	IFN-a	and	PMA/ionomycin.	International	Journal	of	Onocolgy.	1998.	12:1165-1170.		Perryman,	L.E.,	2004.		Molecular	pathology	of	severe	combined	immunodeficiency	in	mice,	horses,	and	dogs.	Vet	Pathol.	41,	95-100.		Pregram,	H.J.,	Andrews,	D.M.,	Smyth,	M.J.,	Darcy,	P.K.,	Kershaw,	M.H.,	2010.	Activating	and	inhibitory	receptors	of	natural	killer	cells.	Immun	and	Cell	Biol.	89,	216–224.		Pintarič,	M.,	Gerner,	W.,	Saalmüller,	A.,	2008.	Synergistic	effects	of	IL-2,	IL-12	and	IL-18	on	cytolytic	activity,	perforin	expression	and	IFN-γ	production	of	porcine	natural	killer	cells.	Vet	Immunol	Immunopathol.	121,	68–82.		
  
107 
Schuetz,	C.,	Neven,	B.,	Dvorak,	C.C.,	Leroy,	S.,	Ege,	M.J.,	Pannicke,	U.,	et	al.	2014.	SCID	patients	with	ARTEMIS	vs	RAG	deficiencies	following	HCT:	increased	risk	of	late	toxicity	in	ARTEMIS-deficient	SCID.	Blood.	123,	281–289.			Waide,	E.H.,	Dekkers,	J.C.M.,	Ross,	J.W.,	Rowland,	R.R.R.,	Wyatt,	C.R.,	Ewen,	C.,	Thekkoot,	D.M.,	Boddicker,	N.J.,	Tuggle,	C.K.,	2015.	Not	all	SCID	pigs	are	created	equally:	Two	independent	mutations	in	Artemis	gene	found	to	cause	Severe	Combined	Immunodeficiency	(SCID)	in	pigs.	Journal	of	Immunology.	(in	press).		Wickham,	H.	ggplot2:	Elegant	Graphics	for	Data	Analysis.	Springer-Verlag	New	York,	2009.		Vivier,	E.,	Raulet,	D.H.,	Moretta,	A.,	Caligiuri,	M.A.,	Zitvogel,	L.,	Lanier,	L.L.,	Yokoyama,	W.M.,		Ugolini,	S.,	2011.	Innate	or	Adaptive	Immunity?	The	example	of	Natural	Killer	Cells.	Science.	331,	44–49.		Xiao,	Z.,	Dunn,	E.,	Singh,	K.,	Khan,	I.S.,	Yannone,	S.M.,	Cowan,	M.J.,	2009.	A	non-leaky	Artemis-deficient	mouse	that	accurately	models	the	human	severe	combined	immune	deficiency	phenotype,	including	resistance	to	hematopoietic	stem	cell	transplantation.	Biol	Blood	Marrow	Transplant.	15,	1-11.		Yang,	W.C.,	Schultz,	R.D.,	1986.	Ontogeny	of	natural	killer	cell	activity	and	antibody	dependent	cell	mediated	cytotoxicity	in	pigs.	Dev	Comp	Immunol.	10,	405-18.	
  
108 
Figures			
	
Figure	1.	Human	cancer	cell	lines	are	killed	by	IL-2	activated	porcine	NK	cells.	PBMCs	
from	SCID	and	non-SCID	piglets	incubated	in	the	presence	or	absence	of	recombinant	
human	IL-2	(rh	IL-2)	and	tested	for	cytotoxicity	against	A375-SM,	K562,	or	PANC-1	
human	cell	lines.	Percent	Cytotoxicity	was	reported	for	5:1,	10:1,	and	20:1	effector:target	ratios.	SCID	PBMCs	had	the	highest	percent	cytotoxicity	(dotted	line)	compared	to	non-SCID	(NS)	littermate	cells	(solid	line).	PBMCs	not	treated	(activated)	with	IL-2,	but	rather	treated	with	media	alone,	did	not	lyse	target	cells	from	any	of	the	tumor	lines	(gray	lines).		
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	Figure	2.	Representative	flow	cytometric	analysis	of	PBMCs	used	for	normalization	of	
data	presented	in	Figure	1.	Percentages	for	CD16/CD172(SWC3a)	populations	shown	in	lower	right	hand	quadrant	(Q4).	Data	shown	in	(a)	is	a	representative	example	of	a	SCID	pig;	49.9%	CD16+/	CD172-	NK	cells,	and	32.4%	CD16+/	CD172+	monocytes.	Data	shown	in	(b)	is	typical	of	a	non-SCID	pig;	5.2%	CD16+/	CD172-	NK	cells	and	4.3%	CD16+/CD172+	monocyte.	The	ratio	of	tumor	target	cell	killed	per	NK	cell	is	depicted	in	(c)	where	SCIDs	and	non-SCIDs	can	be	compared	directly.	Error	bars	represent	standard	errors.		
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	Figure	3.	NK	cells	from	both	SCID	and	non-SCID	pigs	can	kill	human	cancer	cells	when	
activated	with	IL-2.	NK	cell	populations	in	isolated	PBMCs	from	SCID	and	non-SCID	piglets	were	used	in	killing	assays	with	K562	cells.	(a)	Killing	of	K562	cells	by	PBMCs	isolated	from	SCID	pigs	and	non-SCID	pigs	and	incubated	with	rhIL-2	at	5:1,	10:1,	&	20:1	effector-to-target	ratios.	Each	effector-to-target	ratio	was	averaged	for	SCID	and	non-SCID	animals	across	all	days	(4-31	days	post	farrowing).	(b)	Average	percent	cytotoxicity	of	cells	from	SCID	and	non-SCID	animals	at	the	10:1	effector-to-target	ratio.	The	first	two	week	time	point	includes	time	points	from	days	4-11,	and	the	second	two	week	time	point	includes	days	18-31	(c)	Number	of	K562	tumor	targets	killed	per	NK	cell	is	based	on	total	effectors	and	targets	in	a	well	when	activated	with	IL-2.	Ratio	is	averaged	across	all	effector-to-target	ratios.	Error	bars	represent	standard	errors.			
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	Figure	4.	NK	cells	from	both	SCID	and	non-SCID	pigs	can	kill	human	cancer	cells	when	
activated	with	a	combination	of	IL-12	and	IL-18.	(a)	Killing	of	K562	cells	by	PBMCs	isolated	from	SCID	pigs	and	non-SCID	pigs	and	incubated	with	IL-12	and	IL-18	across	effector-to-target	ratios.	Each	effector-to-target	ratio	was	averaged	for	SCID	and	non-SCID	animals	across	all	days	(8-31	days	post	farrowing).	(b)	Percent	cytotoxicity	is	averaged	for	SCID	and	non-SCID	animals	at	the	10:1	effector-to-target	ratio.	The	first	two	week	time	point	includes	bleeds	from	days	4-11,	and	the	second	two	week	time	point	includes	days	18-31	(c)	Ratio	of	K562	tumor	targets	killed	per	NK	cell	based	on	total	effectors	and	targets	in	a	well	when	activated	with	combined	IL-12	and	IL-18.	Ratio	is	averaged	across	5:1,	10:1,	20:1	effector-to-target	ratios.	Error	bars	represent	standard	errors.		
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	Figure	5.	Production	of	perforin	by	SCID	and	non-SCID	CD16+	CD172-	NK	cells	after	
activation	with	recombinant	human	IL-2.	Perforin	production	by	NK	cells	from	a	(a)	SCID	pig	incubated	without	(IL2-)	or	with	(+IL2)	addition	of	rh	IL-2	and	(b)	by	non-SCID	and	SCID	pig	NK	cells	following	3	days	of	rhIL-2	stimulation.	Non-specific	isotype	matched	antibody	was	used	a	staining	for	the	intracellular	control.		 	
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CHAPTER 6.  		
SUCCESSFUL	DEVELOPMENT	OF	METHODOOGY	FOR	DETECTION	OF	HAPTEN-
SPECIFIC	CONTACT	HYPERSENSITIVITY	(CHS)	MEMORY	IN	SWINE		 Prepared	for	publication	in	Veterinary	Immunology	and	Immunopathology		
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Abstract			Hapten	contact	hypersensitivity	(CHS)	elicits	a	well-documented	inflammation	response	that	can	be	used	to	illustrate	training	of	immune	cells	through	hapten-specific	CHS	memory.	Although	the	education	of	hapten-specific	memory	T	cells	has	been	established,	recent	research	in	mice	has	expanded	the	“adaptive”	characteristic	of	a	memory	response	from	solely	a	function	of	the	adaptive	immune	system	to	Natural	Killer	(NK)	cells,	an	innate	lymphocyte.	To	test	whether	similar	responses	are	seen	in	a	non-
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rodent	model,	we	used	hapten-specific	CHS	to	measure	the	ear	inflammation	response	of	outbred	pigs	to	dinitrofluorobenzene	(DNFB),	oxazolone	(OXA),	or	vehicle	controls.	We	adapted	mouse	innate	memory	literature	protocols	to	the	domestic	pig	model.	Animals	were	challenged	up	to	32	days	post	initial	sensitization	exposure	to	the	hapten,	and	specific	ear	swelling	responses	to	this	challenge	were	significant	for	7,	21,	and	32	days	post-sensitization.	We	established	hapten-specific	CHS	memory	exists	in	a	non-rodent	model.	We	also	developed	a	successful	protocol	for	demonstrating	these	CHS	responses	in	a	porcine	system.			
Introduction		The	Contact	Hypersensitivity	(CHS)	memory	response	to	the	haptens	dinitrofluorobenzene	(DNFB)	or	oxazolone	(OXA),	typically	driven	by	T	cells	is	well-documented	(Askenase	2001;	Szczepanik	et	al.	1996;	Majewska-Szczepanik	et	al.	2012,	2013).	This	memory	can	be	illustrated	by	the	ability	to	form	specific,	long-lived	memory	responses,	including	hapten-induced	CHS,	where	chemically-modified	proteins	trigger	a	delayed	but	specific	response.	T	cell	hapten	responses	are	mediated	by	antigen	presenting	cells	(APCs)	such	as	Langerhans	or	dendritic	cells	that	upon	activation	migrate	to	draining	lymph	nodes	from	the	site	of	challenge	(Kimber	et	al.	2002).	In	lymph	nodes,	APC	presentation	of	haptenized	antigen	to	naïve	T	cells	facilitates	clonal	expansion	to	create	long	lived,	hapten-specific	CD4+	and	CD8+	T	cells	(Erkes	et	al.	2014).	Unlike	effector	T	cells,	Natural	Killer	(NK)	cells	are	cytotoxic	innate	lymphocytes	that	target	cells	lacking	or	not	displaying	‘self’	Major	Histocompatibility	Complex	I	(MHC	I)	(Vivier	et	al.		2011).	Recently,	
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the	classically	adaptive	characteristic	of	immune	memory	has	been	expanded	to	certain	innate	cells,	including	monocytes	(Ifrim	et	al.	2014)	and	NK	cells	(Majewska-Szczepanik	et	al.		2013;	O’Leary	et	al.	2006;	Paust	et	al.	2010,	2011;	O’Sullivan	et	al.	2015).	Several	studies	used	similar	CHS	challenges	in	mice	to	show	innate	immune	memory	driven	by	NK	cells,	with	an	emphasis	on	liver	resident	NK	cell	populations	(Majewska-Szczepanik	et	al.		2013;	O’Leary	et	al.	2006;	Paust	et	al.	2010,	2011).		This	study	seeks	to	investigate	the	parameters	of	hapten-specific	CHS	memory	responses	in	a	large	animal	model.	The	pig	is	more	similar	to	the	human	immunologically	and	physiologically,	with	a	closer	“immunome”	(Dawson	et	al.		2013)	to	humans	than	is	the	mouse	(Meurens	et	al.		2012).	The	pig	may	be	an	advantageous	model	to	relationships	between	adaptive	and	innate	systems,	and	study	the	specific	mechanism	of	innate	memory	as	it	could	be	relevant	to	commercial	swine	health	in	vaccine	development	as	well	as	human	therapies.		Haptens	have	been	used	to	illicit	inflammatory	responses	in	swine.	Both	DNFB	and	OXA	haptens	have	been	shown	to	respond	in	a	porcine	model	of	allergic	contact	dermatitis	(Nuhaily	et	al.	2009;	Vana	and	Meingassner	2000).	However,	to	our	knowledge,	no	work	has	been	done	to	confirm	hapten-specific	CHS	memory	exists	in	the	swine	model.		Research	has	established	that	CHS	memory	through	NK	cells	is	independent	of	the	adaptive	immune	system.	To	do	this,	rodent	studies	utilize	severe	combined	immunodeficiency	(SCID)	models	(O’Sullivan	et	al.	2015),	where	memory	responses	are	reported	in	T-B-NK+	SCIDs	but	disappear	using	the	non-functional	NK	cell	(Majewska-Szczepanik	et	al.	2013)/	or	NK	cell	absent	T-B-NK-	SCID	environments	(O’Leary	et	al.		2006).	Numerous	SCID	pig	models	have	emerged	recently	including	models	with	NK	cells	
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present	as	well	as	NK	cell	absent	(reviewed	in	Powell	et	al.	2017),	thus	the	genetic	tools	exist	to	demonstrate	whether	innate	memory	exists	in	swine	and	if	such	memory	is	carried	by	NK	cells.	However,	to	facilitate	development	of	the	pig	as	a	large	animal	model	for	such	studies,	a	CHS	memory	protocol	is	important	to	establish	in	swine.			
Materials	and	Methods			All	animal	experiments	were	approved	by	the	Iowa	State	University	Institutional	Animal	Care	and	Use	Committee	(IACUC).			
Animals	Used:	Commercial	outbred	15-30	kg	finishing	pigs	were	purchased	from	the	Iowa	State	University	Swine	Nutrition	Farm.	For	the	ear	thickness	studies	described	below,	20	pigs	were	used	for	the	5	day	sensitization	trial,	20	pigs	were	used	for	the	32	day	sensitization	trial,	36	pigs	were	used	for	the	21	day	sensitization	trial,	and	38	pigs	were	used	for	the	7	day	sensitization	trial.		
Sensitization	and	challenge:	For	experimental	trials	(described	below),	pigs	were	sedated	with	intramuscular	telazol/ketamine/xylazine	(TKX)(2mL/20	kg)	injection	for	sensitization	and	challenge	procedures.	For	21	and	7	day	topical	sensitization,	TKX	dosages	of	(1mL/20	kg)	were	used.	Pigs	were	housed	individually	at	the	Iowa	State	University	Swine	Nutrition	farm.	All	animals	were	euthanized	by	captive	bolt	and	exsanguinated.		
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5	or	32	Day	Sensitization	periods:	Pigs	were	sensitized	via	intradermal	injection	with	either	1mL	10%	2,4-dinitrofluorobenzene	(DNFB,	Sigma	Aldrich	cat.	D1529)	in	vehicle	(Vana	and	Meingassner	2000),	1	mL	1%	oxazolone	(OXA)	in	vehicle	(Nuhaily	et	al.	2009),	or	1	mL	1:1	acetone:olive	oil	vehicle;	all	solutions	were	injected	with	the	volume	distributed	across	ten	sites	on	the	dorsal	back.	After	a	sensitization	period	of	5	or	32	days,	animals	were	challenged	with	0.1	mL	1%	OXA,	0.1	mL	1%	DNFB,	and	0.1	mL	vehicle	via	intradermal	injection	in	separate	ear	locations	(two	injection	sites	per	ear).	We	measured	ear	thickness	at	24,	48,	and	72	hours	post	challenge	using	skinfold	calipers	(Harpenden).			
7	or	21	Day	Sensitization	periods:	Pigs	were	sensitized	by	adding	0.2	mL	of	solution	dropwise	to	the	pig’s	shaved	back	between	their	shoulder	blades	(“painting”)	with	either	2.5	%	DNFB	(Sigma-Aldrich	Cat	#	D1529),	10%	DNFB,	or	4:1	acetone:olive	oil	vehicle	which	in	preliminary	comparisons	to	1:1	vehicle	was	faster	drying	(original	vehicle	from	Nuhaily	et	al.	2009).	After	a	sensitization	period	of	7	or	21	days,	animals	were	challenged	with	0.2	mL	1%	DNFB,	1%	OXA	(Sigma-Aldrich	Cat	#	E0753),	or	vehicle	via	intradermal	injection	in	separate	ear	locations	(one	injection	site	per	ear).	We	measured	ear	thickness	at	24,	and	48	hours	post	challenge	using	skinfold	calipers.				
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Ear	punch	collection	and	histology	scoring:	Upon	euthanasia,	ears	were	removed	and	biopsy	punches	(Fisher,	cat.	#	475.20040.2)	were	collected	at	site	of	challenge	injection.	Ear	punch	biopsies	were	fixed	in	10%	formaldehyde	and	then	transitioned	to	70%	ethanol	after	24	hours.	For	preparation	and	scoring,	samples	were	submitted	to	the	Iowa	State	University	College	of	Veterinary	Medicine	Pathology	Department	who	reviewed	samples	blind	to	sensitization	treatment	throughout	evaluations.			
Statistical	analysis:		
	
Statistical	analysis	of	pathology	ear	scores:	Statistical	analysis	of	pathology	scores	were	conducted	with	a	paired	t-test	comparing	VD	and	DD	groups	(respectively).	Statistical	significance	was	declared	with	a	p-value	≤	0.05.			
Statistical	analysis	of	ear	thickness:	Cohorts	were	analyzed	with	R	(R	Core	Team,	2016).	Basic	least-squares	fixed-effects	models	were	fit	for	all	cohorts	(using	the	lm	function	equivalent	to	PROC	GLM	from	SAS).	The	following	models	were	run	for	each	of	the	four	cohorts	with	the	number	of	levels	given	in	parentheses.			
5,	32	day	Model:		Ear	Thickness	(increase	from	time	0)	=		
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trial	(2)	+	sex	(2)	+	ear	location	(4)	+	challenge	treatment	(4)	+	sensitization	treatment	(4)	+	challenge	treatment*sensitization	treatment	+	e		Trial	was	the	effect	of	the	two	separate	groups	of	pigs	for	each	the	5	and	32	day	sensitization	lengths;	sex	was	the	effect	of	either	castrated	males	or	female	pigs;	ear	location	was	the	effect	of	each	location	A,	B,	C,	or	D	(2	on	each	ear);	challenge	treatment	was	the	effect	from	no	injection,	vehicle,	OXA,	or	DNFB	injection	in	the	ear;	sensitization	treatment	was	the	effect	from	either	no	injection,	vehicle,	OXA,	or	DNFB	injection	on	the	back.			
21	day	Model:	Ear	Thickness	(increase	from	time	0)	=			Trial	(2)	+	Sex	(2)	+	challenge	treatment	(2)	+	sensitization	treatment	(3)	+	challenge	veh	(2)	+	challenge	method	(2)	+	challenge	treatment*sensitization	treatment	+	challenge	treatment*challenge	method	+	e		Trial	and	sex	are	defined	above;	challenge	treatment	was	the	effect	of	either	vehicle	or	DNFB;	sensitization	treatment	was	the	effect	of	either	vehicle,	low	2.5%	DNFB,	or	high	10%	DNFB	painted	on	the	back;	challenge	vehicle	is	the	effect	of	4:1	or	1:1	acetone:olive	oil;	and	challenge	method	was	the	effect	of	injection	or	painting	on	the	ear.					
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7	day	Model:	Ear	Thickness	(increase	from	time	0)	=		trial	(3)	+	sex	(2)	+	challenge	treatment	(3)	+	sensitization	treatment	(2)	+		challenge	treatment*sensitization	treatment	+	e		Trial	and	sex	are	defined	above;	challenge	treatment	was	the	effect	of	either	vehicle,	OXA,	or	DNFB	injection	in	the	ear;	sensitization	treatment	was	the	effect	of	either	vehicle	or	10%	DNFB	painted	on	the	back.			Type	III	ANOVA	tests	were	used	for	all	effects.	LSmeans	and	associated	contrasts	(i.e.	differences	in	LSmeans)	were	calculated	from	the	lsmeans	package	in	R	(Lenth,	2016).			
Results		 This	research	sought	to	develop	a	protocol	to	measure	hapten-specific	CHS	memory	responses	in	swine.	CHS	responses,	measured	as	the	increase	in	ear	thickness	from	time	zero	(challenge)	to	the	post-challenge	time,	were	higher	for	ear	locations	challenged	with	the	chemical	for	which	the	animal	had	been	sensitized	as	compared	to	other	treatments	(Fig	1A,	Fig	3).	Significance	was	determined	by	evaluating	the	interaction	of	each	ear	treatment	(challenge)	with	each	back	treatment	(sensitization).	Initially	our	protocol	to	detect	CHS	memory	was	to	inject	animals	on	the	dorsal	back	over	10	intradermal	locations	and	then	to	challenge	pigs	with	four	ear	injections	(two	per	ear)	of	DNFB,	OXA,	and	vehicle	controls.	Results	demonstrated	hapten-specific	ear	swelling	for	DNFB	and	OXA	was	
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statistically	significant	for	sensitization	period	of	32	days	(p-value	<	0.01)	as	seen	in	Fig	
1A.	However,	when	the	same	protocol	was	utilized	with	a	5	day	sensitization	period,	no	evidence	of	hapten-specific	swelling	was	detectable	(p-value	0.98,	Fig	1B).	We	observed	that	the	short	sensitization	period	left	the	inflammation	at	back	injection	sites	incompletely	resolved,	which	occurred	before	challenge	in	the	32	day	study	(data	not	shown).	Further,	we	had	used	two	challenge	injections	per	ear,	reasoning	that	the	CHS	effect	should	be	local	and	this	design	would	decrease	the	number	of	animals	needed	for	the	studies.	However,	visual	cues	of	ear	irritation	and	high	inflammation	throughout	the	ear	post	challenge	in	studies	led	us	to	statistically	evaluate	whether	one	ear	treatment	injection	could	affect	the	other	challenge	injection	in	the	same	ear.	Ear	injection	location	(whether	the	injection	site	was	proximal	or	distal	to	the	pig’s	head)	was	found	to	be	a	significant	fixed	effect	for	ear	swelling	with	a	p-value	<0.01	for	the	5	day	sensitization	period	but	this	effect	was	not	significant	for	32	day	sensitization	(p-value	=	0.72).	Therefore,	to	improve	our	protocol	we	adjusted	numerous	components	of	our	methodology.		First,	to	avoid	any	potential	within-ear	interactions	of	challenge	treatments,	only	one	challenge	injection	was	applied	per	ear,	although	this	increased	the	number	of	animals	required	for	these	studies.	Second,	we	tested	several	adjustments	to	the	dorsal	sensitization	protocol.	To	decrease	inflammation	due	to	intradermal	sensitization,	we	moved	to	a	topical	application	of	sensitizing	agents	on	the	cranial	back	of	the	pig,	which	required	a	faster	drying	vehicle.	We	found	that	4:1	acetone:olive	oil	was	substantially	faster	drying	than	the	1:1	acetone:olive	oil	used	previously.	Further,	to	determine	if	we	could	reduce	the	concentration	of	DNFB	applied	to	the	back,	we	tested	two	topical	concentrations	of	DNFB	2.5%	or	10%	(0.2	mL)	as	seen	in	Fig	2A.	While	hapten-specific	inflammation	was	
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detected	in	both	high	and	low	concentrations	of	DNFB	sensitization	(p-value	<	0.01),	the	effect	was	larger	for	the	high	concentration	of	DNFB	(LSmeans	of	1.82	mm	vs	1.44	mm,	p-value=	0.04).	We	also	tested	if	topical	painting	application	of	hapten	onto	the	pig	ears	could	be	used	in	the	challenge	component,	rather	than	intradermal	injection	(Fig	2B).	The	difference	in	LSmeans	for	change	in	thickness	effect	size	for	challenge	treatments	between	VEH	and	DNFB	was	similar,	but	higher	for	the	injection	method	(1.0	mm	for	injection	and	0.7	mm	for	topical	painting).	Additionally,	a	single	well-defined	injection	site	allowed	for	more	accurate	measuring	of	ear	thickness	compared	to	the	larger	surface	area	covered	by	painting	(data	not	shown).	We	chose	to	move	forward	with	topical	sensitization	with	10%	DNFB	on	the	dorsal	back	and	intradermal	injection	ear	challenge	methods.		After	we	developed	the	improved	protocol	which	successfully	demonstrated	hapten-specific	inflammation	with	a	21	day	sensitization	period,	we	also	wanted	to	test	if	we	could	use	this	protocol	over	a	short	term	sensitization	period	of	7	days.	The	initial	protocol	could	not	detect	short	term	memory	(5	day	trial),	so	evidence	of	hapten-specific	inflammation	after	a	7	day	sensitization	period	would	demonstrate	successful	protocol	revisions.	Developing	a	CHS	memory	protocol	that	can	establish	memory	in	a	shorter	sensitization	time	may	be	important	for	innate	cell	training	work	in	immune	compromised	animal	models.	With	the	new	protocol	the	effect	of	prior	sensitization	was	significant	for	specific	challenges	as	measured	by	the	interaction	of	challenge	treatment*sensitization	treatment	for	7	days	(Fig	3A)	p-value	<	0.01,	and	21	days	(Fig	3B)	p-value	<0.01.	Table	1	shows	statistical	evidence	(p-values)	for	significant	differences	in	response	to	treatment	combinations	for	specific	contrasts.	Significant	differences	in	ear	thickness	increases	were	observed	between	vehicle	sensitized/	DNFB	challenged	(VD)	and	DNFB	sensitized/	DNFB	
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challenged	(DD)	groups	(DD	ear	measurements	higher	for	all)	for	both	24	and	48	hours	post	challenge	for	all	sensitization	periods.		To	directly	address	the	effect	of	prior	sensitization,	we	compared	the	difference	in	LSmeans	in	ear	thickness	change	between	the	VD	and	DD	treated	animals	across	sensitization	period	(5,	7,	21,	32	days)	and	at	time	of	collection	post	challenge	(24,	48,	or	72	hours	(only	available	for	32	and	5	day	sensitization	periods))	(Fig	4).	The	trend	in	difference	in	LSmeans	increased	with	length	of	sensitization	period	(5	to	32	days).		At	day	5,	contrasts	were	not	significantly	different	from	zero,	but	longer	sensitization	period	led	to	statistically	significant	contrasts	starting	at	7	days.		To	provide	further	evidence	of	hapten-specific	inflammatory	responses,	post-mortem	ear	biopsy	punches	were	collected	at	72	hours	post	challenge	for	32	and	5	day	sensitizations	and	48	hours	post	challenge	for	21	and	7	day	sensitization	periods.	Sections	of	fixed	tissue	samples	were	evaluated	for	infiltrating	lymphocytes,	vasculitis	and	thrombosis,	and	necrosis	and	infarction	with	a	pathology	scoring	system	0-4	(0	is	absent,	while	4	is	completely	diffuse).	Table	2	depicts	average	scores	for	four	ear	punches	per	treatment	(VD	and	DD)	from	the	21	day	sensitization	period	(1	ear	punch	per	animal).	Punches	went	all	the	way	through	the	ear	at	the	site	of	challenge	intradermal	injection.	Histopathological	analysis	revealed	that	infiltrating	lymphocytes	were	on	the	opposite	side	of	the	ear	tissue	from	the	challenge	site.	DD	ear	punches	had	significantly	higher	infiltrating	lymphocytes	(p-value	0.02)	and	more	necrosis	(p-value	0.01)	than	VD	treated	ears,	but	there	was	no	statistical	evidence	of	difference	due	to	sensitization	for	thrombosis	scores	(p-value	0.38).		
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Discussion		 The	work	herein	described	provides	clear	evidence	of	hapten-specific	CHS	memory	for	7,	21,	and	32	day	sensitization	periods.	This	accomplishes	the	primary	objective	of	this	work,	which	was	to	determine	if	hapten-specific	CHS	memory	existed	in	a	non-rodent	model	system.	We	also	established	a	CHS	protocol	for	measuring	hapten-specific	ear	swelling	inflammation	responses	in	swine	across	a	range	of	sensitization	periods.	For	development	of	a	porcine	CHS	memory	protocol,	we	saw	the	largest	effect	of	sensitization	with	10%	DNFB	topically	applied	sensitization	treatment,	and	an	intradermal	single-ear	injection	challenge	treatment.	Although	we	demonstrated	larger	effects	for	longer	sensitization	periods,	it	was	important	to	establish	we	can	successfully	detect	hapten-specific	CHS	memory	after	both	long-	and	short-term	sensitization	times.	Work	with	the	lowest	numbers	of	normal	pigs	possible	may	best	utilize	a	longer	sensitization	period	with	the	strongest	power	of	detection	as	the	effect	size	observed	(VD	vs	DD	in	this	example)	is	inversely	proportional	to	the	sample	size	and	proportional	to	the	power	of	the	statistical	test.	However,	work	assessing	interactions	of	innate	and	adaptive	immune	systems	or	training	of	innate	porcine	cells	may	be	necessary	in	immune	compromised	SCID	animals	whose	health	status	may	only	be	able	to	be	secured	for	a	short	amount	of	time.	Genetically	engineered	SCID	pigs	have	reported	failure	to	thrive	phenotypes	and	had	to	be	euthanized	after	the	first	30	days	of	life	(Lee	et	al.	2014).	Researchers	addressing	CHS	memory	questions	in	a	porcine	model	should	choose	the	most	appropriate	sensitization	period	for	their	experimental	design.	
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	In	addition,	we	showed	evidence	of	higher	infiltrating	lymphocytes	in	DD	animals	compared	to	VD	pigs,	consistent	with	increased	lymphocyte	migration	reported	in	the	mouse	studies	(O’Leary	et	al.	2006).	Histology	data	also	found	higher	scores	of	necrosis	and	infarction	in	the	DD	ear	samples	compared	to	VD	ear	samples.	Although	it	is	likely	that	damage	to	tissue	is	directly	caused	by	the	DNFB	challenge,	additional	inflammatory	swelling	and	necrosis	in	the	DD	compared	to	the	VD	group	could	be	interpreted	as	the	results	of	effector	cells	responding	specifically	to	the	challenge	and	causing	inflammatory	damage.				In	conclusion,	we	interpret	these	results	as	evidence	that	hapten-specific	CHS	memory	exists	in	swine.	Exploring	immune	memory	could	be	important	for	expanding	our	understanding	of	communication	between	the	porcine	adaptive	and	innate	immune	system	training	and	education,	which	has	implications	for	vaccine	development	in	the	commercial	swine	industry	and	biomedicine.			
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Figures		
		Figure	1:	Ear	thickness	shows	hapten-specific	ear	inflammation	response	in	ears	of	
pigs	for	32	day	sensitization	but	not	for	5	day.	15-30	kg	pigs	were	injected	intradermally	on	the	back	with	DNFB,	OXA,	or	1:1	acetone:olive	oil	vehicle	alone.	Animals	were	re-challenged	after	32	or	5	days	following	with	intradermal	ear	injections	of	DNFB,	OXA,	or	respective	vehicle.	Shown	here	is	the	LS	means	of	ear	thickness	difference	(mm)	from	time	zero	for	sensitization	periods	of	(A)	32	days	or	(B)	5	days.	The	interaction	of	back	sensitization*ear	treatment	was	evaluated	for	significance	to	provide	evidence	for	hapten-specific	memory.	With	a	threshold	p-value	<0.05,	32	day	(p-value	<	0.01)	sensitization	period	showed	evidence	of	hapten-specific	ear	swelling,	while	the	5	day	sensitization	period	(p-value	<	0.98)	did	not.				 	
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Figure	2:	Improvements	to	CHS	protocol	shows	topical	application	of	sensitizing	
agent	causes	less	background	inflammatory	response.	(A)	Dosage	comparison	for	sensitizing	concentration	of	topical	dorsal	application	(paint)	of	DNFB	low	(2.5%)	versus	DNFB	high	(10%).	(B)	Ear	challenge	methodology	comparison	between	injection	vs	topical	painting	application	across	both	sensitization	concentrations.					 	
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		Figure	3:	Improved	protocol	Ear	thickness	shows	hapten-specific	ear	inflammation	
response	in	ears	of	normal	pigs	as	early	as	7	days	post-sensitization.	15-30	kg	pigs	had	DNFB	or	4:1	acetone:olive	oil	vehicle	applied	dropwise	to	their	backs.	Animals	were	re-challenged	after	21	or	7	days	with	intradermal	ear	injections	of	DNFB,	OXA,	or	respective	vehicle.	Shown	here	is	the	LS	means	of	ear	thickness	difference	(mm)	from	time	zero	for	sensitization	periods	of	(A)	21	days	or	(B)	7	days.	The	interaction	of	back	sensitization*ear	treatments	were	evaluated	for	significance	of	hapten-specific	memory.	With	a	threshold	p-value	<0.05,	21	day	(p-value	<	0.01)	and	7	day	(p-value<	0.01)	sensitization	periods	showed	evidence	of	hapten-specific	ear	swelling.				 	
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	Figure	4	:	Hapten-specific	ear	swelling	effect	differences	between	sensitization	
periods	and	time	of	data	collection.	While	7,	21	and	32	day	sensitization	periods	yielded	significant	hapten-specific	inflammation	responses,	the	32	day	sensitization	period	showed	the	largest	effect	of	prior	sensitization.				 	
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Tables		Table	1:P-values	of	contrasts	examining	the	effect	of	a	sensitizing	hapten.	Reported	are	ANOVA	p-values	for	the	overall	interaction	of	sensitization*ear	treatment,	followed	by	p-values	of	the	hapten-specific	contrasts	at	either	24	or	48	hours	post	challenge.		Comparisons	investigated	the	effect	of	sensitizing	the	pig	with	a	hapten	prior	to	hapten	challenge.	Primary	comparisons	included	vehicle	sensitized,	DNFB	challenged	(VD)	compared	to	DNFB	sensitized,	DNFB	challenged	(DD)	and	vehicle	sensitized,	OXA	challenged	(VO)	compared	to	OXA	sensitized,	OXA	challenged	(OO).	Also	included	is	the	contrast	of	OXA	sensitized,	DNFB	challenged	(OD)	compared	to	DNFB	sensitized,	DNFB	challenged	(DD)	and	contrast	of	DNFB	sensitized,	OXA	challenged	(DO)	compared	to	OXA	sensitized,	OXA	challenged	(OO)	which	explores	the	hapten-specific	response	of	the	inflammation.				
						 	
Sensitizing		Method	 Sensitization	Period	(days)	 Hours	post	challenge	 ANOVA		p-value	back*ear	interaction		
VD	vs	DD	(p-value)	 OD	vs	DD			(p-value)	 VO	vs	OO		(p-value)	 DO	vs	OO		(p-value)	Dorsal	back	injection	 32	 24	 <0.01	 <0.01	 <0.01	 <0.01	 <0.01	48	 <0.01	 <0.01	 <0.01	 <0.01	 <0.01	5	 24	 0.93	 0.79	 0.80	 0.32	 0.45	48	 0.61	 0.34	 0.23	 0.13	 0.47	Dorsal	back	topical	paint	
21	 24	 <0.01	 <0.01	 N/A	 N/A	 N/A	48	 <0.01	 <0.01	 N/A	 N/A	 N/A	7	 24	 <0.01	 <0.01	 <0.01	 N/A	 N/A	48	 <0.01	 <0.01	 <0.01	 N/A	 N/A	
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	Table	2:	Histology	of	ear	sections	from	VD	and	DD	hapten	treated	animals	(21	day	
sensitization	period).	Infiltrating	lymphocytes,	vasculitis	and	thrombosis,	and	necrosis	as	scored	by	the	ISU	Pathology	Department	on	a	0-4	scale.	Depicted	is	the	average	of	4	ear	punches	per	VD	and	DD	treatment.				
Treatment		 Lymphocyte	
Infiltrate	 Vasculitis/Thrombosis	 Necrosis/Infarction		VD	 1.25	 2.5	 3	DD	 2.33	 2.75	 3.75	DD	vs	VD		(p-values)	 0.02	 0.38	 0.01					 	
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CHAPTER 7. GENERAL DISCUSSION 
 	
General	Objectives	
	As	a	large	animal	research	model,	the	porcine	species,	particularly	the	SCID	pig,	offers	the	potential	for	insight	into	the	mechanisms	of	disease,	and	offers	a	valuable	tool	for	development	of	biomedical	therapies.	The	SCID	pig	presents	a	unique	opportunity	to	explore	specific	roles	of	immune	cells	and	the	relationship	between	the	innate	and	adaptive	immune	systems.	This	thesis	provides	important	basic	research	for	the	development	of	the	biomedical	pig	model,	cellular	characterization	of	the	ISU	Artemis-defective	SCID	pig,	and	explores	evolving	parameters	of	swine	immunology	including	innate	cell	training.		Classic	rodent	models	have	cost	advantages,	and	SCID	mice	are	available	reliably	with	low	facility	preparation,	consistent	genetic	backgrounds	limiting	genetic	variation	between	individuals	(especially	convenient	for	immunological	and	transplant	work),	and	extremely	well-developed	resources	(reagent	availability,	annotated	genomics	(Immgen.org)).		A	critical	component	to	developing	a	large	animal	SCID	porcine	model	is	to	produce	and	make	available	healthy	SCID	piglets	in	large	enough	numbers	for	research.	The	availability	and	utilization	of	the	porcine	SCID	model	will	in	turn,	drive	the	development	of	additional	swine	resources.		As	the	use	of	the	SCID	pig	expands,	so	will	the	understanding	and	characterization	of	the	naturally	occurring	SCID	pig	model	itself.	To	best	utilize	the	SCID	pig,	it	is	crucial	to	understand	the	intrinsic	immunity	present	within	the	SCID	environment.	This	thesis	
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provided	an	in-depth	analysis	of	the	population	of	NK	cells,	an	innate	lymphocyte	present	within	these	pig,	thus,	providing	implications	of	immune	capabilities	of	the	primarily	T	and	B	cell	negative	environment.		The	SCID	pig	offers	a	unique	asset	to	the	biomedical	community	for	studying	SCID	disease	pathogenesis,	transplantation,	cancer	therapy,	and	regenerative	medicine.	In	addition,	the	SCID	model	is	poised	to	enable	research	regarding	pig	health,	including	elucidating	the	role	and	responsibilities	of	immune	cells,	studying	mechanisms	of	disease,	and	vaccine	development.	The	more	we	learn	about	the	SCID	immune	system	through	characterization,	and	continuing	research,	the	more	we	learn	about	general	porcine	immunity.		
Development,	characterization,	and	future	uses	of	the	SCID	pig	model		
The	SCID	Pig	Colony	Initially	it	was	important	to	identify	and	establish	breeding	founders	for	a	full-fledged	SCID	colony.	As	described	in	the	introduction	chapter,	our	SCID	phenotype	is	caused	by	two	separate	recessive	mutations	in	the	Artemis	gene	(H12	and	H16)	(Waide	et	al.	2015).	To	increase	the	percentage	of	SCID	piglets	produced	per	litter,	we	set	out	to	rescue	the	SCID	phenotype	via	bone	marrow	transplant	(BMT)	in	animals	who	were	genetically	SCID.	In	an	unexpected	twist,	three	of	the	four	BMTs	had	to	be	euthanized	at	11-13	months	of	age	due	to	failing	health.	Upon	necropsy,	it	was	discovered	that	all	three	had	cancer;	both	H16/H16	homozygotes	were	diagnosed	with	T	cell	lymphoma	and	one	with	an	additional	leukemia	while	the	third	H12/H16	heterozygote	presented	with	a	
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nephroblastoma.	Such	a	high	occurrence	of	cancer	in	such	a	limited	number	of	animals	has	implications	for	the	SCID	pig	as	a	naturally	occurring	cancer	model.	The	literature	offers	cases	of	human	Artemis	defective	patients	that	have	a	hypomorphic,	‘leaky’	phenotype	associated	with	lymphoma,	where	some	T	cell	subsets	still	exist	(Moshous	et	al.	2003).	The	two	mutations	present	in	our	system	make	for	a	particularly	unique	opportunity,	where	cancer	research	teams	may	be	interested	in	the	natural	cancer	occurrence	of	the	homozygous	H16	line,	but	other	research	groups	might	find	the	in-theory	‘non-leaky’	H12	SCIDs	more	suitable	for	their	research	goals.	In	hindsight,	it	would	have	been	valuable	to	collect	samples	more	thoroughly	from	the	two	lymphoma	cases,	particularly	to	culture	cancerous	cells	for	further	characterization.	This	is	an	important	note	to	be	prepared	for	future	H16/H16	animal	necropsies,	particularly	older	animals,	who	may	be	at	risk	for	lymphoma.			 Logically,	if	you’re	going	to	make	SCID	piglets,	you	need	an	appropriate	environment	to	raise	them.	We	have	had	some	success	raising	SCID	piglets	in	high	sanitation	rooms	but	have	been	unable	to	rear	them	past	80	days	of	age	due	to	opportunistic	infections.	An	important	step	in	the	SCID	colony	development	was	the	construction	of	the	‘bubbles’,	not	unlike	the	bubble	that	kept	David	Vetter,	the	original	“bubble	boy”,	alive	for	all	13	years	of	his	life.	The	two	bubbles	(a	short	term	and	long	term	unit)	feature	HEPA	filtered	positive	air	pressure,	UV	treated	water,	and	irradiated	feed,	and	are	only	entered	by	staff	gowned	in	protective	suits,	face	masks,	hair	nets,	and	double	gloved	hands.	Though	we’ve	encountered	isolated	cases	of	contamination	and	illness	of	SCID	piglets	snatch	farrowed	into	the	bubble,	we	were	able	to	catch	the	infection	early	and	thanks	to	the	quarantine	and	two	bubble	system,	were	able	to	isolate	infected	animals	and	keep	the	long	term	bubble	free	of	disease.	
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Along	with	the	physical	facilities,	the	SCID	team	has	developed	protocols	and	operating	procedures	to	successfully	raise	and	care	for	SCID	pigs.	The	utility	of	the	bubbles	has	been	apparent.	Not	only	have	we	been	able	to	greatly	reduce	the	loss	of	SCID	piglets	to	infection,	but	we	have	been	able	to	keep	them	alive	for	record	lengths	of	time.	Although	she	did	not	remain	in	the	bubble	for	her	entire	life,	one	SCID	gilt	lived	for	a	record	nine	months,	and	was	healthy	for	eight	of	them.	This	is	a	crucial	component	to	producing	healthy	piglets	that	can	be	provided	to	clients	and	collaborators	for	a	slew	of	research	interests	including	joint	and	arthritis	repair,	wound	healing,	cardiac	function,	cancer	therapy,	and	regenerative	medicine.	As	an	unexpected	benefit,	the	bubble	system	has	also	facilitated	characterization	of	our	model	that	was	unachievable	previously	including	continued	exploration	of	the	cellular	phenotype	of	the	SCID	pig.	As	previously	mentioned	in	the	cases	of	the	bone	marrow	transplanted	H16/H16	SCIDs,	this	could	further	provide	evidence	toward	the	potential	of	a	leaky	SCID	phenotype,	which	would	also	have	implications	for	the	development	of	a	lymphoma	cancer	model	from	the	homozygous	H16	SCIDs.		The	longer	we	study	SCID	animals,	the	more	we	learn	about	their	breeding	and	management,	as	well	as	recognize	hurdles	left	to	overcome.	The	ISU	SCID	pig	was	serendipitously	discovered	during	a	PRRS	challenge	study	in	collaboration	with	Kansas	State	University	(Cino	Ozuna	et	al.	2012).	As	a	result,	the	genetic	base	of	the	founder	individuals	carrying	the	SCID	mutations	starts	with	the	founder	pigs	that	went	on	to	be	selected	for	Residual	Feed	Efficiency	(RFI)	(Cai	et	al.	2008).	Already	starting	with	a	closed	genetic	population,	over	the	last	three	generations	of	SCID	animals	paired	with	the	limited	sire	use	has	left	us	with	the	potential	of	inbreeding	issues.	The	limited	sire	problem	(the	two	BMT	sires	discussed	herein)	present	several	issues.	First,	the	creation	of	replacement	
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boars	has	proved	difficult.	With	more	varied	MHC	haplotypes	among	carrier	dams,	100%	MHC	matches	became	less	common,	and	two	recent	successful	transplants	were	either	reproductively	damaged	or	succumbed	to	disease.	With	the	successful	BMT	sires,	once	they	started	to	fail	reproductively	and/or	were	euthanized,	we	moved	to	artificial	insemination	of	frozen	semen,	which	is	notoriously	poor	in	breeding	efficiency	for	the	swine	species	(McNamara	et	al.	2013).	Also	of	note,	due	to	space	constraints,	our	bubble	facilities	do	not	house	live	boars,	meaning	female	sows	and	gilts	are	not	exposed	to	natural	pheromones	and/or	additional	signals	that	traditionally	contribute	to	normal	reproductive	cycling.	There	are	difficulties	in	detecting	heats	in	SCID	carrier	dams,	as	well	as	low	breeding	efficiencies.	All	these	factors	contribute	to	decreasing	litter	sizes	in	the	SCID	breeding	herds.	As	the	Artemis	defective	SCID	model	is	further	developed,	there	could	be	advantages	to	breeding	the	SCID	mutations	into	commercially	available	sows.	Commercial	sows	have	been	selected	for	high	turnover	and	large	litter	size	and	consequently	also	select	against	reproductive	inconsistencies.	SCID	litter	sizes	average	8.5	piglets	per	litter,	while	the	modern	commercial	sow	averages	12.7-15.2	piglets	per	litter	(PigChamp	Benchmarking).	Incorporating	genetics	for	larger	litter	size	into	SCID	genetics	could	be	done	with	frozen	compound	heterozygote	SCID	semen	into	a	commercial	sow	over	a	single	generation	likely	producing	carrier	females	with	each	mutation.	This	would	instantly	address	inbreeding	and	hopefully	reproductive	complications,	while	at	the	same	time	encouraging	higher	production	numbers	of	SCID	piglets	for	scientific	use.	As	a	note,	it	would	be	important	to	assess	the	capacity	of	the	bubble	facilities	to	ensure	it	could	easily	accommodate	larger	production	numbers.			
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The	SCID	Cellular	Characterization	A	general	cellular	characterization	of	the	SCID	phenotype	was	performed	by	Kansas	State	University	early	after	the	discovery,	which	confirmed	the	absence	of	T	and	B	cells	but	the	presence	of	NK	cells	(Ewen	et	al.	2014).	Among	Primary	Immune	Deficiencies	(PIDs)	and	NK	cell	deficiencies,	there	are	documented	cases	where	NK	cells	are	present,	but	not	functional	(Kotlarz	et	al.	2013;	Jouanguy	et	al.	2013).	NK	cells	are	innate	lymphocytes	with	important	roles	in	detection	and	clearance	of	cancer	and	virally	infected	cells,	as	well	as	important	producers	of	signaling	cytokines	such	as	IFN-g	(Vivier	et	al.	2011).	Presence	of	functional	NK	cells	has	been	documented	to	affect	human	SCID	patient	treatments	such	as	the	likelihood	of	developing	Graft	versus	Host	Disease	(GvHD),	which	can	critically	affect	the	success	of	life	saving	bone	marrow	transplantation	procedures	(Hassan	et	al.	2014).	Understanding	the	function	and	role	of	NK	cells	present	in	the	SCID	pig	provides	a	platform	to	improve	human	patient	procedures	as	well	as	impact	the	sensitivity	of	the	pigs	to	BMT	complications.	NK	cells	are	also	recognized	for	their	anti-tumor	activity	and	are	being	studied	for	therapeutic	use	for	cancer	patients	(Eguizabal	et	al.	2014).		This	thesis	directly	addressed	the	functionality	of	SCID	pig	NK	cells	in	vitro.	We	defined	the	function	of	the	NK	cell	as	the	ability	to	kill/lyse	non-MHC	class	I	cell	targets	(cytotoxicity),	respond	to	activation	signals,	and	produce	IFN-γ.	Although	we	showed	that	NK	cells	derived	from	the	ISU	SCID	pig	are	intrinsically	functional	in	vitro,	this	does	not	fully	answer	questions	about	the	capabilities	of	these	SCID	NK	cell	in	vivo	which	could	have	important	implications	regarding	the	innate	capabilities	present	within	the	SCID	pig.	If	anything,	other	components	of	SCID	research	suggest	evidence	that	SCID	NK	cells	could	
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have	activation	deficiencies	or	migration	inadequacies	in	the	SCID	environment,	which	we	will	discuss	in	detail	below.		To	further	understand	the	SCID	pig	phenotype,	Basel	et	al.	(2012)	injected	SCID	pigs	with	two	human	tumor	cell	lines,	PANC-1	(pancreatic	carcinoma)	and	A375-SM	(melanoma).	Tumor	cells	injected	into	the	SCID	animals	survived,	while	the	control	non-SCID	animals	did	not	have	cancer	cells	persist	(Basel	et	al.	2012).	Although	this	study	confirmed	the	immune	system	deficiency	and	suggested	the	use	of	the	SCID	pig	as	a	cancer/xenograft	model,	an	important	question	that	arose	from	these	results	is	that	since	these	immune	compromised	animals	possess	NK	cells,	yet	failed	to	reject	cancer	target	cells,	what	is	the	capability	of	the	NK	cells	in	vivo?	In	another	study	that	examined	the	innate	response	of	pigs	to	influenza,	SCID	pigs	and	non-SCID	littermates	were	infected	with	influenza	virus.	The	SCID	pigs	were	not	capable	of	controlling	viral	replication,	despite	the	elevated	presence	of	NK	activating	agents,	such	as	IFN-a	(Rajao	et	al.	2017).	Further,	pathology	of	the	SCID	pig	lungs	revealed	significantly	less	inflammatory	damage,	yet	increased	levels	of	virus,	inconsistent	with	a	fully	functional	innate	immune	response	(Rajao	et	al.	2017).	These	findings	initially	could	be	interpreted	as	an	inefficiency	of	SCID	innate	cells,	which	could	include	unknown	defects	in	SCID	NK	function.		Another	immune	response	we	examined	also	offers	clues	toward	SCID	NK	capabilities	(described	in	detail	in	Appendix	A).	Although	the	NK	cell	has	always	been	regarded	as	an	innate	effector	cell	with	little	to	no	adaptive	function,	work	accomplished	in	mouse	models	utilizing	contact	hypersensitivity	(CHS)	has	demonstrated	that	NK	cells	also	exhibit	memory-like	behavior	(Majewska-Szczepanik	et	al.	2013;	Paust	et	al.	2010;	Paust	et	al.	2011;	O’Sullivan	et	al	2015;	O’Leary	et	al.	2006).	Adoptive	transfer	studies	identified	that	
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educated	NK	cells	were	found	in	the	liver	but	had	the	capabilities	to	migrate	to	areas	of	re-challenge	(Majewska-Szczepanik	et	al.	2013;	Paust	et	al.	2010;	O’Sullivan	et	al.	2015;	O’leary	et	al.	2006).	The	virus	and	tumor	targeting	activity	of	NK	cells	sparks	interest	in	harnessing	their	education	for	therapeutic	uses	and	vaccine	development.	For	biomedical	purposes,	the	pig	offers	a	more	similar	model	to	a	human	system,	and	from	an	agricultural	standpoint,	the	commercial	swine	industry	would	be	a	significant	target	for	vaccine	development.	As	NK+	containing	SCID	mice	were	used	in	the	NK	memory	field,	our	T-B-NK+	SCID	pig	model	would	be	a	prime	candidate	for	exploring	NK	cell	memory	in	the	pig.	However,	as	described	in	chapter	6,	the	first	stage	of	establishing	the	pig	as	a	model	was	to	determine	if	hapten	specific	contact	hypersensitivity	exists	in	the	non-rodent	large	animal	pig	model.	To	accomplish	this,	we	sensitized	commercial	pigs	with	di-nitrofluorobenzene	(DNFB),	oxazolone	(OXA),	or	vehicle	controls	on	the	dorsal	back	and	then	re-challenged	the	animals	with	ear	injection	combinations.	There	is	a	well-documented	memory	T	cell	response	to	CHS	(Askenase	et	al.	2001;	Szczepanik	et	al.	2006),	which	would	be	expected	in	this	normal	porcine	immune	system.	However,	we	specifically	investigated	NK	cell	activation	by	measuring	cytotoxicity	and	perforin	and	IFN-g	production.	Consistent	with	the	work	reported	in	O’Leary	(2006),	we	found	preliminary	evidence	that	animals	that	had	twice	been	exposed	to	a	specific	hapten	(ex.	DNFB	sensitized	and	DNFB	challenged)	had	heightened	liver	NK	cell	activation	in	terms	of	tumor	target	lyses	and	cytokine	production	compared	to	peripheral	blood	NK	cells	and	control	treatment	groups	(Majewska-Szczepanik	et	al.	2013;	O’Leary	et	al.	2006);	see	Appendix	A.	To	directly	ask	if	the	hapten	CHS	memory	was	independent	of	the	adaptive	immune	system,	we	also	sensitized	and	challenged	two	groups	of	SCIDs	and	non-SCID	littermates	with	DNFB	and	vehicle	control	
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for	11	and	21	day	sensitization	periods	as	described	in	Appendix	A.	Surprisingly,	although	the	SCIDs	showed	an	inflammatory	response	to	hapten	treatment,	no	evidence	of	hapten	specific	memory	could	be	documented	trough	a	statistical	analysis.	In	contrast,	the	non-SCID	littermates	behaved	as	we	observed	in	our	previous	commercial	animal	trials,	and	showed	expected	hapten	specific	inflammation	upon	hapten	challenge.	Furthermore,	no	detection	of	differences	in	cytotoxicity,	perforin	and	IFN-g	production	were	detected	in	the	SCID	animals.	The	central	conclusion	is	that	the	SCID	pigs	lack	an	important	component	crucial	to	the	mechanism	of	hapten-specific	memory.	There	are	several	interpretations	for	these	results.	First,	we	are	not	detecting	significant	innate	memory	in	the	commercial	pig,	but	rather	the	response	is	driven	by	the	intact	adaptive	immune	system.	Second,	there	is	a	component	of	NK	cell	training	present	in	the	normal	pig,	but	the	SCID	pig	has	an	additional	unknown	NK	cell	defect	inhibiting	the	memory	response	in	our	specific	SCID	environment.	Third,	for	at	least	one	of	the	SCID	trials,	SCID	piglets	were	additionally	exposed	and	infected	with	bacterial	pathogens	(Staph.	hyicus),	which	could	induce	a	heightened	inflammatory	state	where	hapten-specific	responses	were	not	detectable.		Immune	signaling	is	a	complex	and	interdependent	system.	It	is	conceivable	the	SCID	NK	cells	are	simply	not	being	activated	properly	by	a	system	lacking	certain	cytokines	(such	as	IL-2),	but	otherwise	completely	functionally	intact	as	suggested	by	our	in	vitro	findings.	Another	plausible	scenario	is	that	the	NK	cells	have	an	undetected	defect,	such	as	in	migration	toward	a	stimulant,	and	are	thus	incapable	of	performing	to	their	full	capacity.	Additional	research	needs	to	be	completed	to	investigate	these	options,	possibly	including	comparisons	with	the	artificially	engineered	Recombination	Activating	Genes	(RAG)	T-B-NK+	knock-out	SCID	pig	models	(Lee	et	al.	2014;	Ito	R	et	al.	2012;	Ito	T	et	al.	2014)	which	
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may	be	more	comparable	to	the	SCID	mouse	models	used	in	the	hapten	CHS	memory	responses.	Karo	et	al.	(2014)	reported	that	NK	cells	established	in	RAG	knock-out	mouse	models	have	functional	differences	compared	to	other	NK	cell	populations	in	other	environments;	these	included	heightened	cytotoxicity	and	less	long-lived	survivability.	Of	note,	the	RAG-/-	NK	cells	from	the	O’Leary	work	(2006)	seem	to	elicit	a	memory	response	similar	to	that	of	a	complete	immune	system	while	the	NK	cells	from	a	DNA-dependent	kinase	catalytic	subunit	(DNA-PKcs)	SCID	defect	in	the	Majewska-Szczepanik	(2013)	work	show	a	significantly	weakened	response	in	the	NK	cell	alone	environment	compared	to	the	fully	immune	competent	control	mice.		Regardless,	the	SCID	pig	provides	a	promising	model	to	explore	these	types	of	mechanisms	and	investigate	the	relationship	between	innate	and	adaptive	responses.	To	address	remaining	questions,	in	vivo	testing	of	NK	cell	function	is	needed,	but	from	a	more	encompassing	stand	point.	A	more	in-depth	characterization	of	ISU	Artemis	defective	SCID	pig	immunity	and	the	SCID	environment	is	necessary.	Although	this	is	a	broad	objective,	certain	analyses	would	greatly	contribute	to	some	central	unknowns.	The	first	would	be	a	cytokine	profile	within	the	SCID	pig	before	and	after	an	immune	stimulation,	to	determine	what	functional	cell	signaling	is	intact	in	the	SCID	environment	and	in	the	context	of	NK	cells,	which	activating	cytokines	are	actually	being	produced.	One	condition	to	be	aware	of	is	the	time	sensitivity	of	the	proposed	experiment.	Cytokine	responses	are	seen	in	typically	narrow	time	windows	and	IL-2	is	known	to	have	a	short	half-life	of	one	hour	post	intravenous	injection	in	the	human	(Wagner	et	al.	2014).	Also,	cytokines	and	activation	signals	are	energy	expensive	to	produce,	it	may	be	necessary	to	challenge	the	system	with	a	disease	and/or	adjuvant	and	take	a	detailed	time	course	of	
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samples.	A	systematic	challenge	with	a	disease	(such	as	influenza)	may	be	required	to	cause	the	appropriate	activation	of	immune	cells	to	produce	cytokines,	but	would	also	compromise	the	SCID	animal	who	would	likely	not	recover.	An	additional	option	may	be	an	adjuvant,	such	as	polyinosinic:polycytidylic	acid	(Poly-IC),	which	should	not	be	life	threatening	to	a	SCID	pig.	In	may	in	fact	be	necessary	to	measure	cytokine	responses	to	different	challenges	that	may	activate	and	depend	on	different	cell	types	and	signaling	cascades.	To	fully	flesh	out	the	capabilities	of	the	SCID	NK	cells,	migration	competencies	also	need	to	be	assessed.	Although	NK	cell	specific	porcine	reagents	need	to	be	further	developed	(such	as	histology	antibodies	and	RNAscope	probes),	the	hapten	memory	experimental	design	provides	tissue	samples	from	the	treated	ears	of	sensitized	pigs	(in	the	original	mouse	work	there	is	strong	support	of	NK	cell	infiltration	to	these	re-challenge	regions)	that	would	be	appropriate	for	histological	characterization,	and	would	be	informative	as	to	whether	SCID	NK	cells	had	infiltration	and	accumulation	abilities.	Another	localized	option	would	be	to	inject	cancer	cells	into	the	SCID	pigs	and	once	tumor	were	established	as	in	work	by	Basel	et	al	(2012),	look	for	NK	cell	infiltration	into	the	tumor	mass.	The	more	elegant	approach,	and	a	major	step	for	the	porcine	SCID	model,	would	be	an	adoptive	transfer	investigation	that	tracked	how	established	functional	NK	cells	behaved	in	the	SCID	environment.	Injected	cells	could	be	pre-stained	with	a	KHYG-1	ion	marker	that	has	been	used	successfully	in	mice	to	show	NK	cell	infiltration	and	homing	to	a	tumor	(Mallett	et	al.	2012).	This	would	provide	important	data	about	if	or	how	the	SCID	system	influences	activation	of	cells,	as	well	as	answering	questions	about	cell	migration.	
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Another	critical	component	to	understanding	SCID	pig	immunity	is	to	assess	the	evidence	of	a	leaky	phenotype.	Coupled	with	the	instances	of	host-based	T	cell	lymphomas	in	the	two	BMT	SCIDs	mentioned	above,	inconsistent	evidence	of	CD3	cells	found	in	the	peripheral	blood	of	SCID	animals	urgently	needs	clarification.	Determining	whether	these	CD3+	cells	are	CD4+,	CD8+,	CD4+/CD8+	double	positives,	abT	cells,	or	gdT	cells	would	be	informative	for	exploration	of	the	SCID	defect	pathogenesis.	This	also	raises	interesting	questions	about	the	structure	and	function	of	immune	tissues	in	the	SCID	pig,	such	as	whether	SCID	pig	thymus	can	facilitate	T	cell	development,	and	whether	immune	cell	lymph	node	signaling	is	different	than	normal	swine.		It	has	already	been	established	that	SCID	pigs	have	small	or	nonexistent	thymus	tissue	and	abnormalities	in	other	secondary	immune	tissues	(Cino	Ozuna	et	al.	2012;	Ewen	et	al.	2014).	The	pig	species	specifically	hosts	a	circulating	population	of	CD4+,	CD8+	double	positives	(as	do	monkeys	and	chickens),	as	well	as	a	high	percentage	of	gdT	cells	in	the	circulating	blood	(Talker	et	al.	2013).		A	population	of	CD3+NKp46+	cells	also	have	been	recently	described	in	swine	(Mair	et	al.	2016).	While	development	of	most	T	cell	subsets	takes	place	in	the	thymus,	the	environment	of	the	periphery	can	induce	phenotypic	changes	in	these	cell	subsets	(Talker	et	al.	2013).	Jointly	these	CD3+	cell	subsets	would	need	to	be	assessed	for	presence,	differentiation,	and	functionality.	This	could	have	implications	for	immunity	in	the	SCID	pig,	‘leaky’	SCID	model	opportunities,	as	well	as	cell	signaling	capabilities,	for	example,	in	the	context	of	cytokine	production.	More	specifically,	functional	T	cells	could	produce	and	introduce	IL-2	to	the	SCID	cellular	environment,	which	in	the	absence	of	T	cells	you	would	expect	to	be	void	of	IL-2	but	this	is	unconfirmed.			
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Lastly,	gene	expression	states	of	immune	cells	have	been	rigorously	explored	in	the	human	and	the	mouse	(Immgen	(Shay	et	al.	2013;	Bezman	et	al.	2013)	and	ENCODE	projects	(Pazin	2015;	Raney	et	al.	2011)),	but	less	so	in	the	swine.	Gene	expression	changes	can	also	inform	us	about	the	activation	states	of	NK	cells,	and	similarly	important	effector	cells.	Understanding	activation	states,	molecular	signatures,	and	gene	expression	profile	unique	to	the	porcine	NK	cell	population	would	be	a	valuable	tool	for	the	swine	community.	Work	facilitated	by	unique	cell	functional	profiles	in	the	SCID	pig	and	non-SCID	littermates	could	be	the	beginning	of	a	transcriptome	library	of	immune	based	cell	populations	in	swine.	This	would	provide	valuable	comparison	between	SCID	and	normal	pigs,	and	explore	gene	expression	dependencies	among	cell	types.	As	the	porcine	model	becomes	increasingly	more	utilized,	researchers	will	rely	more	on	these	needed	databases.		The	ISU	Artemis	defective	SCID	pig	is	a	naturally	occurring,	immune-compromised,	large	animal	model	has	potential	to	expand	the	genetic,	immunological,	and	biomedical	resources	for	many	types	of	studies	including	regenerative	medicine,	pre-clinical	testing,	cancer	and	stem	cell	therapeutics,	as	well	as	provide	insight	into	agriculturally	valuable	fields	such	as	porcine	immunity,	health,	and	vaccine	development.	The	characterization	of	NK	cells	is	critical	to	fully	understanding	the	intrinsic	immunity	present	within	the	SCID	pig	model,	which	is	crucial	to	reaching	its	fully	potential.	As	a	biomedical	model,	the	ISU	SCID	pig	is	more	physiologically	similar	to	humans	with	defective	Artemis.	The	unique	NK	cell	population	also	offers	insight	into	advancing	treatment	of	SCID	patients	and	in	areas	of	cancer	therapy	development.		Jointly,	NK	cell	research	in	the	context	of	the	T-B-NK+	SCID	environment	offers	a	platform	for	the	extended	understanding	of	porcine	immunity	and	the	relationship	between	the	innate	and	adaptive	immune	systems.		
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APPENDIX	A.	
	
CONTACT	HYPERSENSITIVITY	(CHS)	HAPTEN-SPECIFIC	MEMORY	IN	NORMAL	SWINE	
MAY	BE	ASSOCIATED	WITH	ACTIVATION	OF	LIVER	NATURAL	KILLER	(NK)	CELLS	
	
	
Preface		 This	appendix	is	preliminary	analysis	of	data	collected	and	described	in	conjuncture	with	Chapter	6:	Successful	Development	of	Methodology	for	detection	of	Hapten	Specific	Contact	Hypersensitivity	(CHS)	Memory	in	Swine.	See	chapter	for	respective	additional	background	and	methodology.	Results	presented	herein	show	interesting	trends	that	require	additional	follow	up	with	larger	animal	numbers	to	provide	the	statistical	power	to	validate.	Until	this	is	completed,	these	results	should	be	considered	preliminary,	with	a	low	animal	numbers	reported.				 	
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Abstract		Training	of	immune	cells	can	be	illustrated	using	hapten-specific	contact	hypersensitivity	(CHS),	which	elicits	an	inflammation	response,	and	if	re-challenged,	an	CHS	memory	response.	Although	hapten	memory	T	cells	behavior	is	well-established,	recent	research	in	mice	has	demonstrated	that	the	classically	adaptive	characteristic	of	a	memory	response	can	be	accomplished	by	Natural	Killer	(NK)	cells,	which	are	innate	lymphocytes.	In	chapter	6	we	established	that	we	can	use	hapten	specific	CHS	to	measure	the	ear	inflammation	response	of	outbred	pigs	to	the	haptens	dinitrofluorobenzene	(DNFB)	and	oxazolone	(OXA).	We	detected	significant	hapten-specific	ear	swelling	responses	for	7,	21,	and	32	day	sensitization	periods	in	normal	pigs.	Mouse	literature	provides	evidence	that	educated	NK	cells	contributing	to	the	hapten	specific	ear	swelling	are	found	in	the	liver.	We	analyzed	the	activation	of	liver	resident	porcine	NK	cells	by	cytotoxicity	function	against	tumor	cell	targets	and	cytokine	production	of	perforin	and	IFN-g.	We	find	supporting	evidence	in	the	pig	that	liver	NK	cells	from	sensitized	and	challenged	animals	have	heightened	activation	states	compared	to	cells	from	challenged	alone	or	vehicle	control	animals.			
Introduction	The	memory	T	cell	Contact	Hypersensitivity	(CHS)	response	to	the	haptens	dinitrofluorobenzene	(DNFB)	and	oxazolone	(OXA),	is	well	established	(Majewska-Szczepanik	et	al.	2012,	2013;	Szczepanik	et	al.	1996;	Askenase,	2001).	In	an	intact	immune	system,	this	memory	behavior	is	driven	by	T	cells	which	form	specific,	long-lived	memory	responses,	including	responses	to	hapten-induced	CHS.	Activated	antigen	presenting	cells	
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(APCs)	such	as	dendritic	cells	and	Langerhans	cells	travel	to	the	draining	lymph	nodes	from	the	hapten	challenge	site	(Kimber	et	al.	2002).	In	lymph	nodes,	APC	presentation	of	haptenized	antigen	to	naïve	T	cells	facilitates	clonal	expansion	to	create	long	lived,	hapten	specific	CD4+	and	CD8+	T	cells	(Erkes	et	al.	2014).		NK	cell	lymphocytes	of	the	innate	immune	system	with	cytotoxic	activity	against	target	cells	not	displaying	‘self’	Major	Histocompatibility	Complex	I	(MHC	I)	such	as	virally	infected	or	tumor	cells	(Vivier	et	al.		2011).	NK	cells	use	a	varied	repertoire	of	receptors	to	recognize	their	targets	(Pegram	et	al.		2010)	and	induce	apoptosis	through	exocytosis	of	proteins	including	perforin	and	granzyme	B,	or	through	Fas-Fas	or	TRAIL	‘death’	pathway	activation	(Maher	et	al.	2002;	Denyer	et	al.	2006;	Vivier	et	al.	2011).	Although	resting	NK	cells	have	low	levels	of	perforin	and	granzyme	B,	if	exposed	to	activating	cytokines	including	IL-2,	or	the	combination	of	IL-12	and	IL-18,	NK	cells	significantly	increase	their	production	of	these	proteins	(Fehniger	et	al.		2007;	Mori	et	al.		1998;	Pintarič	et	al.		2008;	Powell	et	al.	2016).	Activated	NK	cells	also	communicate	with	other	components	of	the	immune	system	through	the	production	of	IFN-g	(Pintarič	et	al.	2008;	Duluc	et	al.	2009).	Recently,	mouse	research	has	determined	that	innate	cells,	including	monocytes	(Ifrim	et	al.	2014)	and	Natural	Killer	(NK)	cells	are	capable	of	immune	training	and	memory-like	behavior	(Majewska-Szczepanik	et	al.		2013;	O’Leary	et	al.	2006;	Paust	et	al.	2010,	2011;	O’Sullivan	et	al.	2015).	Murine	CHS	challenges	demonstrate	NK	cells	driven	memory,	with	an	emphasis	on	hepatic	NK	cell	(Majewska-Szczepanik	et	al.		2013;	O’Leary	et	al.	2006;	Paust	et	al.	2010,	2011).	Adoptive	transfer	studies	in	mice	showed	that	trained	NK	cells	populations	were	present	in	the	liver	but	absent	in	peripheral	blood	and	spleen	after	sensitization	(Majewska-Szczepanik	et	al.	2013;	O’Leary	et	al.	2006).	Upon	a	second	
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exposure	to	the	same	hapten,	NK	cells	exhibiting	memory-like	behavior	accumulated	in	the	site	of	re-challenge	and	show	a	heightened	activation	state	(illustrated	with	IFN-g	production	and	activation	receptors	such	as	Ly49C	and	NKG2D)	(Majewska-Szczepanik	et	al.		2013;	O’Leary	et	al.		2006;	Paust	et	al.	2010,	2011).		Many	studies	rely	on	severe	combined	immunodeficiency	(SCID)	models	(O’Sullivan	et	al.	2015)	to	explore	NK	cell	training.	Memory	responses	are	shown	in	models	lacking	adaptive	cells	(T-B-NK+)	SCIDs	but	disappear	when	NK	cell	function	is	inhibited	(Majewska-Szczepanik	et	al.	2013)	or	when	NK	cells	are	absent	(T-B-NK-)	SCID	(O’Leary	et	al.		2006).		Although	the	hapten-specific	CHS	responses	examined	here	were	accomplished	in	normal	immune-competent	pigs,	this	appendix	seeks	to	investigate	the	parameters	of	NK	cell	activation	associated	with	hapten	specific	CHS	memory	responses	in	a	large	animal	model.			
Materials	and	Methods	See	methods	and	materials	reported	in	Chapter	6	for	sensitization	and	challenge	methods.		
Isolation	of	PBMCs	from	whole	blood:		Blood	was	collected	into	Vacutainer	heparinized	tubes	(BD	#367874	Becton	Dickinson	and	Company,	Franklin	Lakes,	NJ)	and	diluted	in	HBSS	(Life	Technologies,	Grand	Island,	NY).	Diluted	blood	was	layered	onto	Ficoll-paque	Plus	(GE	Healthcare	Bio-Sciences	Corp,	Piscataway,	NJ)	and	mononuclear	cell	buffy	coat	was	collected	and	washed	twice	with	HBSS	then	suspended	in	complete	RPMI.	Cell	counts	were	determined	via	a	cell	viability	kit	(BD	
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#349480).	Cells	were	diluted	to		2	x	106	cell/mL	and	either	used	for	flow	cytometry	staining	or	plated	in	a	96	well	plate	at	1	x	105,	2	x	105,	or	4	x	105	cells/well	for	10:1,	20:1,	and	40:1	effector	to	target	ratios	(E:T).	For	stimulated	wells,	2ng/well	recombinant	human	(rh)	IL-2	(Sigma-Aldrich-Cat#17908)	was	added,	and	plates	were	incubated	overnight	with	7%	CO2	and	at	37°C.			
Liver	cell	and	liver	flow-through	cell	isolation:		After	opening	the	main	body	cavity,	the	hepatic	portal	vein	above	and	the	inferior	vena	cava	below	the	liver	were	clamped.	Liver	lobes,	or	entire	liver	were	then	removed	from	the	body	cavity.	Butterfly	catheters	were	inserted	into	hepatic	vessels	and	livers	were	perfused	with	HBSS	(supplemented	with	0.5%	gentamicin).	15-40	grams	of	liver	tissue	was	harvested	and	minced	and	incubated	with	HBSS	containing	collagenase	IV	(500	mg/L,	312	U/mg),	and	DNase	(50	ug/L)	for	30	minutes	at	37°C.	Enzymatic	activity	was	halted	by	the	addition	of	cold	RPMI	containing	50%	FBS.	Cell	suspensions	were	filtered	through	sterile	4x4	medical	gauze	and	spun	for	10	minutes	at	500xg.	After	filtering,	cell	solution	was	layered	over	Ficoll	and	centrifuged		for	30	minutes	at	500xg.	For	liver	flow-through	cell	collection,	distal	lobes	of	the	liver	(not	containing	the	gallbladder)	were	removed	as	described	above	and	perfused	with	HBSS	and	gentamicin	at	high	pressure	over	a	funnel	where	a	solution	of	flushed	cell	could	be	collected	into	50	mL	conical	tubes.	Cell	solutions	were	filtered	over	sterile	4x4	medical	gauze	and	were	centrifuged	for	10	minutes	at	500xg.	After	filtering,	the	cell	solution	was	layered	over	Ficoll	and	centrifuged	for	30	minutes	at	500xg.	For	both	tissue	derived	and	flow-through	cell	collection	methods,	buffy	coats	were	collected	after	Ficoll	separation	and	washed	with	HBSS	and	complete	RPMI.		
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Cytotoxicity	Assay:		These	assays	were	performed	as	previously	described	in	Powell	et	al.	2016.	In	summary:		
Labeling	of	Tumor	Target	Cells:		K562	cells	(ATCC	–	CCL-243)	were	maintained	at	7%	CO2	and	37°C	in	complete	RPMI.	On	assay	day,	cells	were	counted	and	200uCi	chromium	(Cr	51)	was	added	dropwise.	The	cells	were	incubated	for	80	minutes	at	7%	CO2	and	37°C.	The	Cr	51	labeled	target	cells	were	washed	thrice	with	complete	RPMI	to	remove	excess	Cr	51	and	recounted.	Target	cell	solutions	were	diluted	to	2x105	cells/mL	and	50	µL	of	(1x104)	cells	was	added	to	all	wells	of	96	well	plates	with	pre-plated	PBMC’s.	As	PBMCs	were	plated	at	concentrations	of	1x	105,	2x	105,	or	4x	105cells	per	well	respectively	resulting	in	10:1,	20:1,	or	40:1	effector:target	ratios.	Plates	were	incubated	6	hours	at	37°C		and	7%	CO2.		
Harvesting	of	Plates:		Total	release	wells	(to	determine	maximum	lysing	possible)	were	lysed	with	10%	Triton-X	and	plates	were	centrifuged	at	200	rpm	for	5	min.	Each	well	had	120	µL	of	supernatant	collected	into	separate	counting	tubes	which	were	used	to	determine	Cr51	present	using	a	gamma-counter	(Gamma	trac	1191,	TM	Analytic	Inc.,	ElkGrove	Village,	IL).	Counts	per	minute	(CPM)	were	recorded.	Triplicates	were	averaged	to	determine	percent	cytotoxicity	as	follows:		Percent	Cytotoxicity	=	100	x	(CPM	experimental	average)-(CPM	spontaneous	release)												 	 	 	 							(CPM	total	release)-(CPM	spontaneous	release)	
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Flow	cytometry:	Data	was	analyzed	using	Flowjo	(V.10.1).	
Surface	Staining:	We	describe	NK	cells	having	a	CD16+,	SWC3a/CD172-	cell	surface	phenotype.		After	cell	counts,	1x105-3x105	live	PBMCs	were	diluted	in	Phosphate	Buffered	Saline	(PBS)-	Sodium	Azide	(0.05%)	(PBS-Azide)	and	stained	using	titered	mouse,	anti-pig	CD16	(IgG1,	AbD	Serotec-Cat#	MCA1971),	a	mouse	anti-pig	SWC3a/CD172	(IgG2b,	BD	Biosciences-Cat	#553640),	and	heat-inactivated	swine	serum	for	blocking.	Secondary	antibodies	used	were	goat	anti-mouse	IgG1-	(Southern	Biotech-Cat#1072-09)	and	goat	anti-mouse	IgG2b-	(Southern	Biotech-Cat#1090-02)	respectively.	Cell	solutions	were	washed	again	with	PBS,	and	fixed	with	a	2%	formaldehyde/PBS	solution	and	submitted	to	the	Iowa	State	University	Flow	Cytometry	Facility	for	flow	analysis	on	a	BD	Biosciences	FACSCanto	II	(San	Jose,	CA).		
Intracellular	staining:	PBMCs	were	treated	with	a	protein	transport	inhibitor	(BD	GogliPlug,	Cat#	555029)	for	6	hours	prior	to	staining	(1	µL	per	106	cells).	Cells	were	washed	with	PBS-Azide	and	were	surface	stained	for	CD16	(as	described	above)	and	then	simultaneously	permeabilized	and	fixed	using	kit	instructions	(BD	Cytofix/Cytoperm	Cat#	555028).	Cells	were	then	stained	using	directly	conjugated	anti-perforin	(BD	Pharmingen	Cat#	563762)	and	anti-IFN-g	(FITC)(Cat	#	554700).					
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Statistical	analysis	of	Percent	Cytotoxicity	and	Tumor	Target	Killed	per	NK	Cell:	Basic	least-squares	models	were	fit	with	the	ls	function	in	R	(R	Core	Team,	2016;	equivalent	to	PROC	GLM	in	SAS).	Type	III	ANOVA	tests	were	used	for	all	effects.	LSmeans	and	associated	contrasts	(i.e.	differences	in	LSmeans)	were	calculated	from	the	lsmeans	package	in	R	(Lenth,	2016).		Significance	was	evaluated	with	a	p-value	≤	0.05.	Initially,	a	full	model	was	fit	with	all	terms	up	to	a	5	day	interaction	of	all	fixed	effects.	To	select	a	more	parsimonious	model,	the	step	function	was	utilized	with	the	“both”	option	(forward	and	reverse	selection)	to	select	a	model	subset.	BIC	was	utilized	in	the	selection	criteria.	The	final	models	utilized	were	as	follows:		
Percent	Cytotoxicity	Model:	Percent	Cytotoxicity	(%)	=		Trial	+	HaptenTRT	+	CellSource	+	Dilution	+	CellTRT	+	Trial:HaptenTRT	+	Trial:CellSource	+	Trial:CellTRT	+	CellSource:CellTRT	+	Dilution:CellTRT	+	Trial:CellSource:CellTRT	+	e		
Tumor	Target	Killed	per	NK	Cell		Model:	Tumor	targets	killed	per	NK	cell	(TTKpNK)=	Trial	+	CellSource	+	CellTRT	+	HaptenTRT	+	Trial:CellSource	+	CellSource:CellTRT	+	HaptenTRT:CellTRT	+	HaptenTRT:CellSource	+	HaptenTRT:CellTRT:CellSource		Trial	was	the	effect	of	either	7	or	21	day	sensitization;	HaptenTRT	was	the	effect	of	the	combination	of	back	sensitization	and	ear	challenge	(VV,	VD,	or	DD);	CellSource	is	the	effect	
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of	the	tissue	(blood	or	liver);	Dilution	was	the	effect	of	the	effector	to	target	ratio	(10:1,	20:1,	or	40:1);	and	CellTRT	was	the	effect	of	either	IL2	or	media.			 	
Results		 As	established	in	Chapter	6,	CHS	responses	measured	as	an	increase	in	ear	thickness	from	time	zero	due	to	treatment	were	higher	for	ear	locations	challenged	with	the	chemical	for	which	the	animal	had	been	sensitized	as	compared	to	other	treatments.	Significance	was	determined	by	evaluating	the	interaction	of	each	ear	treatment	(challenge)	with	each	back	treatment	(sensitization).		Although	in	immune-competent	animals	we	would	anticipate	a	T	cell	memory	response	to	hapten	specific	CHS	(Askenase	2001),	we	wanted	to	investigate	whether	we	could	detect	a	response	from	hepatic	NK	cells	as	reported	for	mice	(Majewska-Szczepanik	et	al.	2013;	O’Leary	et	al.		2006).	At	necropsy,	two	types	of	sampling	of	liver	were	collected;	(a)	liver	tissue	that	had	been	gently	perfused,	and	(b)	high	pressure	liver	flow	through	solution.	Mononuclear	liver	cells	were	isolated	for	further	analysis	of	functional	activation	of	liver	NK	cells.	Peripheral	blood	mononuclear	cells	(PBMCs)	were	also	isolated	from	the	same	animals	for	comparison	(blood	collected	immediately	prior	to	necropsy).	Cells	from	DD,	VD,	and	VV	pigs	treatment	groups	were	tested	for	their	capabilities	to	recognize	and	lyse	human	K562	tumor	cells	(chronic	myelogenous	leukemia),	which	are	well	established	as	a	target	cell	line	for	NK	cell	cytotoxicity	assays.	As	previously	reported	in	Powell	et	al.	(2016),	resting	NK	cells	from	PBMCs	required	cytokine	activation	(human	recombinant	IL-2,	rhIL-2)	to	kill	K562	tumor	cells	in	vitro.	Both	cells	from	liver	and	peripheral	blood	from	
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all	treatment	groups	demonstrated	increased	percent	cytotoxicity	with	rhIL-2	stimulation	followed	10:1,	20:1,	40:1	effector	to	target	(E:T)	ratios	(Fig	1B).	As	expected	in	a	media	alone	environment,	blood	derived	effector	cells	from	DD,	VD,	or	VV	animals	did	not	show	any	lysis	of	target	cells	at	any	of	the	three	effector	to	target	ratios	(E:T)	(Fig	1A).	Interestingly,	although	not	statistically	significant,	in	contrast	to	the	blood	cell	results,	the	DD	liver	cells	demonstrated	a	trending	ability	to	lyse	target	cells	without	additional	stimulation	compared	to	VD	and	VV	liver	cells	(for	10:1,	20:1,	40:1	E:T	ratios	respectively)(Fig	1A).		Since	these	assays	used	mixed	cell	populations	that	were	not	quantified	for	proportions	of	NK	cells,	the		E:T	ratios	are	based	on	the	numbers	of	live	effector	cells	added	to	wells.	It	is	important	to	note	the	difference	in	percentages	of	CD16+	SWC3a/CD172-	NK	cells	(see	supplemental	Fig	1)	between	sources	of	cells	(blood	versus	liver)	and	between	treatment	groups	(Table	1).	We	did	not	see	statistically	different	percentages	of	NK	cells	from	tissue	or	tissue	flushing	(data	not	shown).	The	percent	cytotoxicity	and	percent	NK	cell	data	was	used	to	calculate	tumor	targets	killed	per	CD16+,	SWC3a-	NK	cell	(Fig	2).	As	suggested	in	the	percent	cytotoxicity	data	of	Figure	1A,	the	DD	liver	cells	showed	slightly	higher	tumor	targets	killed	per	NK	cell	in	the	K562	media	alone	environment	(not	statistically	significant)	compared	to	VD	treated	cells	(Fig	2A).	There	was	no	significant	difference	between	DD	and	VD	treatment	groups	with	IL-2	supplementation	(Fig	2B).			To	further	investigate	the	heighted	activation	states	of	DD	liver	cells	shown	with	the	cytotoxicity	data,	we	explored	additional	components	of	NK	cell	function.	Intracellular	flow	staining	shows	slight	increases	for	DD	compared	to	VD	cells	for	both	IFN-g	and	
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perforin	production	for	32	day	(Fig	3A),	21	day	(Fig	3B),	and	7	day	(Fig	3C)	sensitization	periods.	See	Supplemental	Fig	2	for	flow	cytometry	gating	strategy.				
Discussion		 The	data	presented	in	Chapter	6	establishes	hapten-specific	CHS	memory	exists	in	a	large	animal	model	and	the	Chapter	6	protocol	developed	ways	to	detect	and	measure	this	response	in	swine.		Associated	liver	NK	cells	analysis,	particularly	of	hapten	sensitized	and	challenged	(DD)	NK	cells	showed	a	trend	toward	heightened	cytotoxic	activity	against	K562	tumor	cells,	compared	to	DD	peripheral	blood	cells	as	well	as	VD	liver	cells.	Consistent	with	activation,	DD	hepatic	NK	cells	showed	an	increase	in	the	production	of	perforin	and	IFN-g	compared	to	VD	liver	NK	cells.	It	is	possible	that	liver	flow-through	cell	collections	also	included	non-resident	circulating	NK	cell	populations	traveling	through	the	liver	that	might	not	share	the	activation	of	‘trained’	hepatic	NK	cells.	Such	cells	would	dilute	the	phenotype	of	true	trained	NK	cells	and	could	explain	the	low	fraction	of	targets	killed	per	effector	cell	in	the	liver	flow-through	samples.	However,	these	cell	populations	were	shown	to	be	significantly	different	from	non-sensitized	pig	samples.	Thus,	although	additional	evidence	is	needed	to	establish	the	full	role	of	NK	cells	in	the	context	of	porcine	CHS	memory,	our	results	suggest	that	there	is	a	specific	NK	cell	response	associated	with	hapten	treatment	groups,	and	they	are	different	depending	on	sensitized	and	challenged	with	the	same	hapten	or	challenged	only.	Our	data	did	not	clarify	whether	this	is	a	direct	effect	or	whether	this	effect	on	NK	cells	is	dependent	on	other	lymphocytes	such	as	T	cells.	
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In	conclusion,	consistent	with	the	similar	results	in	mice	(O’Leary	et	al.	2006;	Majewska-Szczepanik	et	al.	2013),	hapten-specific	CHS	memory	may	show	an	association	with	the	activation	of	liver	NK	cells	in	swine.	Exploring	immune	memory,	especially	investigating	the	parameters	of	innate	memory,	could	be	important	for	expanding	our	understanding	of	communication	between	the	porcine	adaptive	and	innate	immune	system	and	NK	cell	training	and	education,	which	has	implications	for	biomedical	therapy,	and	commercial	swine	vaccine	development.			
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Figures		
		
	Figure	1:	Cytotoxicity	of	PBMCs	and	isolated	liver	cells	shows	higher	target	lysis	for	
liver	cells,	even	in	un-activated	cells.	Percent	cytotoxicity	of	blood	and	liver	cells	from	DNFB	sensitized,	DNFB	challenged	(black,	DD),	vehicle	sensitized,	DNFB	challenged	(medium	gray,	VD),	and	vehicle	sensitized,	vehicle	challenged	(light	gray,	VV)	pigs.	Samples	were	tested	against	K562	target	cells	in	media	alone	(A)	or	with	IL-2	supplementation	(B)	at	10:1,	20:1,	40:1	effector	to	target	ratios.	Data	shown	are	from	samples	collected	from	21	and	7	day	sensitization	periods.		 	
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	Figure	2:	Sensitized	and	challenged	DD	liver	cells	had	higher	tumor	targets	killed	per	
CD16+	SWC3a-	NK	cell	in	media	alone	across	all	effector	to	target	ratios	and	
responded	to	activating	agents.	Percent	cytotoxicity	(depicted	in	Fig1)	can	be	normalized	for	number	of	NK	cells	present	in	unsorted	cell	preps	of	liver	cells	from	DNFB	sensitized,	DNFB	challenged	(black,	DD),	vehicle	sensitized,	DNFB	challenged	(medium	gray,	VD),	and	vehicle	sensitized,	vehicle	challenged	(light	gray,	VV)	pigs.	Samples	were	tested	against	K562	target	cells	in	media	alone	(A)	or	with	IL-2	activation	(B).	Data	shown	are	from	samples	collected	from	21	and	7	day	sensitization	periods.			 	
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	Figure	3:	Heightened	activation	states	of	CD16+	NK	cells	from	the	liver	of	Hapten	
treated	animals.	Intracellular	staining	of	liver	cells	from	DNFB	sensitized/DNFB	challenged	(light	gray,	DD),	vehicle	sensitized/DNFB	challenged	(medium	gray,	VD),	and	vehicle	sensitized/vehicle	challenged	(dark	gray,	VV)	pigs	for	perforin	and	IFN-g	from	(A,B)	32	day,	(C,D)	21	day,	and	(E,F)	7	day	sensitization	periods.		
Tables	 	
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	Table	1:	Percentages	of	CD16+	SWC3a-	NK	cells	in	PBMCs	and	isolated	liver	cells	of	
hapten	treated	animals.	Cells	from	blood	and	liver	cells	from	vehicle	sensitized,	vehicle	challenged	(VV),	vehicle	sensitized,	DNFB	challenged	(VD),	and	DNFB	sensitized,	vehicle	challenged	(DV),	DNFB	sensitized,	DNFB	challenged	(DD),	pig	were	stained	from	trials	over	7,	21,	and	32	day	sensitization	periods.					Treatment	 %NK	PBMCs	 Standard	Error	 %NK	Liver	cells	 Standard	Error	VV	 14.88	 ±	2.55	 34.76	 ±	2.96	VD	 5.68	 ±	1.72	 26.27	 ±	6.86	DV	 13.83	 ±	3.39	 35.75	 ±	2.17	DD	 8.12	 ±	1.93	 26.02	 ±	4.3					 	
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Supplemental	Figures			
		Supplemental	Fig	1:	Flow	cytometry	gating	strategy	illustrating	how	we	obtain	CD16+	
SWC3a-	NK	cell	percentages	within	PBMCs	and	isolated	mononuclear	liver	cells	of	
hapten	treated	animals.	Panel	A)	depicts	forward	and	side	scatter	of	a	PBMC	sample.	Largely	all	live	cells	are	selected	and	viewed	with	side	scatter	height	and	side	scatter	area	to	gate	for	single	cells	(panel	B).	Lastly,	single	cells	are	quadrant	gated	for	CD16-PE	and	SWC3a-FITC	parameters	as	seen	in	C).	We	define	our	NK	cells	as	CD16+	SWC3a-	in	quadrant	one	(Q1),	monocytes	would	be	the	primary	composition	of	CD16+	SWC3a+	quadrant	two	(Q2),	and	other	cell	types	including	T	and	B	cells	would	be	found	in	quadrant	four	(Q4).			 	
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	Supplemental	Fig	2:	Flow	cytometry	gating	strategy	illustrating	intracellular	CD16+	
liver	NK	cell	production	of	perforin	and	IFN-g		from	hapten	treated	animals.	Panel	A)	depicts	forward	and	side	scatter	of	a	mononuclear	sample	gated	for	lymphocytes	alone	(also	gated	for	single	cells	with	side	scatter	height	and	side	scatter	(not	shown)).	To	identify	the	CD16+	lymphocyte	population	we	gate	using	the	PE	isotype	control	(B),	which	captures	CD16+	lymphocytes	in	a	sample	containing	the	primary	CD16	PE	antibody	as	seen	in	panel	C).	NK	cells	are	the	only	CD16+	lymphocyte	so	within	the	CD16+	population	we	can	analyze	PerCP-Cy5.5	perforin	and	FITC-IFN-g		content	which	we	show	in	histogram	format	(D	and	E	respectively).					 	
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APPENDIX	B.	
	
CONTACT	HYPERSENSITIVITY	(CHS)	HAPTEN-SPECIFC	MEMORY	IS	NOT	DETECTED	IN	
SEVERE	COMBINED	IMMUNODEFICIENT	(SCID)	SWINE	
	
	
Preface	
	The	observations	reported	here	were	collected	with	SCID	and	non-SCID	littermate	pigs	in	sterile	room	facilities	at	the	ISU	School	of	Veterinary	Medicine.	Litters	were	naturally	farrowed.	SCID	piglets	exposed	to	the	sow	in	non-bubble	environments	have	a	high	incidence	of	bacterial	infection	including	common	agents	of	Streptococcus	suis	and	
Staphylcoccus	hyicus.	It	is	possible	that	underlying	infections	and	pathogen	stress	could	affect	these	findings.	Additional	trials	in	the	hyper	clean	bubble	with	snatch	farrowed	SCID	and	non-SCID	piglets	could	confirm	and	expand	these	results.	Until	this	is	completed,	these	results	should	be	considered	preliminary,	with	a	low	animal	numbers	reported.		This	appendix	is	directly	related	to	Chapter	6:	Contact	hypersensitivity	(CHS)	hapten-specific	memory	exists	in	normal	swine	and	is	associated	with	activation	of	liver	Natural	Killer	(NK)	cells,	as	well	as	Appendix	A:	Contact	hypersensitivity	(CHS)	hapten-specific	memory	in	normal	swine	and	may	be	associated	with	activation	of	liver	Natural	Killer	(NK)	cells.	See	both	for	respective	additional	background	and	methodology.			 	
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Abstract/Summary		 Recent	research	in	mice	has	expanded	the	“adaptive”	characteristic	of	a	long	term	memory	response	from	solely	a	responsibility	of	the	adaptive	immune	system	to	Natural	Killer	(NK)	cells,	an	innate	lymphocyte.	Dermal	Hapten	contact	hypersensitivity	(CHS)	can	be	used	to	measure	a	memory	response,	where	a	chemical	hapten	can	illicit	an	inflammation	response.	We	first	established	hapten	specific	CHS	ear	swelling	is	detected	in	15-30	kg	outbred	pigs	when	sensitized	and	re-challenged	with	di-nitrofluorobenzene	(DNFB)	or	oxazolone	(OXA),	compared	to	vehicle	controls.	In	immune	competent	pigs,	NK	cells	specifically	isolated	from	the	liver	show	heighted	activation	states	compared	to	NK	cells	in	the	peripheral	blood.	To	confirm	the	results	are	independent	of	T	and	B	cells	we	tested	the	naturally	occurring	Severe	Combined	Immunodeficiency	(SCID)	pig,	which	have	a	T	cell	-,	B	cell	-,	NK	cell	+	cellular	phenotype.	However,	hapten	specific	ear	swelling	was	not	detected	in	the	SCID	pig	environment	after	11	or	21	day	sensitization	periods.	Although	some	in	vivo	activation	was	present	in	the	SCID	animals,	it	was	not	specific	between	hapten	groups.	Adaptive	immune	components	not	present	in	the	natural	Artemis	SCID	pig	are	important	in	the	mechanism	of	Hapten	specific	memory.			
Introduction	
	Mouse	literature	has	established	that	innate	cells	such	as	monocytes	and	NK	cells	are	capable	of	immune	‘training’	and	mounting	a	memory	response	(Ifrim	et	al.	2014;	Paust	
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et	al.	2010;	O’Sullivan	et	al.	2015;	O’Leary	et	al.	2006).	To	illustrate	this	phenomenon,	studies	frequently	use	hapten	contact	hypersensitivity	(CHS),	where	a	chemical	hapten	causes	a	protein	change,	is	recognized	by	the	immune	system,	and	an	inflammation	response	can	be	mounted	(O’Leary	et	al.		2006;	Majewska-Szczepanik	et	al.	2013).	In	order	to	show	the	resulting	memory	is	truly	independent	of	the	adaptive	immune	system,	many	of	the	NK	training	rodent	studies	are	conducted	within	or	with	severe	combined	immunodeficiency	(SCID)	models	(O’Leary	et	al.	2006;	Majewska-Szczepanik	et	al.	2013).	To	ask	specific	questions	about	NK	cells	in	an	environment	absent	of	B	and	T	cells,	these	studies	utilize	several	variations	of	SCID	mice.	SCID	disease	can	result	from	over	30	gene	defects	(Cossu	2010)	and	includes	assorted	cellular	phenotypes	depending	on	the	specific	mutation.	The	original	SCID	mouse	has	a	defect	in	the	DNA-dependent	kinase	catalytic	subunit	(DNA-PKcs)	protein	that	affects	the	DNA	repair	during	non-homologous	end	joining	(NHEJ)	and	results	in	a	T-	B-	NK+	cellular	phenotype	(Meek	et	al.	2001)	(Cossu	2010).	Also	unable	to	make	recombined	T	or	B	cell	Receptors	but	still	develop	functional	NK	Cells	are	cases	of	Recombination	Activating	Gene	(RAG)	SCID	models	(Notarangelo	2016;	Karo	et	al.	2014).	To	further	validate	NK	driven	training,	many	studies	show	the	hapten	specific	CHS	response	disappears	using	the	NK	cell	absent	SCID	environments.	This	T-B-NK-	cell	profile	is	commonly	accomplished	using	the	double	knockout	RAG	and	common	gamma	chain	(IL2Ry)	(O’Leary	et	al.	2006).	Alternatively,	the	role	of	NK	cells	can	be	investigated	with	SCID	beige	mouse	models	which	have	a	present	population	of	NK	cells,	but	are	unable	to	produce	granules	leaving	resident	NK	cells	non-functional	(Majewska-Szczepanik	et	al.	2013).		
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A	key	innate	effector	cell,	NK	cells	have	distinct	roles	in	immune	system	communication	as	well	as	target	recognition	and	lysis.	NK	cells	identify	targets	based	on	lacking	or	down-regulated	MHC	class	I	complexes,	which	makes	them	uniquely	effective	against	cancerous	and	virally	infected	cells	(Orange	2013;	Vivier	et	al.	2011).	Once	activated,	NK	cells	achieve	lysis	of	their	targets	through	ligand	recognitions	(FAS-FAS	or	TRAIL),	Antibody	Dependent	Cell	Cytotoxicity	(ADCC),	and/or	granule	exocytosis	and	the	release	of	perforin	and	granzyme	B	(Eguizabal	et	al.	2014;	Fehniger	et	al.	2007;	Maher	et	al.	2002;	O’Leary	et	al.	2006).	Production	of	perforin	and	granzyme	B	can	be	measured	as	indicators	of	NK	cell	activation,	along	with	quantifiable	lysis	of	target	cells	(cytotoxicity)	(Fehniger	et	al.	2007;	Powell	et	al.	2016).	NK	cells	also	communicate	with	other	components	of	the	immune	system	such	as	macrophages,	dendritic	cells,	B	cells,	and	T	cells	through	the	production	of	IFN-g	(Pintarič	et	al.	2008;	Vivier	et	al.	2011).	As	a	tool	to	explore	the	capacity	of	NK	cell	training	we	utilize	the	serendipitously	discovered	naturally	occurring	SCID	pigs	at	Iowa	State	University.	The	ISU	SCID	pigs	have	two	separate	mutations	in	the	Artemis	gene	responsible	for	their	T-	B-	NK+	phenotype	(Waide	et	al.		2015;	Ewen	et	al.		2015;	Cino-Ozuna	et	al.		2012).	To	date,	no	contact	hypersensitivity	in	Artemis	SCID	mice	has	been	reported.	Functionally	active	in	vitro,	the	ISU	SCID	pig’s	NK	cells	have	been	shown	to	produce	signaling	cytokines	and	perforin	as	well	as	lyse	target	cancer	cells	in	response	to	activating	stimulus	(Powell	et	al.	2016).						
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Materials	and	Methods	In	addition	to		Materials	and	Methods	section	from	Appendix	A.		
Creation	of	SCID	piglets	SCID	pigs	litters	were	created	internally	by	crosses	of	a	SCID	carrier	female	to	a	SCID	boar	who	had	been	phenotypically	rescued	by	bone	marrow	transplantation.	Following	a	Mendelian	recessive	mode	of	inheritance,	this	results	in	litters	with	approximately	50%	SCID	piglets.		Carrier	females	are	brought	in	from	the	Iowa	State	University	Lauren	Christian	Swine	Research	into	a	‘clean’	environmentally-controlled	room	at	the	ISU	College	of	Veterinary	Medicine.		SCID	status	was	determined	in	the	first	week	of	life	by	PCR	test	and	confirmed	by	CBC.	All	animal	experiments	and	standard	operating	procedures	(SOPs)	were	recorded	and	approved	by	the	Institutional	Animal	Care	and	Use	Committee	(IACUC).	For	these	results	11	SCID	piglets	and	7	non-SCID	littermates	were	utilized	from	two	separate	litters	(separate	dams	and	same	sire).		
Sensitization	and	challenge:	For	all,	pigs	were	sedated	for	sensitization	and	challenge	procedures.	For	all	experimental	trials	(described	below),	pigs	were	sedated	with	intramuscular	xylazine	(TKX)(2mL/20	kg)	injection	for	sensitization	and	challenge	procedures.	SCID	pigs	and	non-SCID	control	littermates	were	group	housed	by	back	treatment	in	a	clean	room	at	the	Iowa	State	University	School	of	Veterinary	Medicine.	All	animals	were	euthanized	by	captive	bolt.		 	
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11	Day	Sensitization	periods:	Pigs	were	sensitized	via	intradermal	injection	with	either	0.5	mL	2.5%	DNFB,	or	0.5	mL	acetone	and	olive	oil	vehicle	over	six	injection	sites	on	the	dorsal	back.	After	a	sensitization	period	of	11	days,	animals	were	challenged	with	0.2	mL	1%	OXA,	0.2	mL	1%	DNFB,	and	0.2	mL	vehicle	via	intradermal	injection	in	separate	ear	locations	(one	hapten	per	ear).	
21	Day	Sensitization	period:	Pigs	were	sensitized	by	adding	0.2	mL	of	solution	dropwise	to	pig’s	shaved	back	between	their	shoulder	blades	with	10%	DNFB	or	4:1	acetone	and	olive	oil	vehicle	(faster	drying	than	previously	used	1:1	vehicle).	After	a	sensitization	period	of	7	or	21	days,	animals	were	challenged	with	0.2	mL	1%	DNFB,	and	0.2	mL	vehicle	via	intradermal	injection	in	separate	ear	locations	(one	injection	site	per	ear).		
Isolation	of	PBMCs	from	whole	blood:		Blood	was	collected	into	Vacutainer	heparinized	tubes	(BD	#367874	Becton	Dickinson	and	Company,	Franklin	Lakes,	NJ)	and	diluted	in	HBSS	(Life	Technologies,	Grand	Island,	NY).	Diluted	blood	was	layered	onto	Ficoll-paque	Plus	(GE	Healthcare	Bio-Sciences	Corp,	Piscataway,	NJ)	and	mononuclear	cell	buffy	coat	was	collected	and	washed	twice	with	HBSS	then	suspended	in	complete	RPMI.	Cell	counts	were	determined	via	a	cell	viability	kit	(BD	#349480).	Cells	were	diluted	to		2	x	106	cell/mL	and	either	used	for	flow	cytometry	staining	or	plated	in	a	96	well	plate	at	1	x	105,	2	x	105,	or	4	x	105	cells/well	for	10:1,	20:1,	and	40:1	effector	to	target	ratios	(E:T).	For	stimulated	wells,	2ng/well	recombinant	human	(rh)	IL-2	(Sigma-Aldrich-Cat#17908)	was	added,	and	plates	were	incubated	overnight	with	7%	CO2	and	at	37°C.		
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Liver	cell	and	liver	flow-through	cell	isolation:		After	opening	the	main	body	cavity,	the	hepatic	portal	vein	above	and	the	inferior	vena	cava	below	the	liver	were	clamped.	Liver	lobes,	or	entire	liver	were	then	removed	from	the	body	cavity.	Butterfly	catheters	were	inserted	into	hepatic	vessels	and	livers	were	perfused	with	HBSS	(supplemented	with	0.5%	gentamicin).	15-40	grams	of	liver	tissue	was	harvested	and	minced	and	incubated	with	HBSS	containing	collagenase	IV	(500	mg/L,	312	U/mg),	and	DNase	(50	ug/L)	for	30	minutes	at	37°C.	Enzymatic	activity	was	halted	by	the	addition	of	cold	RPMI	containing	50%	FBS.	Cell	suspensions	were	filtered	through	sterile	4x4	medical	gauze	and	spun	for	10	minutes	at	500xg.	After	filtering,	cell	solution	was	layered	over	Ficoll	and	centrifuged		for	30	minutes	at	500xg.	For	liver	flow-through	cell	collection,	distal	lobes	of	the	liver	(not	containing	the	gallbladder)	were	removed	as	described	above	and	perfused	with	HBSS	and	gentamicin	at	high	pressure	over	a	funnel	where	a	solution	of	flushed	cell	could	be	collected	into	50	mL	conical	tubes.	Cell	solutions	were	filtered	over	sterile	4x4	medical	gauze	and	were	centrifuged	for	10	minutes	at	500xg.	After	filtering,	the	cell	solution	was	layered	over	Ficoll	and	centrifuged	for	30	minutes	at	500xg.	For	both	tissue	derived	and	flow-through	cell	collection	methods,	buffy	coats	were	collected	after	Ficoll	separation	and	washed	with	HBSS	and	complete	RPMI.						
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Cytotoxicity	Assay:		These	assays	were	performed	as	previously	described	in	Powell	et	al.	2016.	In	summary:		
Labeling	of	Tumor	Target	Cells:		K562	cells	(ATCC	–	CCL-243)	were	maintained	at	7%	CO2	and	37°C	in	complete	RPMI.	On	assay	day,	cells	were	counted	and	200uCi	chromium	(Cr	51)	was	added	dropwise.	The	cells	were	incubated	for	80	minutes	at	7%	CO2	and	37°C.	The	Cr	51	labeled	target	cells	were	washed	thrice	with	complete	RPMI	to	remove	excess	Cr	51	and	recounted.	Target	cell	solutions	were	diluted	to	2x105	cells/mL	and	50	µL	of	(1x104)	cells	was	added	to	all	wells	of	96	well	plates	with	pre-plated	PBMC’s.	As	PBMCs	were	plated	at	concentrations	of	1x	105,	2x	105,	or	4x	105cells	per	well	respectively	resulting	in	10:1,	20:1,	or	40:1	effector:target	ratios.	Plates	were	incubated	6	hours	at	37°C		and	7%	CO2.		
Harvesting	of	Plates:		Total	release	wells	(to	determine	maximum	lysing	possible)	were	lysed	with	10%	Triton-X	and	plates	were	centrifuged	at	200	rpm	for	5	min.	Each	well	had	120	µL	of	supernatant	collected	into	separate	counting	tubes	which	were	used	to	determine	Cr51	present	using	a	gamma-counter	(Gamma	trac	1191,	TM	Analytic	Inc.,	ElkGrove	Village,	IL).	Counts	per	minute	(CPM)	were	recorded.	Triplicates	were	averaged	to	determine	percent	cytotoxicity	as	follows:		Percent	Cytotoxicity	=	100	x	(CPM	experimental	average)-(CPM	spontaneous	release)												 	 	 	 							(CPM	total	release)-(CPM	spontaneous	release)		
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Flow	cytometry:	Data	was	analyzed	using	Flowjo	(V.10.1).	
Surface	Staining:	We	describe	NK	cells	having	a	CD16+,	SWC3a/CD172-	cell	surface	phenotype.		After	cell	counts,	1x105-3x105	live	PBMCs	were	diluted	in	Phosphate	Buffered	Saline	(PBS)-	Sodium	Azide	(0.05%)	(PBS-Azide)	and	stained	using	titered	mouse,	anti-pig	CD16	(IgG1,	AbD	Serotec-Cat#	MCA1971),	a	mouse	anti-pig	SWC3a/CD172	(IgG2b,	BD	Biosciences-Cat	#553640),	and	heat-inactivated	swine	serum	for	blocking.	Secondary	antibodies	used	were	goat	anti-mouse	IgG1-	(Southern	Biotech-Cat#1072-09)	and	goat	anti-mouse	IgG2b-	(Southern	Biotech-Cat#1090-02)	respectively.	Cell	solutions	were	washed	again	with	PBS,	and	fixed	with	a	2%	formaldehyde/PBS	solution	and	submitted	to	the	Iowa	State	University	Flow	Cytometry	Facility	for	flow	analysis	on	a	BD	Biosciences	FACSCanto	II	(San	Jose,	CA).	
Intracellular	staining:	PBMCs	were	treated	with	a	protein	transport	inhibitor	(BD	GogliPlug,	Cat#	555029)	for	6	hours	prior	to	staining	(1	µL	per	106	cells).	Cells	were	washed	with	PBS-Azide	and	were	surface	stained	for	CD16	(as	described	above)	and	then	simultaneously	permeabilized	and	fixed	using	kit	instructions	(BD	Cytofix/Cytoperm	Cat#	555028).	Cells	were	then	stained	using	directly	conjugated	anti-perforin	(BD	Pharmingen	Cat#	563762)	and	anti-IFN-g	(FITC)(Cat	#	554700).		
Statistical	Analysis:	
Statistical	analysis	of	ear	thickness:	Cohorts	were	analyzed	with	R	(R	Core	Team,	2016).	Basic	linear	fixed-effects	models	were	fit	for	all	cohorts.	The	following	models	were	run	for	each	of	the	four	cohorts	with	the	
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number	of	levels	given	in	parentheses.	Type	III	ANOVA	tests	were	used	for	all	effects.	LSmeans	and	associated	contrasts	(i.e.	differences	in	LSmeans)	were	calculated	from	the	lsmeans	package	in	R	(Lenth,	2016).			
21	day	Model:	Ear	Thickness	(increase	from	time	0)	=			Sex(2)+(SCID	status)(2)+	(challenge	treatment)(2)	+(sensitization	treatment)(3)+		(challenge	treatment)*(sensitization	treatment)+	e	
11	day	Model:	Ear	Thickness	(increase	from	time	0)	=		Sex(2)	+	(SCID	status)(2)+	(challenge	treatment)(3)	+	(Ear	Location)(4)+		
(sensitization	treatment)(2)	+	(challenge	treatment)*(sensitization	treatment)+	e		Sex	was	the	effect	of	either	castrated	males	or	female	pigs;	SCID	status	was	the	effect	of	SCID	or	non-SCID	genotype;	ear	location	was	the	effect	of	each	location	A,	B,	C,	or	D	(2	on	each	ear)	for	the	11	day	model	(not	applicable	to	21	day);	challenge	treatment	was	the	effect	of	vehicle,	OXA,	or	DNFB	injection	in	the	ear;	sensitization	treatment	was	the	effect	of	either	vehicle	or	DNFB	injection	on	the	back.			
Statistical	analysis	of	Percent	Cytotoxicity	and	Tumor	Target	Killed	per	NK	Cell:	Basic	least-squares	models	were	fit	with	the	ls	function	in	R	(R	Core	Team,	2016;	equivalent	to	PROC	GLM	in	SAS).	Type	III	ANOVA	tests	were	used	for	all	effects.	LSmeans	and	associated	contrasts	(i.e.	differences	in	LSmeans)	were	calculated	from	the	lsmeans	
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package	in	R	(Lenth,	2016).		Significance	was	evaluated	with	a	p-value	≤	0.05.	Initially,	a	full	model	was	fit	with	all	terms	up	to	a	5	day	interaction	of	all	fixed	effects.	To	select	a	more	parsimonious	model,	the	step	function	was	utilized	with	the	“both”	option	(forward	and	reverse	selection)	to	select	a	model	subset.	BIC	was	utilized	in	the	selection	criteria.	The	final	models	utilized	were	as	follows:		
Percent	Cytotoxicity	Model:	Percent	Cytotoxicity	(%)	=		Status	+	HaptenTRT	+	CellSource	+	Dilution	+	CellTRT	+	Status:HaptenTRT	+	Status:CellSource	+	Status:CellTRT	+	CellSource:CellTRT	+	Dilution:CellTRT	+	Status:CellSource:CellTRT	+	e		
Tumor	Target	Killed	per	NK	Cell		Model:	Tumor	targets	killed	per	NK	cell	(TTKpNK)=	Status	+	CellSource	+	CellTRT	+	HaptenTRT	+	Status:CellSource	+	CellSource:CellTRT	+	HaptenTRT:CellTRT	+	HaptenTRT:CellSource	+	HaptenTRT:CellTRT:CellSource		SCID	status	was	the	effect	of	SCID	or	non-SCID	genotype;	HaptenTRT	was	the	effect	of	the	combination	of	back	sensitization	and	ear	challenge	(VV,	VD,	or	DD);	CellSource	is	the	effect	of	the	tissue	(blood	or	liver);	Dilution	was	the	effect	of	the	effector	to	target	ratio	(10:1,	20:1,	or	40:1);	and	CellTRT	was	the	effect	of	either	IL-2	or	media.				
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Results	
	In	normal	swine	it	was	determined	that	pigs	will	have	significantly	higher	ear	swelling	in	response	to	an	ear	injection	of	the	hapten	they’ve	previously	been	sensitized	with	on	the	dorsal	back	(Chapter	6).		Results	are	reported	as	the	LSmeans	of	ear	thickness	difference	from	time	zero,	and	the	interaction	of	(challenge	treatment)*(sensitization	treatment)	is	evaluated	for	significance.	These	results	compare	SCID	pigs	and	non-SCID	littermates	that	had	been	sensitized	with	DNFB	and	challenged	with	DNFB	(DD)	or	vehicle	sensitized	and	challenged	DNFB	(VD).	Contrary	to	previous	results	in	normal	pigs,	the	SCID	pigs	did	not	show	significant	hapten	specific	swelling	for	sensitization	periods	of	11	days	(p-value=	0.421),	or	21	days	(p-value=	0.102	with	increased	VD	pig	ear	swelling	over	DD	ears)	(Fig	1).		Since	the	ISU	SCID	pig	is	void	of	T	and	B	cells,	we	analyzed	histology	ear	sections	from	SCID	animals	to	look	for	lymphocyte	infiltration	that	would	be	indicative	of	NK	cell	migration	to	challenge	ear	site.	In	a	very	preliminary	analysis,	the	ISU	Pathology	department	evaluated	DD,	DV	(DNFB	sensitized,	vehicle	challenged),	VD,	and	VV	(vehicle	sensitized,	vehicle	challenged),	ear	sections	on	a	0-4	point	scale	for	infiltrating	lymphocytes,	thrombosis,	and	necrosis	(see	Table	1).	Unexpectedly,	the	DD	and	VD	ear	sections	had	the	lowest	infiltrating	lymphocytes,	but	as	expected	with	the	injection	of	toxic	DNFB,	had	the	highest	scores	of	thrombosis	and	necrosis	(Table	1).		 To	evaluate	whether	NK	cells	from	SCID	animals	were	being	activated	among	hapten	treatments,	we	measured	the	percent	cytotoxicity	of	PBMCs	and	isolated	liver	cells	from	DD	and	VD	treated	animals	from	SCID	and	non-SCID	littermates.	Effector	cell	
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solutions	were	tested	for	lysis	ability	against	K562	target	cells	at	10:1,	20:1,	or	40:1	effector	to	target	ratios	(E:T	ratios).	Current	activation	states	of	effector	cells	were	analyzed	in	an	media	alone	environment	while	response	to	activating	agents	were	determined	through	supplementation	of	IL-2	(Fig	2).	PBMCs	nor	liver	cells	lysed	tumor	targets	with	media	alone	(Fig	2AC),	but	all	responded	to	IL-2	activation	(Fig	BD)	and	were	not	different	between	DD	and	VD	sources	for	non-SCID	(Fig	2AB)	or	SCID	(Fig	2CD)	cells.	Although	not	statistically	significant,	livers	cells	from	non-SCID	pigs	showed	a	possible	heighted	activation	with	media	alone	as	expected	from	results	described	in	Appendix	A	(Fig	2A).	Percentages	of	CD16+	SWC3a-	vary	in	NK	cells	from	SCID	PBMCs	and	isolated	liver	cells	of	hapten	treated	animal	as	seen	in	Table	2.	Liver	samples	contain	significantly	more	NK	cells	than	PBMCS	(p-value=0.05),	and	thus	comparisons	between	PBMC	and	liver	percent	cytotoxicity	should	not	directly	be	made.	To	account	for	this,	we	determine	the	percent	CD16+	SWC3a-	NK	cells	in	each	sample	and	calculate	the	number	of	tumor	targets	killed	per	NK	cell.	This	data	is	normalized	in	Fig	3	and	adjusted	Lsmeans	are	reported.		The	non-SCID	animals	follow	trends	identified	in	Appendix	A	where	liver	sourced	DD	cells	potentially	show	heighten	activation	with	media	alone	(Fig	3A),	but	all	non-SCID	cells	responded	as	expected	to	activating	IL-2	stimulation	(Fig	3B).	There	was	no	significant	difference	in	tumor	target	cells	killed	per	NK	cell	between	SCID	DD	and	VD	PBMCs	or	liver	cells	for	media	alone	(Fig	3C)	or	with	IL-2	supplementation	(Fig3D).			 Lastly,	to	investigate	the	activation	state	of	NK	cells	by	cytokine	production,	we	analyzed	intracellular	staining	of	DD	and	VD	SCID	liver	cells	for	IFN-g	(Fig	4A)	and	perforin	(Fig	4B).	Although	production	of	each	cytokine	was	determined,	levels	were	not	different	between	hapten	treated	DD	or	VD	groups	for	SCID	animals	(Fig	4A,B).	Also	for	comparison	
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is	SCID	DD	and	non-SCID	DD	pig	production	of	IFN-g	and	perforin	(Fig	4C,D),	illustrating	that	SCID	animal	liver	cells	are	being	activated	at	levels	similar	to	that	of	normal	animals.		
Discussion		 Collectively,	we	consider	these	results	as	preliminary	evidence	that	immune	components	not	present	in	the	natural	Artemis	SCID	pig	are	important	in	the	mechanism	of	hapten	specific	memory.	Although	we	know	from	previous	studies	and	from	results	presented	herein	SCID	NK	cells	can	be	activated	to	kill	tumor	targets	and	produce	IFN-g	and	perforin,	we	find	no	evidence	of	hapten	treatment	specific	activation	that	appears	to	be	present	in	normal	animals.		There	are	several	plausible	factors	that	could	contribute	to	the	lack	of	distinguishable	CHS	memory	in	the	Artemis	SCID	pig.	First,	because	the	mechanism	of	NK	cell	training	is	still	largely	unknown,	it’s	possible	that	signaling	components	(such	as	certain	cytokines)	are	not	produced	in	the	SCID	environment	are	crucial	to	the	education	of	‘memory’	NK	cells	or	to	the	mechanism	to	which	trained	cells	travel	to	the	liver	and/or	migrate	to	the	site	of	re-challenge	(the	ear).	We	established	previously	that	the	SCID	NK	cells	are	functional	in	vitro.	While	SCID	NK	cells	can	respond	to	activation,	produce	cytokines,	and	kill	tumor	targets	in	vitro,	it	is	possible	that	additional	defects	exist	within	the	SCID	NK	cell	that	could	hinder	their	full	function	in	vivo.	Lastly,	although	contrary	to	the	SCID	mice	literature,	it’s	possible	the	memory	response	is	influenced	by	variations	of	NK	cells	mediated	by	the	specific	type	of	SCID	model	being	used.	Interestingly,	studies	deeply	phenotyping	NK	cell	function	have	uncovered	that	RAG	knockout	mice	have	hyper	cytotoxic	
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sensitivity	as	well	as	weakened	proliferation	and	survival	of	NK	cells	under	challenge	stress	(Karo	et	al.	2014).	The	O’Leary	et	al.	(2006)	paper	utilizes	such	RAG	SCID	mice	models	and	shows	nearly	equal	hapten	specific	swelling	(indicative	of	memory)	to	mice	with	both	adaptive	and	innate	immune	cells.	By	contrast,	the	study	led	by	Majewska-Szczepanik	et	al.	(2013),	uses	classic	SCID	mice	with	a	DNA-dependent	kinase	catalytic	subunit	(DNA-PKcs)	defect,	and	shows	existent,	significant	memory	response	of	NK	cells,	but	one	that	is	significantly	reduced	compared	to	the	immune	competent	BALB	control	mice.	This	would	be	expected	considering	the	well-established	contribution	of	T	cells	to	a	CHS	memory	response.	Although	both	the	RAG	and	DNA-PKcs	SCID	mice	have	T-B-NK+	cellular	phenotype	they	portrayed	very	different	degrees	of	response	to	hapten	specific	memory.	The	exploration	of	the	lack	of	memory	response	in	the	ISU	SCID	pig	could	open	the	next	chapter	in	swine	NK	memory	characterization.			 Any	of	these	hypotheses	would	shed	light	on	crucial	components	of	the	mechanism	of	hapten	specific	CHS	memory	training	of	NK	cells	and	suggests	the	Artemis	ISU	SCID	pig	is	a	valuable	model	for	investigating	the	relationship	between	the	innate	and	adaptive	immune	system	as	well	as	the	new	paradigm	of	innate	memory.	The	next	step	for	assessing	the	memory	response	in	the	SCID	animals	is	to	repeat	experiments	in	the	sterile	bubble	environment.			 	
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Figures	
	Figure	1	:	Ear	thickness	does	not	show	hapten	specific	memory	inflammation	
response	in	ears	of	SCID	pigs.	For	sensitization	periods	of	11	and	21	days	7-30	kg	SCID	pigs	had	DNFB	or	4:1	acetone:olive	oil	vehicle	injected	or	applied	dropwise	to	their	backs.	Animals	were	re-challenged	11	or	21	days	with	intradermal	ear	injections	of	DNFB,	OXA,	or	respective	vehicle.	Shown	here	is	the	LS	means	of	ear	thickness	difference	from	time	zero	for	sensitization	periods	of	(A)	11	days,	or	(B)	21	days.	The	interaction	of	(back)	x	(ear)	treatments	were	evaluated	for	significance	of	hapten	specific	memory.	With	a	threshold	p-value	<0.05,	11	day	(p-value=	0.421),	and	21	day	(p-value=	0.102	(opposite	of	expected	direction))	sensitization	periods	showed	no	evidence	of	hapten	specific	ear	swelling.	Bars	represent	standard	errors.				 	
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		Figure	2	:	Cytotoxicity	of	mononuclear	liver	cells	and	PBMCs	from	hapten	treated	
SCID	animals	and	non-SCID	littermates.	Percent	cytotoxicity	of	PBMCs	(Blood)	and	mononuclear	liver	cells	(Liver)	from	DNFB	sensitized,	DNFB	challenged	(DD)	and	vehicle	sensitized,	DNFB	challenged	(VD)	non-SCID	(A,B)	and	SCID	(C,D)	pigs.	Samples	were	tested	against	K562	target	cells	in	media	alone	(A,C)	or	with	IL-2	supplementation	(B,D)	at	10:1,	20:1,	40:1	effector	to	target	ratios.	Samples	are	presented	from	the	21	day	sensitization	period.	Bars	represent	standard	errors.						
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		Figure	3	:	Tumor	target	killed	per	CD16+	SWC3a-	NK	cell	in	SCID	isolated	liver	cells	
from	hapten	treated	animals.	Percent	cytotoxicity	(Fig	2)	normalized	for	number	of	NK	cells	present	in	cell	preps	of	liver	cells	from	DNFB	sensitized,	DNFB	challenged	(DD),	and	vehicle	sensitized,	DNFB	challenged	(VD)	treated	non-SCID	(A,B)	and	SCID	(C,D)	pig	littermates.	Samples	were	tested	against	K562	target	cells	in	media	alone	(A,	C),	or	with	IL-2	activation	(B,	D).	Samples	are	presented	from	the	21	day	sensitization	period.	Bars	represent	standard	errors.				
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	Figure	4	:	No	differences	in	NK	production	of	perforin	and	IFN-g	from	liver	cells	of	
hapten	treated	SCID	animals.	Intracellular	staining	of	DNFB	sensitized,	DNFB	challenged	(dark	gray,	DD)	SCID	pigs	and	vehicle	sensitized,	DNFB	challenged	(light	gray,	VD)	SCID	pigs	for	IFN-g	(A)	and	perforin	(B)	showing	no	differential	activation	for	the	DD	vs	VD	SCID	animals.	For	comparison	is	shown	IFN-g	(C)	and	perforin	(D)	for	SCID	DD	vs	non-SCID	DD	treated	pigs.	Black	peaks	denotes	isotype	control.			 	
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Tables		Table	1:	Histology	of	ear	tissue	samples	from	SCID	animals	(21	day	sensitization	
period).	Infiltrating	lymphocytes,	thrombosis,	and	necrosis	scored	on	a	0-4	scale	by	ISU	Pathology	Department	pathologist.	Portrayed	is	an	n=1	per	treatment.			 			 	Treatment		 Lymphocyte		infiltrate	 Vasculitis/	thrombosis	 Necrosis	VV	 1	 1	 1	VD	 0-1	 4	 4	DV	 2	 3	 1	DD	 0-1	 4	 4	
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Table	2:	Percentages	of	CD16+	SWC3a-	NK	cells	in	SCID	PBMCs	and	isolated	liver	cells	
of	hapten	treated	animals.	Cells	from	blood	and	liver	cells	from	DNFB	sensitized,	DNFB	challenged	(DD),	and	vehicle	sensitized,	DNFB	challenged	(VD)	pigs	were	stained	from	trials	over	11	and	21	day	sensitization	periods.				
Treatment	 %NK	PBMCs	 Standard	Error	 %NK	Liver	cells	 Standard	Error	DD	 32.9	 ±	2.61	 46.23	 ±	8.14	VD	 22.28	 ±	4.62	 42.03	 ±	15.39				
